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Abstract 
Thrombotic complications often occur in stenosed coronary artery, causing permanent damage 
and even death. Although the exact factors and events leading to thrombus formation are not 
entirely known, the local rheological conditions as well as the different tendency for clotting of 
the blood of each individual are considered to have an important role both in progress of the 
disease and the relevant complications. Recently a statistical correlation between the exact 
location of the stenosis and the evolution of the disease has been reported [1]. In this work we 
investigated whether this connection can be predicted by computational simulations.  
For this purpose, a simplified model for blood coagulation, focusing mainly on thrombin 
activation, has been formulated in three steps. A phenomenological sub-model for thrombin 
generation was developed and calibrated, based on clinical tests (not laboratory experiments). 
The model was proved capable of reproducing with acceptable accuracy the rate of thrombin 
generation for blood samples from individuals with different thrombogenic potential, including 
haemophilia cases. A second sub-model for platelet aggregation on reacting surface was 
developed and calibrated in order to reproduce experimental data [2]. Finally, the whole 
coagulation model was adapted for application under flow conditions, based on the threshold 
behaviour of blood coagulation under flow in respect to wall shear rate and reacting surface 
stream-wise length [3]. 
In order to test the developed models, 3 groups of left anterior descending (LAD) geometry 
models have been constructed based on the location of the stenotic lesion. Each group consisted 
by geometries with different degrees of stenosis. Two of these groups (named MI1 and MI2)  
were statistically assessed as of higher risk for complications with the third one (STA) 
considered safer. Transient flow simulations were performed for these three groups, with 
representative coronary flow conditions.   Flow was resolved by employing the incompressible 
Navier-Stokes equations for Newtonian fluid, which are considered to describe with acceptable 
accuracy the blood motion in arteries. Processing of the results have shown that appropriate 
surface quantities can distinct between high and low complication risk cases. Finally, based on 
the results of the healthy model and on previous works, a set of flow-based risk indices was 
proposed in order to distinguish among arbitrary geometries the ones that are more likely to 
lead to coronary artery disease complications. 
Finally the developed model for coagulation was applied in selected (based on the flow 
simulation results) geometries for the three groups, under the previously calculated pulsating 
blood flow conditions. The simulation results have indicated that in geometries with higher 
degree of stenosis and higher wall shear values (regardless of the geometric group considered) 
the propagation of thrombin is slower. All MI2 models had similar behaviour: low average 
thrombin concentration and production rate with high thrombin concentration restricted in 
specific sites. On the contrary, in STA and MI1 models we could not identify a uniform pattern. 
In most cases high risk sites (elevated concentration and production rate of thrombin) were 
found near the wall at the areas of recirculation vortices formed after the stenotic lesion. 
Although this study showed that computational simulations can be used for the assessment of 
stenosed LAD and probably coronary arteries in general, it also showed that in order to obtain 
results that can be safely trusted for diagnosis the method should be applied on a large number 
of real geometries from patients with known disease outcome. 
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Abbreviations 
ACS: Acute Coronary Syndrome 
APC: Activated Protein C, inhibitor of coagulation 
ATIII: Antithrombin III, inhibitor of coagulation, most important inhibitor of thrombin. 
CAD: Coronary Artery Disease 
CAI: Coagulation Activation Index 
Cmax: Maximum concentration of thrombin in TGA assay. 
CFD: Computational Fluid Dynamics 
CHD: Coronary Heart Disease 
ETP: (Estimated thrombin potential) The integral of thrombin concentration in respect to time 
in TGA or in other words the area underneath the curve representing thrombin concentration vs 
time 
 fII,.. fXIII: Coagulation factors in non-activated form (zymogenes) f))a,… fXIIIa: Coagulation factors in activated form (enzymes) 
Ht: Haematocrit, volume fraction of red blood cells in blood. 
LAD: Left Anterior Descending (artery) 
MI1, MI2: Groups of stenosed LAD geometrical models with higher complication risk 
OSI: Oscillatory Shear Index. 
RBC: Red Blood Cells 
RRT: Relative Residence Time. 
STABLE: Group of stenosed LAD geometrical models with lower complication risk 
TAWSS: Time Averaged Wall Shear Stress 
TFPI: Tissue Factor Pathway Inhibitor, inhibitor of the coagulation process. 
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TGA: Thrombin Generation Assay 
Tlag: Time until thrombin production reaches amplification phase in TGA 
Tmax: Time until thrombin reaches maximum concentration in TGA 
Tp: Propagation time, the time interval between the triggering and downstream propagation of 
thrombin. 
WBC: White Blood Cells 
WSS: Wall Shear Stress 
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Chapter 1 Introduction 
1.1  Coronary artery disease: impact and complications 
Coronary Artery Disease (CAD) or Coronary Heart Disease (CHD) is the formation of plaques on 
the interior walls of human coronary artery. The development and growth of these plaques, 
known as atheromatous plaques, initially results in the reduction of the lumen of coronary 
vessels. The progression of CAD however, is often followed by sudden complications known as 
acute coronary syndromes (ACS), when blood clots (or thrombi) are formed in the area of the 
plaque after erosion or rupture. The thrombus occludes the supply of blood and oxygen to the 
heart muscle. When coronary artery or one of its branches is permanently blocked the part of 
the myocardium that depended on the specific branch for blood and oxygen supply is at the risk 
of dying due to lack of oxygen, a situation known as myocardial infarction (MI).  
There are several different conditions classified under the term MI. They are divided in two 
main categories based on the results of the electrocardiogram (ECG), STEMI and NSTEMI. 
STEMI cases usually correspond to total blockage of a part of the coronary network and the ST 
part of the ECG curve of the patient presents an elevation (STE) compared to the ECG curve of a 
healthy person. Non-STEMI or NSTEMI usually corresponds to partial blockage and no elevation 
of the ST part of the ECG is observed (NSTE) compared to the ECG curve of a healthy person. In 
Figure 1-1: The different cases of ACS. (Image taken from 
http://www.nottingham.ac.uk/nursing/practice/resources/cardiology/acs/arteries.php) 
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the cases where the occlusion is transient or of smaller degree (unstable angina) the part of the 
muscle depending on the specific vessel does not infarct (die) due to lack of oxygen supply but 
may malfunction (Figure 1-1). On the other hand, in a large number of cases the progress of the 
disease is mild or slow, and the symptoms are limited to chest pain or discomfort and breathe 
shortening (stable angina) occurring only when the patient is under physical or psychological 
stress conditions. 
The complications of CAD are the leading cause of death worldwide, as they are responsible for 
one out of six deaths in the USA [4], 13% of men and 6.5% of women under 65 years old and 
about 21% of total deaths [5]. They are also responsible for the 10% of lost life years due to 
disability in Europe [6]. The consequences of CAD complications show how important is to 
distinct the cases that are more likely to lead to ACS and decide on the optimum 
treatment. Currently, the routine non-invasive medical tests performed for CHD (physical 
condition, blood pressure and haematological tests) do not lead to accurate diagnosis of the 
disease. At the same time, the available imaging techniques used for coronary network are 
either invasive and therefore cannot be used as a routine check-up (Coronary Angiography), or 
do not achieve the desired accuracy and are quite expensive (Computed Tomography and 
Intravascular Ultrasound). Even when the imaging techniques are used, they provide only 
geometric information of the stenosed area; they cannot give predictions on the possible 
evolution of CAD, therefore the decision on the optimum treatment is left to the doctorǯs 
judgment by experience.  
 
 
Figure 1-2: Thrombus formation in occluded coronary after rapture of the plaque (left) 
and stable stenosis without thrombotic complications (right).(images: M.H. Davidson, 
American Journal of Managed care) 
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1.2 Risk factors, symptoms and treatment 
Specific behaviours and health characteristics have been identified as major or contributing risk 
factors for CAD, mainly via statistical correlations, with some of them probably being 
interrelated. Some of these factors can be controlled up to a point without the involvement of 
medical procedures. The non-physiological concentration of cholesterol and other lipids in 
blood, high blood pressure, diabetes, inactivity and obesity, and of course smoking, considered 
as major risk factors, and psychological stress, not-healthy diet and alcohol, considered as 
contributing factors [7] are probably subject to adjustment by modifying the diet and the habits 
of the patient. On the other hand, a number of major risk factors are not subject to change via 
modification of the behaviour of the patient; these are the gender -after 40 years of age the risk 
for developing CAD is 49% for men and 32% for women-age for both genders and inheritance 
[4]. As part of the causes of CAD cannot be controlled so no matter how good work is done 
regarding the prevention of the disease and more importantly, as lots of cases of CAD by the 
time they are first diagnosed they already require intervention, a number of patients will at 
some point of their life be in the need of medical treatment for CAD, especially in the 
developed world where the average age is higher. 
While 64% of lethal cases in USA have no previous reported symptoms [4], in a lot of patients 
Figure 1-3: Revascularization with the use of 
catheter and stent (PCI).Image taken from: 
http://www.birlaheart.org/Research/clinical_res
earch.html 
Figure 1-4: Coronary bypass. Vessel grafts 
connect the aorta with a point distal the 
stenosis. Image taken from: 
http://uvahealth.com/services/heart/treatm
ent/14782 
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the reduction of blood supply to the myocardium (also called ischemia), especially during 
hyperaemia [8], gives some initial symptoms; pain in the chest related with physical activity or 
psychological stress, shortening of breath, and feeling of fatigue can function as a warning signs 
and lead a patient to seek for the appropriate medical examinations. Once a patient is diagnosed 
with CAD, the doctors have to choose between two options. The moderate one is to prescribe 
medical treatment (MT), usually drugs that prevent blood clotting and improve blood 
composition and reduce the heart load in order to relief the symptoms. At the same time they 
will advice the patient to adopt a number of life changes in order to reduce the risk of 
deterioration and perform regular medical check-ups.  
In other cases the doctors judge that a more drastic approach is required. Then the patient 
undergoes either non-surgical angioplasty or a surgery, both combined with anti-thrombotic 
medication. In the first case (Figure 1-3) reopening of the blocked artery is performed with the 
insertion of a flexible tube with an attached balloon; this method is known as Ǯpercutaneous 
coronary interventionǯ (PCI). When the balloon reaches the blocked location it is inflated and 
presses the plaque against the coronary walls. In some cases it is possible that a small mesh 
called stent is inserted in the previously stenosed location in order to hold the vessel walls in 
place. In the second case referred to as Ǯcoronary artery bypass graftingǯ (CABG) (Figure 1-4), a 
part of vessel from another part of the patientǯs body is used for the construction of an 
alternative route for the blood around the stenosed location. The vessel graft –as it is called- 
connects the aorta with a site of the coronary distal the stenosis. The choice of the treatment 
method (PCI, CABG or MT) is based on the severity of the stenosis -in what percentage is the 
lumen reduced and on how many sites- the classification based on the ECG and the general 
clinical image of the patient (symptoms, risk factors). The effectiveness of a treatment method is 
judged by the rate of survival and the following clinical events. The choice of the optimum 
treatment in respect to survival and complications expectancy is still under discussion [9]. 
Up to  2010, approximately 30 randomized controlled trials comparing the progress of patients 
undergoing either revascularization or MT  for different follow up times were published [10]. 
Analysis of the first 7 studies comparing CABG with medical treatment showed that patients 
that had undergone CAGB exhibited reduced mortality for a period 5 to 10 years [11]. A 
systematic review of the trials comparing PCI to medical treatment using 17 published 
randomized studies showed reduced mortality for patients that were subscribed to PCI [12] 
over an average period of 51 months compared to those who underwent MT. However, network 
analysis of the same studies showed no effect of PCI on the occurrence of severe complications 
compared to medical treatment [13] in accordance with the results of COURAGE trial which 
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included 2287 patients with an average 4.6 years follow up [14] [15]. A most recent meta-
analysis including 28 randomized trials performed between 1977 and 2007 showed that 
revascularization in general improves the survival rate of patients compared to medical therapy 
but not the rate of non-fatal myocardial infarction [16]. At the same time MASS II trial, after 
following 603 patients treated at a single institution for 5 years, observed no significant 
difference among the results of the three methods [17]. For the patients where 
revascularization is prescribed, the choice between PCI and CABG is mainly based on the 
complexity of the case. According to three [18] and five [19] year follow-up results of the 
SYNTAX study, CAGB seems to work better in cases with multiple occlusion sites with PCI being 
a better alternative for cases with single branch stenosis.  
To see the overall effectiveness of the treatment from a different perspective, in USA the 
statistical predicted number of recurrent events is approximately 36% of the number of the new 
events [4]. The same percentage of recurrent events was reported in a more detailed clinical 
study in Germany [20] performed using a smaller number of patients. In other words, 
approximately one out of three people who undergo treatment of any kind for CHD have a 
follow-up incident. Although the stenosed lesions are often characterized as culprit (the ones 
that require intervention) and non-culprit, the recurring events (total 20% in 697 monitored 
patients) in a period of three years were equally distributed among these categories [21]. The 
reported statistics on recurrent events include all ages including patients over 75 years and in 
general the total elimination of relapse seems utopic. However, the statistics show that there 
is room for further improvement of the decision making process regarding the choice of 
the treatment that will lead to better results, especially when keeping in mind that the two 
revascularization procedures have inherent complications; the graft sometimes is occluded, 
while thrombus is also formed on the stent after the procedure in some cases. Additionally, 
CAGB has also a small but considerable (about 1-3% in USA and UK) percentage of operating 
mortality, varying according to the special conditions of each case. It is of high importance the 
fact that both ACS and after-treatment complications are related to thrombus formation.  
As the appropriateness of revascularization in a large number of clinical scenarios, especially 
with low and intermediate risk findings is uncertain [22, 23], it is almost certain that some  
patients take the risk of an unnecessary procedure or surgery, while others are unintentionally 
deprived from  a necessary for their condition revascularization. It is possible that statistical 
analysis alone is not sufficient to indicate the optimum treatment in a patient specific manner. It 
may be more fruitful instead to find and determine some additional case specific criteria. 
These criteria should be able to be measured or calculated and expressed in numbers, in 
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the form of arithmetic risk indices, in a similar manner as the non-physiological concentrations 
of blood components or the results of haematological tests are expressed. The quantities chosen 
for monitoring and the resulting complication risk indices will be based on the underlying 
physical mechanism that leads to deterioration and complications while the final derivation of 
the physiological limits for each proposed quantity will be supported via statistical validation 
over a large number of patients. 
1.3 The role of geometry  
Besides the risk factors that have already been mentioned, there is at least another known 
parameter that seems to be related with the emergence and evolution of CAD, the geometrical 
shape of the coronary artery. The shape of the coronary is not an independent factor as it can be 
mainly attributed to heredity which has been included in the major risk factors, but it has some 
interesting characteristics that make it appealing in the pursuit of more specific risk factors and 
corresponding arithmetic risk indexes. Firstly, it is absolutely case specific and it seems there 
are significant differences between the shape of the coronary trees of different individuals 
(Figure 1-5), not just small details. Secondly, the coronary geometry is related to a number of 
parameters (some obvious and some more concealed) that are measureable and therefore 
suitable for defining arithmetic indexes. The apparent parameters that can be measured is the 
specific characteristics of the coronary vessels, such as curvature, length of specific segments, 
diameter and tapering, bifurcationsǯ location and bifurcation angles, provided that an accurate image of the patientǯs coronary artery is available.  
 
Figure 1-5: Left coronary trees of different patients (same view). Note the significant 
variation of the shape of the coronary arterial tree between different individuals 
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The not-so-obvious parameter that is decisively influenced (but not fully determined) by the 
geometry of the artery is the local flow field in stenosed coronary vessels near the area of the 
stenosis. While the exact flow conditions are also influenced by other factors such as the blood pressure, the exact viscosity of a personǯs blood (which can even vary for the same person 
during rest and hyperaemia), the shape of the coronary imposes a general pattern for the flow 
conditions that will prevail in a vessel. As it will be shown as part of the present Thesis, there is 
both experimental evidence and identified underlying mechanisms that relate the flow 
and the geometry of the vessels with the emergence and the progress of CAD and the 
formation of thrombus.  
The connection between the location of the plaque and the geometric characteristics of the 
vessel has long been indicated [24, 25]. Besides the surface effects of flow that depend on the 
exact location, the thickness of the vessel wall, which is not uniform, also depends on the 
coronary geometry; specific sites of the coronary wall (opposite bifurcations or at the external 
side of curvature) which are characterized by low values of wall shear are usually thicker 
(intima-media thickening) [26, 27] and this extra thickness is considered to predispose the 
specific locations to atherogenesis [28]. The general idea of using quantitative characterization 
of the coronary geometry as a dynamic risk factor for coronary disease [29] is under discussion 
for decades. Recently, statistical correlation between the location of the stenotic lesion and the 
incidence of acute coronary syndrome ACS [1, 30] has been reported. Events believed to occur 
previously of the final stages of the disease, such as rapture, erosion and thinning of the cap of 
the plaque [31], can also be related to mechanical factors (friction, residence time and stretching 
of vessel wall). But so far, it is has not been possible to quantitatively correlate the progression 
of CAD and the emergence of ACS with the shape of the coronary, while the available clinical 
information that leads to treatment decisions is often misleading or insufficient [22, 23]. An 
alternative new approach that to the best of my knowledge has not been suggested so far is the 
correlation of the geometry of the coronary of a patient to the overall risk of severe 
deterioration, using a number of blood flow-based indices.  
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1.4 The influence of flow  
As plaque development and thrombus formation are processes 
that mainly occur on the vessel wall, the basic flow-related 
quantities that are considered more important influence are 
wall shear stress τ and wall shear rate γ. These two quantities 
at a specific location of the flow are proportional (        
where Ɋ is the viscosity of the fluid a quantity with significant 
variations for blood depending on the conditions). Shear rate 
expresses the change of the velocity in a direction normal to the 
vessel wall (Figure 1-6) and therefore it is an indication of the 
velocity magnitude near the surface. As convection is the basic transfer mechanism of blood 
flowing substances, wall shear rate has long been correlated with the presence of atheroma in 
specific locations of human arteries [32]. Besides the supply of reactants, shear rate determines 
the velocity of the biomolecules and particles in the flowing blood as they pass near the vesselǯs 
wall. The magnitude of this velocity enables, facilitates or makes impossible certain interactions 
between the blood flowing substances and cells and the cells of the vessel wall, purely by 
affecting the residence time and the friction between flowing blood and endothelium cells. 
Different mechanical stimulation alters the behaviour the same holds for the cells of 
endothelium [33-36]. Recent insights on the properties of vessel walls showed that while under 
physiological conditions they are not thrombogenic, pathological flow conditions can alter this 
behaviour.  
Finally, another local factor considered of high importance for ACS is the nature of the 
atheromatous plaque, in terms of morphological characteristics and specific composition [31]. 
The assessment of the characteristics of the plaque up to a point is possible using advanced 
medical imaging techniques (multi-slice computed tomography or intravascular ultrasound), 
and there is a number of studies that have reported such results in the last decade (indicatively 
[37-42]). However, as this technique is invasive and of high cost it is not included in the routine 
clinical practice. The morphological characteristics of the plaque though, as vulnerability [43], 
and even the composition [44] are also related to flow and the same holds for the progress of 
CAD [45]. So while imaging techniques provide information for a specific time instance 
and at a high cost, a quantitative correlation between flow and the evolution of CAD can 
serve both as diagnostic and predictive tool. 
 
Figure 1-6: Schematic 
representation of shear rate 
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1.5 Blood flow and thrombus formation 
Formation of blood clot or thrombus occurs after the initiation of the haemostatic process 
within the circulatory system. This happens due to an initial stimulation, usually an injury on 
the wall of a vessel. In the case of CAD the stimulus is believed to be the rupture or erosion of 
the atheromatous plaque. The final outcome of the process of thrombus formation is a jelly-like 
mass composed mainly by platelets and a cross-linked protein called fibrin, also known as 
activated factor I of coagulation. Fibrin forms a mesh (Figure 1-7a), and in this mesh are also 
trapped other blood flowing particles as red blood cells and white blood cells (Figure 1-7b). 
Typically in arteries, thrombi consist mainly by platelets (white thrombi), while in veins the 
dominant component is red blood cells (red thrombi). Between the initial stimulation and the 
formation of thrombus take place a large number of biochemical reactions and cell responses. 
The process of thrombus formation will be described in more detail in the next chapter. 
Most of the cells and reacting substances participating in the coagulation are transported in the 
flowing blood. Therefore, flow determines the supply, residence time and abduction over the 
reacting site and subsequently the concentrations for these species. This is done via the balance 
of convection and diffusion mechanisms and via the flow dominated collisions of circulating 
cells and particles [46, 47]. So, at first sight stagnation points and areas with reduced flow look 
suspicious for thrombus formation as these conditions allow more time for interaction between 
blood-transported substances and the wall of the vessel or the surface of the plaque. 
a                                                                          b 
Figure 1-7: (a) Fibrin mesh as depicted by scanning electron microscopy Image: 
http://www.leeds.ac.uk/light/research/cdr/mechanisms_of_thrombosis.html (left) (b) 
Scanning electron microscopy image of fibrin mesh (blue) with trapped platelets 
(purple) and red blood cells (red)Image: Yuri Veklich and John W. Weisel, University 
of Pennsylvania School of Medicine (right) 
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Nevertheless, studies on the effect of flow on coagulation mechanism revealed that increased 
flow can also contribute to the initiation of thrombus formation. Flow induced mechanical stress 
alters the behaviour of blood flowing particles and substances related to thrombus formation, as 
von Willebrand factor [48] and platelets [49]. High values and extreme variations of shear stress 
can cause activation of platelets [50-52], increase of Ca levels of blood (indicative of platelet 
activation and required mineral in different stage of coagulation) [53], aggregation of platelets 
to each other and to vessel wall [54] and generally initiation of the coagulation mechanism [46]. 
So especially for the cases of arterial stenosis where shear rates in the stenotic lesion is 
increased upstream the peak of the stenosis, triggering due to high values of shear stress may be 
equally important factor to the effect of transport on the concentration of the reactants. 
Therefore, knowledge of the flow field in a stenosed, stented or grafted coronary artery 
and generally in any susceptible vessel can provide information on whether it is more or 
less possible for a thrombosis to occur. The tools that can classify different cases as of 
different risk for thrombosis it is not necessary (and probably it is infeasible as well) to model 
the whole process of thrombus formation from the initiation to the total occlusion. It is enough 
to provide some well-defined flow related information that will be based on the process of 
coagulation, provided that this information will be expressed in a manner that will allow 
statistical validation and correction. 
1.6 Basis and aims of this work 
From the data presented so far it is clear that the choice of optimum treatment for CAD is a 
problem of high importance and at the same time far from understood. While the 
diagnostic methods and applied treatments are constantly improving and this leads to a 
reduction of annual death rate due to CHD both in USA[4] and Europe [5], it seems that there is 
still need and space for improvement. More specifically, it seems that the assessment of each 
specific case is based mainly on the current clinical image/condition of the patient, and 
there is no tool able to perform even a rough estimation of the possible evolution. While 
this looks perfectly fine for patients with acute symptoms or patients with severe and multiple 
stenosis that obviously require immediate intervention of some kind, in patients with low but 
not negligible degree of stenosis though and chronic CAD this static perception of the case does 
not help in making a decision on whether the patient requires some kind of intervention or 
medical treatment is preferable. Trying to base such decision only on the statistics of random 
controlled trials and meta-analysis underestimates the importance of specific conditions 
prevailing for each patient. 
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The shape of the coronary artery plays decisive role on the evolution of CAD. However, to our 
knowledge there are very few studies that attempt to achieve a quantification of the effect of 
this risk factor. To be more accurate, there have only been some efforts for statistical 
classifications, i.e. to average the characteristics of stable and dangerous cases and to divide the 
stenosed coronaries in groups, depending on the position of the stenosis [1]. But there is no 
advance in studies trying to extract case specific indexes that could be calculated for each 
case and afterwards be statistically calibrated and evaluated. Such a case specific 
assessment that would actually provide some kind of prediction based on the geometry could 
also help on the choice of the optimum therapeutic procedure applied to each patient.  
As the role of geometry seems to influence the progress of CAD via the imposition of different 
flow conditions at different sites of the artery, flow simulations appear to be a very 
promising and novel way to assess different geometries in respect to the risk of ACS 
emergence. Note that, in order such an assessment to be performed, it is not necessary for the 
simulation method to reproduce every detail of the flow field and take into account all the 
complex physical parameters involved in this problem, such as vessel wall elasticity, vessel wall 
movement and exact rheological behaviour of blood. It will be more than enough if, by using a 
simplified method for the simulations we can extract a set of numerical indices that 
afterwards will be validated and calibrated by applying the method on a large number of 
real cases.  
As explained earlier, flow also effects the formation of thrombus, which is the underlying 
mechanism behind ACS and post-treatment coronary complications. Flow simulation techniques 
can be coupled with a model that describes thrombus formation, and indeed in a patient specific 
manner. Such a tool will be able to classify different patients according to their specific 
thrombogenetic potential, as it is determined by the coronary geometry and haematologiacal 
characteristics. The results will be expressed as a group of arithmetic indices. In order to 
perform such simulations the simplifications are inevitable due to the complexity of the 
processes, the large number and inaccessible nature of influencing factors, the different 
temporal and spatial scales that are involved. To give an indicative example, platelets have a 
typical dimension of 2Ɋm, coronary artery has a typical diameter of 4mm. Glycoproteins are 
expressed at non-determinable locations on the surface of platelets after activation and interact 
with circulating proteins with typical dimension of 10nm with the orientation of these bio-
molecules affecting the interaction. In terms of time, the cardiac pulse is of the order of 1sec. 
The time scale of coagulation in vitro is of the order of 10 min, while the onset of CAD symptoms 
and the variations of the heart activity of a human follow a circadian circle (24h). In order to 
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confront this difficulty most contemporary studies move towards the application of biological 
models of increasing complexity on two dimensional and relatively small computational 
domains. The route followed in this study is somehow different. The models were developed in 
a way that the complexity is determined by the amount of the available clinical data instead of 
trying to exploit the available laboratory data. This approach leads directly to patient specific 
simulations with relatively simple models. As throughout this work the details of the models 
including simplifications are thoroughly explained, the application of the method in cases other 
than the ones used in this study is straightforward. This is important as in order for any 
simulation results in these subjects to have comparative value and be suitable for 
statistical validation, they should have been obtained using the exact same methods. 
Throughout the chapters of this Thesis, the following tasks will be performed. In Chapter 2, a 
relatively brief literature review on the state-of-the-art knowledge on blood coagulation and 
formation of thrombus is given, (as a search for articles related only to tissue factor, a substance 
that triggers the coagulation cascade will result to over 10,000 publications, a detailed review of 
all available literature on thrombus formation is infeasible). In the same chapter a review of the 
rheological properties of blood and the difficulties and techniques related to simulations of 
blood flow will be given. Following that, a simplified model for thrombin generation and 
thrombus formation is presented in Chapter 3, based on clinical results and previous studies. 
Then transient simulations of blood flow are reported on a number of different geometries in 
Chapter 4, statistically assessed as of different CAD risk, while some risk indexes are defined 
and compared for the different cases. Finally, the simplified thrombus model is coupled with the 
results of the flow simulations in Chapter 5. I believe that this work is a first step towards a 
case specific prediction for patients with CAD using computational techniques. At the 
moment, the only similar method proposed is the computational calculation of the fractional 
flow reserve (FFR) [55, 56], which is basically an index for ischaemic consequences of the 
stenosis on the myocardium [57]. Additionally, as the accuracy of the non-invasive imaging 
techniques such as multi-slice computed tomography for coronary improves, such a test could 
be in the future applied as a diagnostic tool for prediction of the disease at its early stage, 
and could evolve to a routine clinical test as electrocardiogram or stress test.  
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Main text 
Chapter 2 Literature review 
2.1 Blood flow and blood flow simulations 
2.1.1 Blood rheology 
A general problem when performing blood flow simulations is the complex rheological 
behaviour of blood. The main reason for these complex properties is that blood is a multiphase 
fluid and its macroscopic viscosity in low shear stress is strongly affected by the interactions 
among its components. In more detail, blood consists of plasma, red blood cells, white blood 
cells (RBCs and WBCs respectively) and platelets (1/600 and 1/800 of total volume) and 
various proteins and minerals. Plasma and RBCs consist more than 98% of volume fraction of blood and under physiological conditions determine bloodǯs rheological behavior. Plasma is an 
incompressible Newtonian fluid with density 1060-1080kg/m3 and constant viscosity about ͳ.ʹˑͳͲ-3 Pa∙s ȋͳ.ͳ-ͳ.͵ͷ∙ͳͲ-3 Pa∙s [58] under physiological conditions) at 370 C. RBCs (35-45% 
volume fraction) are deformable cells with biconcave disc shape, diameter about 8Ɋm, thickness 
about 2Ɋm, neck 0.8Ɋm, density very close to plasma (1080-1089 kg/m3) and viscosity about 
 
Figure 2-1: Characteristics of blood: Non-Newtonian (Baskut et al 2003). Bloods 
rheological behaviour becomes Newtonian above a level of shear stress. The exact value 
of the threshold is under discussion but in arterial flow condition the average shear is 
definitely above the threshold. 
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͸ˑͳͲ-3 Pa∙s [59]. As shown in Figure 2-1, for a range of shear rate values blood is very well 
approximated as a Newtonian fluid with constant viscosity. This does not hold for blood flow in 
vessels with diameter comparable to blood cell size [60] where the deformation of RBCs plays 
major role, but this is not the case of this study as the typical diameter of the examined vessels is 
about three orders of magnitude bigger than the red blood cell dimensions. For small values of 
shear rate though, blood generally demonstrates shear thinning behavior regardless of the size 
of the vessel. The basic mechanism behind this non-Newtonian behavior of blood is the 
interactions between red blood cells. RBCs tend to aggregate to each other and in the presence 
of blood proteins and other macromolecules under specific conditions even form linear stacks 
(rouleaux). These linear aggregates when formed may also connect to each other creating three 
dimensional structures. So while for increased blood flow (when shear forces are sufficiently 
high) the links between RBCs break, the contribution of the particulate phase of blood to 
viscosity is stabilized and viscosity settles at a constant value, in low shear rates the effect of 
these forces is flow dependent. The exact value of blood viscosity varies for different 
individuals, as it is influenced by the specific properties of RBCs as the volume fraction 
(hematocrit Ht) [61] and deformability [62]. The pre-measurement treatment and storage of 
blood could affect the properties of RBCs and subsequently alter blood viscosity[63] . The 
measured blood viscosity in tube flow depends also on the diameter of the used tube [64]. All 
these factors cause some variations in the values reported in the existing literature. However for 
wall shear rate values above ~100/s blood can is very well approximated as a Newtonian fluid, 
with generally accepted constant viscosity ~             [59]. 
In large vessels like the coronary artery, the average values of shear rate are relatively 
high (        . Under pulsating flow conditions though, there are time intervals during 
the cardiac cycle where shear is low (in coronary there is even inversion of flow direction) 
and blood exhibits its non-Newtonian character. It is also possible that when shear rate 
drops there is a delay in RBCs re-aggregation, giving blood thixotropic properties. This gel 
formed by RBCs and plasma proteins can slip in respect to the walls depending of wall roughness, making even the Ǯno slip conditionǯ that is usually used as boundary condition 
between fluid and walls inaccurate for the case of blood [65]. However for most part of the 
heart cycle the Newtonian fluid is a valid approximation [59].  
Blood flow modeling exhibits some additional difficulties when it is intended to be combined 
with thrombus formation modeling. Concentration of RBCs is higher near the center of large 
arteries and the concentration profile is influenced by the values of shear rate; the axial 
distribution of platelet concentration is also non uniform and influenced by the value of shear  
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rate [67] and platelets are particles of high interest 
regarding thrombus formation as it is explained in 
the next section. The platelet-platelet and platelet-
vessel wall interactions are influenced by the 
presence and elastic properties of RBCs [68, 69] 
and they are also influenced by the local value of 
shear rate [70]. The rotational motion of RBCs 
increases the diffusivity of platelets by two orders 
of magnitude [70, 71] and probably increases also 
the diffusivity of the other coagulation factors. 
Additionally as RBCs occupy the center of the 
vessel, platelet near wall concentration is increased 
both in steady and pulsatile flow [72] (Figure 2-2). The same probably holds for the 
concentration of all the constitutes of blood with relatively small dimensions. As they are 
pushed towards the wall by the RBCs the near wall concentration is higher than the reported 
bulk concentration values. The exact formula that gives the distribution of platelet 
concentration in respect to the distance from the center (or the wall) for flow in a tube is not 
determined but it has been shown that it is influenced by both hematocrit and shear rate [73, 
74]. Finally after the initiation of blood coagulation, the viscosity of blood near the reacting site 
of the wall will be increased locally by the changes in the constitution of blood [75], more 
specifically by the activation and polymerization of fibrin strands and the adhesive properties of 
activated platelets. 
A number of Newtonian models have been proposed for blood viscosity        , being 
function of RBC volume fraction. Based on experiments and observations a number of non-
Newtonian models have also been developed that express the viscosity as a function of 
haematocrit and shear rate in a time independent          or in a time dependent             manner-reviewed in [59]. As blood is a mixture of plasma and cells that for most 
cases behave as fluid drops, a number of multiphase or particle models have also been proposed 
that could be more appropriate for modeling of blood flow (shortly described and reviewed in 
[76]) as they can reproduce the distribution of different components of blood [77-79] and 
include the interaction between RBCs. To the best of my knowledge, there is not a generally 
accepted model used in CFD simulation and the choice of the mathematical expression  
 
Figure 2-2: Axial distribution of platelet 
concentration. Values are normalized 
using the bulk platelet concentration 
(E.C. Eckstein 1991 [66]). 
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for blood viscosity depends on 
the specific simulation 
requirements. Steady-state 
simulations and simulations of 
flow in large vessels are usually 
performed with constant viscosity, 
while the non-Newtonian models 
seem to be more appropriate for 
simulations of pulsating flow in 
microcirculation. Some studies 
comparing different models for 
blood viscosity show that for the 
same geometry and boundary 
condition the resulting axial 
velocity and wall shear stress 
distribution have significant 
differences both for steady [81] and pulsatile flow [82]. On the contrary, other studies report 
that for transient simulations [56, 83, 84] the Newtonian approach is an adequate 
approximation as it results in similar WSS distributions and the differences in results between 
the two approaches is limited both in terms of location and part of the heart cycle. Several 
models have been used for coronary flow simulations (e.g. the generalized power law model 
with haematocrit dependent constants[83, 85, 86], the Casson model [87, 88] or the Carreau 
model [89]). However, in the large majority of the reviewed CFD studies of coronary flow blood 
is modelled as an incompressible Newtonian fluid and the flow is considered laminar [86, 90-
97] as the calculated Reynolds numbers are small (of the order of 100). 
At first sight, the most appropriate choice for blood flow simulations related to thrombus 
formation seems to be a two-phase model (plasma and RBC), that could describe the non-
uniform concentrations of the platelets and the substances that are involved in thrombus 
formation. Such a model would be even more realistic if it included an expression for the 
viscosity of plasma dependent on the local chemical composition of blood instead of using a 
constant value. Similar approaches are used in the work of Anand et al [98] where the viscosity 
depends on the clot formation, or the work of Bondar and Sequeira [99] where viscosity is a 
function of fibrin concentration. In reality though, this approach would increase significantly the 
computational cost of the simulations and probably affect the stability of the models as well, as 
it would require the solution of the flow equations at every time step coupled to the system of 
 
Figure 2-3: WSS along a stream-wise line in a right 
coronary geometry with the use of different models for 
blood viscosity for steady state simulation [80]. There 
are differences in the exact values but the distribution is 
very similar 
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the equations used for the biochemical reactions that describe thrombus formation. 
Additionally, as detailed information of the specific properties of blood for each patient is not 
available, the increase of the complexity of the method would not necessary lead to increased 
accuracy and would also reduce the patient specific character of the simulations. On the other 
hand, the Newtonian approximation for blood’s viscosity –constant value for           , 
not depending on shear stress and time- is generally considered satisfactory for arterial 
flow conditions [100] (Figure 2-3), it has been used in a great number of blood flow 
simulations, and it allows the application of the thrombus model on flow fields as obtained from 
CFD simulation, without requiring to solve the flow field again at every time step of the 
thrombus model. Finally, as the interactions between platelets and vessel wall will be modeled 
as surface biochemical processes, at least part of the effect of shear rate can be included in 
the method with the use of shear dependent reaction rate constants and locally increased 
concentrations for the reactants near the wall, that will be calibrated after applying the 
model on experimental results. 
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2.1.2 Geometry reconstruction 
The first step for performing coronary blood flow simulation is the reconstruction of the 
appropriate geometry. The geometrical models that are used in coronary flow simulations vary, 
depending on the scope of each study. The reconstructed geometry also depends on the method 
used in order to obtain its shape. In studies that focus on a specific and small part of the 
coronary vessel network e.g. a segment of a stenosed branch, and aim to obtain the resulting 
flow related quantities, simplified geometrical models have been used. Two dimensional 
stenosed tube based on images from stented coronary branches [89], idealized three 
dimensional models of bifurcation with different types of stents [97], in-plane and out-of plane 
coronary-like S-shaped geometries without side branches [95] and simplified in-plane 
geometries with aneurysm in different positions [94] are examples of geometries of reduced 
complexity that have been used in previous CFD studies. Single branch models have also been 
used [56, 78-80, 83, 84, 101, 102] for larger scale simulations as up-to a point it was believed 
that the properties of the flow field depend mainly on the curvature of the main branch with the 
existence of the bifurcations having minor influence [101]. However in more recent CFD studies 
it has been demonstrated that the existence of bifurcation has significant and non-linear  
 
Figure 2-4:Image from conventional coronary angiography and the resulting reconstructed 
geometry (images from Chen et al 2005 [91]). Note the very small pressure drop values 
among the inlet and the outlets of the branches. 
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influence on the flow related quantities [85] and it is also related to the appearance of 
recirculation zones [88]. 
In the cases where a more accurate model of human coronary is used, either single branch or 
with side branches, the reconstruction is usually based on data from medical images (CT or 
conventional coronary X-ray angiography) either for a single branch or a model with 
bifurcations [56, 78-80, 83, 86-88, 91, 92, 101, 103] and the three dimensional model is 
extracted with the use of image processing software (indicatively [104, 105]). There are also 
some studies where the model is extracted post mortem from the vascular system of a 
laboratory animal [90] or a deceased human [106]. 
In most studies the walls of the vessel are considered rigid and not moving. The actual case 
 
Figure 2-5: Methods for modelling the motion of the vessel network. Left: use of 5 different 
images from angiography corresponding to five different instances of the inlet waveform. The 
method uses the exact position of each point of the network (Theodorakakos et al 2008). 
Right: Use of a curvature-versus-time function for the modelling of the motion of coronary 
vessels (Prosi et al 2004). 
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though is somehow different as the coronary network is located on the heart muscle and as a 
result of that, the shape and the diameter of the vessels change within each heart cycle due to 
the muscle contractions. The real vessels exhibit also some elasticity, and the diameter is also 
affected by the pressure changes. While in most of the studies these facts are neglected, there 
are available techniques for incorporating such factors. The elasticity of the vessels can be taken 
into account with the use of fluid-structure interaction approach [96] or with a more 
phenomenological approach that uses data for the diameter for different instances of the pulse 
obtained from medical imaging [102]. The motion of the vessel has also been included in some 
works. This has been performed with the use of different methods. One way is to start from 
different images that correspond to different time instances of the pulse (five different images in 
the specific example) and use linear interpolation of the intermediate geometries for all the 
vessels of coronary network with diameters bigger than approximately 1mm [87]. This method 
takes into account the specific time dependent position of each branch during the heart cycle. 
Another way to model the movement of the coronary vessels is to use the curvature of the 
whole system. In the cited example this was done with the use of approximately 14 time 
instances per pulse, and the geometry was modified according to the resulting function of 
curvature versus time [93]. This method uses a single factor for the deformation (or rather 
bending) of the whole vessel network mode. (Figure 2-5). 
Overall, the results reported these studies indicate that the motion of the geometry has a 
small influence on the results and therefore it can be justified to neglect it when it comes to 
studies that aim to compare different geometries. The case is not the same with the 
bifurcations. The inclusion of bifurcationsin sites of the geometrical model changes the 
flow field quantities both in terms of velocity distribution and wall shear stress in a non-linear 
manner and therefore bifurcations cannot be neglected. 
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2.1.3 Inlet and outlet boundary conditions 
Due to the nature of coronary circulation, 
obtaining proper boundary conditions for 
the inlet and more importantly the outlets 
of a geometrical coronary model that is 
used for flow simulation is not an easy 
task; the optimum way of imposing 
accurate boundary conditions in coronary 
flow simulations is still under discussion 
in the relevant literature. The actual 
factors that determine the pressure and 
the mass flow rates at the inlet and the 
outlets of each branch of the coronary 
network are (or considered to be) known 
in a qualitative manner. Coronary arteries 
originate from the aorta, near the aortic 
root (aortic valve) on the left side of the 
heart and the inlet pressure is equal to the 
aortic pressure with very good 
approximation. Blood entering the CA is distributed through a network of arterioles, capillaries 
and venules that go deep into the myocardium, to end up finally in the right atrium of the heart. 
So for the whole coronary network the driving pressure is the aortic pressure minus the 
pressure of the right atrium. But as the location of the coronary network is on the heart 
muscle, coronary flow cannot be fully determined by the inlet and the outlet pressure of the 
system, because as the heart moves part of this network is blocked and there is also pressure 
exerted by this motion. As a result, coronary flow is mainly determined by the contraction of the 
heart muscle rather than by the inlet pressure and outlet pressure (Figure 2-6). 
While the physical mechanism that determines coronary flow is known and well described, 
most of the information required for quantitative computations is not accessible. The currently 
available medical tools cannot provide individual-specific measurements or even safe 
estimations for the mass flow rate and the pressure at the inlet and mainly at outflows of a part 
of the coronary vessel network that can function as computational domain. Additionally, the 
factors that determine coronary flow have large variations among humans due to anatomic 
differences and even change for the same patients during different levels of physical activity or 
 
Figure 2-6: Non dimensional (maximum values 
set to 1) wave forms for the inlet pressure 
(Westerhoff et al 2006) on the coronary network 
(aortic pressure) and the inlet mass flow rate Q 
(Levi 2001) for non stenosed vessel. The two 
quantities are obviously out of phase as the inlet 
is severely influenced by the motion of the heart 
muscle.  
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psychological stress. Several approaches have been used in order to confront this difficulty. In 
almost all cases where pressure is used as inlet boundary condition, the aortic pressure wave 
forms available in the open literature are utilized. Similarly, anatomically correct generic 
waveforms available in the literature [78, 79, 84-90, 97, 101] are used when mass flow rate is 
used as an inlet boundary condition, while in a few cases simplified inlet pulses have been used 
[101]. An example of inlet pressure (aortic) and mass flow rate for left coronary artery are 
shown in Figure 2-6. Nevertheless, the use of a generic waveform is not the only used approach. 
Inlet boundary condition can also be obtained by in vitro experimental measurements in 
coronary models [106] or utilizing data obtained from laboratory animal models [102]. 
The second (and more difficult part) is to obtain conditions at the outflow boundaries of the 
coronary geometrical model. As the shape of the coronary network varies significantly for 
different individuals, there are no Ǯgeneric waveformsǯ for the outflows or standardized 
distribution of the inlet flow among the different branches. Excluding the cases of single-branch 
geometries where mass conservation and wall elasticity are enough to determine the mass flow 
rate at the outlet, the applied boundary conditions at the outlets always include some 
assumptions and approximations. One simple option is to assume a reference pressure value for 
the outlets (usually zero) [79, 80, 83, 88, 90, 92, 102]. This method results in the same pressure 
drop between the inlet and all the outlets (regardless the distance between them) so this 
approximation leads to bigger errors for larger geometries where the pressure drop is 
noticeably bigger as we move downstream (Figure 2-4). The method is also not applicable in the 
case of stenosed branches as the use of the same pressure value for the outlet distal the stenosis 
will lead to non-realistic reduction of the flow rate in the specific branch. 
Another simple approach suitable for geometries with branches that correspond to healthy 
vessels is the use of predefined outflows. In case specific simulations (both for geometries with 
and without stenotic branches) it is possible to obtain the flow rate or even the velocity profiles 
at the outlets from experiments on vessel models [85, 90]. If experimental data is not available, 
a relatively simple and general way to determine the distribution of mass flow between the 
mother branch and the bifurcations is according to the radii fraction, under the assumption of 
poiseuille flow and constant wall shear stress [87, 91, 92, 103]. In the case of poiseuille flow 
there is a relationship between the wall shear stress the radius and the mass flow rate in a 
branch. The elasticity of the vessel wall are not expected to exhibit significant variations in a 
small area in healthy vessel. Therefore large variations of wall shear stress would be 
compensated via deformation and remodeling. So for the two branches at a bifurcation the 
distribution of the flow under the assumption of poiseuille flow is determined by the radii of the 
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two branches.                                   Equation 2.1 
While this approach has also been used for branches with stenosis [97], the assumption of 
constant properties at the parts of the vessel where atheromatous plaque has developed does 
not seem valid. For these cases, the outflow boundary conditions should be based on 
assumptions describing the behaviour vessel network downstream of the CFD exit boundary, 
which are not included in the simulation. In general, it is reasonable to be assumed that the 
network properties downstream of the CFD exit boundary are not affected by the existence of 
the stenosis. Therefore its behaviour must be the same regardless the existence of stenotic 
lesions in the computational domain. The simplest way to take advantage of this assumption is 
to assume a constant pressure drop between the inlet and a point far downstream of the outlets 
of the computational domain; the pressure drop of the non-simulated the downstream part can 
be simply estimated by subtracting from the assumed total pressure drop the one calculated from the CFD model of the Ǯhealthyǯ geometry (i.e. the one without the stenosis) [87, 91]. 
A more sophisticated method used to simulate 
the behavior of a part of the vessel network (or 
more generally a part of the circulatory system) is the use of Ǯlumped modelsǯ. The 
computational domain is considered as a part 
of a much larger system for which some inlet 
and outlet conditions (pressure or flow rate or 
both) are known. The part of the system 
between the inlet or outlet of the geometry and 
a point with for which pressure and/or flow 
rate are prescribed is modeled as a 
dimensionless system with known properties. 
These lumped models actually impose a predetermined relationship between pressure and/or 
flow rate at the boundaries of the geometry and the pressure/flow rate at the input and output 
of the system. Depending on the specific type of the model used, this relationship may also 
include the time derivatives and the integrals of the flow rate and the pressure. These relations 
are similar to the equations that describe the relationships between the current and the 
potential in RLC electrical circuits (Figure 2-7). The simplest case of lumped model considers 
 
Figure 2-7: Schematic representation of the 
three element Windkessel model.  
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only a plain resistance [87, 91] that results in a simple linear relationship between the mass 
flow Qi at the outlet i, the pressure at the outlet Pi the reference pressure P0 and the resistance 
of the downstream vessel network:                    Equation 2.2 
As real vessels are elastic, a more accurate description of the downstream vessel network 
should include its compliance C (       ) as for increased values of pressure the volume of 
the blood in the vessel would be also increased and the input-output mass balance is not zero at 
a given time instant. For this purpose, more complicated models have been suggested, that 
include also the capacitance of the vessel network after the outlet of the computational region, 
known as Windkessel models; these may consist of two (R-C) or three (R-C-R) elements [107-
110]. Indicatively, the pressure-mass flow relationship at the outlet of the computational 
domain with the use of a three element model with resistance and capacitance is: 
      [                  ]      ⁄               ∫           ⁄              
Equation 2.3 
In an attempt of obtaining patient -specific boundary conditions lumped models with more 
elements for both inlet and outlet have been introduced. These models include resistance, 
capacitance, inductance and pressure sources so that they are capable of using as inputs 
quantities related to the activity of the heart (atrial and ventricular pressures etc) and have 
been used as boundary conditions for both one [111] and three dimensional flow simulations 
[96, 112]. However when it comes to assigning specific values for the properties of each part of 
the flow circuit, the approximations and assumptions for the unknown model coefficients 
become inevitable. 
Concluding, existing methods for obtaining boundary conditions for the coronary network 
include some assumptions and the accordance of the prescribed conditions with those actually 
prevailing on a real human coronary network is still under discussion; larger uncertainties exist 
for the flow outlets. In transient flow simulations of the cardiac cycle the time dependent 
behaviour of the vessels downstream the computational domain cannot be neglected. Use of 
complicated lumped models, while at first sight may seem to improve accuracy, introduces also 
additional uncertainties, as in all the reviewed studies there are assumptions and 
approximations regarding both the inlet and the outlets. Therefore, especially in the current 
Thesis, a simple representation of the time-dependent pressure drop of the vessels 
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network downstream of the exit boundaries has been adopted. The pressure drop was 
introduced via a time dependent resistance term. This method is based on generic data of 
the total pressure drop during the cardiac cycle and the geometrical characteristics of the 
coronary models and can provide consistent comparative results between the 
investigated cases. 
The feasible anatomical hypothesis behind the used method is that for each outlet the 
downstream network is structured in a way that the average wall shear stress is 1-2Pa; this 
value is more or less the same for all branches of a healthy coronary artery. It is based on the 
elasticity of the vessel, assuming that large variations of the wall shear stress would lead to 
remodelling (change of shape) of the arteries. Additionally it is assumed that the possible 
existence of stenosis does not affect the structure of the downstream vessels. Validation of the 
anatomical hypothesis is almost impossible as it would require the knowledge of the shape of 
the entire coronary arterial and vessel network for a specific person (at least) before and after 
the emergence of the stenosis. However, provided that the anatomical hypothesis holds, the 
effect of the stenosis on the flowrate at the inlet and the outlets can be validated using a 
relatively simple experimental setup. Transparent geometrical models of arteries with and 
without stenosis will be mounted in a test rig. At the inlet a pressure pulse will be applied. The 
outlets of the geometries will be connected to a time varying resistance (e.g an elastic tube that 
goes through a compliance tube). The flow rate at the inlet and the outlets will be measured 
both for stenosed and non-stenosed geometries and they will be compared to the flow-rates 
calculated via simulations.  
2.1.4 Indicative results 
The results reported in published works on coronary flow simulations depend strongly on the 
scope of each study. Some works focus mainly on the dependence of the obtained CFD results on 
the relevant techniques used. Simulations on simplified one branch geometries that used a 
physiological and a simplified sinusoidal pressure pulse with the same time averaged flow at the 
inlet resulted in similar stream-wise distributions of WSS (Figure 2-8)on the walls of the model; 
this showed that the average WSS is mainly determined by the geometry rather than the exact 
inlet waveform [95, 101]. The application of different velocity profiles at the inlets has also been 
shown to have minor influence on the result and causing only small differences that are 
restricted near the inlet [101]. 
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On the contrary, there is an approximate 20% difference between the values of WSS for steady 
flow simulations and the averaged WSS for transient simulations with the same time average 
flow rate. The same holds for pressure drop [89], a fact that indicates that the relationship 
between the WSS and the mass flow rate is not linear and that the transient nature of flow 
has to be taken into account. The application of both the Newtonian and non-Newtonian 
models (power law, generalized power law, Carreau, Casson, Wallburn-Schneck) did not 
produce significantly different WSS distributions and the influence of the non-Newtonian model 
was restricted in small specific areas [56, 83, 87]. The changes in the WSS distribution is also 
small when multiphase models were used [79] but a differentiation in the WSS gradient was 
observed [84]. Comparison of simulation results on the same geometry for moving and 
stationary walls, (with constant diameters) did not show significant variation in the results 
except for a small local differentiation at the area of the stenosis [87]. 
On the contrary -as expected- it has been shown that geometrical features of the model have 
major influence on the results. Recirculation zones appear downstream the stenotic lesions, 
both on the main branch and side branches even for moderate stenosis (50%)[87, 88] and 
downstream the LAD-LCX bifurcation in the branch with the bigger diameter [90]. Recirculation 
zones were also observed in simplified models of coronary arteries with the location of the 
 
 
Figure 2-8: WSS distribution along a line in a single branch coronary model for two different 
types of inlet waveforms. The distribution is almost identical and there is an almost constant 
difference between them (Myers et al 2001 [101]) 
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vortex depending on the location of the aneurysm [94], another indication of the strong 
influence of geometry modifications on the flow field. The curvature and the vessel tapering also 
influences the velocity profiles and WSS distribution [95, 101]. The factor that seems to have the 
strongest influence on the simulation results though is the existence and the position of side 
branches compared both to curvature and tapering, and this seems to hold for both steady and 
transient simulations[85, 86, 93]. Geometries with side branches have lower values of WSS, 
something that was expected as the same quantity of fluid is distributed in more branches, but 
also the distribution of WSS along the main branch is significantly different.  
In most of the published studies, the reported values of time averaged WSS are in the range of 
1.5-2 Pa, with the minimum value 0.25-0.4 Pa and local peak maximum values especially at the 
stenotic lesions that reach up to 20Pa [85, 86, 90, 92]. Low WSS is a subject of high interest, as 
reduced WSS at an area of the vessel wall is related to CAD progression and thrombotic 
complications. The reported minimum values of WSS in all reviewed studies lie within the range 
of 0.2-0.5Pa. Despite the previously described important role of WSS in the evolution and 
complications of CAD there is not a generally accepted range for non-pathological WSS 
values in the literature in order to assess the CFD findings. The local value of WSS, as it is 
estimated by CFD simulations, seems very sensitive to geometric changes. The existence of 
stenosis in the artery has also strong effects on WSS values (Figure 2-9). The existence of a 
stent, an obstacle with 100Ɋm intrusion in the flow region, has a strong effect on WSS 
distribution. This finding is repeated for different geometries and flow rates [102]. In another 
computational work in a more complex geometry, the placement of the stent in the location of a 
stenosis, while restores pressure and flow-rate, it does not seem to revert the local WSS 
gradient to a non-pathological distribution [91]. 
At the branches without stenosis, the maximum calculated pressure drop between the inlet and 
the outlets of vessels with diameters up to 1mm is less than 2% of the average inlet (aortic) 
pressure; although the calculated value of absolute pressure value the outlets is depends 
strongly on the choice of boundary conditions, the pressure drop within the computational 
domain does not exceed 200Pa [90-92] and, as shown in Figure 2-4, in some cases it us 
negligible compared to the operating pressure of the system. However when a stenosis is 
involved the pressure downstream the stenotic lesion can be significantly reduced and in an 
unpredictable manner [55, 56, 91]. This pressure drop determines the flow rate in the stenosed 
branch, influences the flow rate at the inlet and therefore affects all the calculated quantities. So 
in cases with stenosis this pressure value cannot be estimated or measured in a non-invasive 
way and the same holds for the flow rate in the stenosed branches. This is the fact that makes 
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necessary the use of models for the behaviour of the network downstream the outlets of the 
computational domain. 
Finally, there are several studies aiming to explore specific scenarios, evaluate the effect of 
specific factors or compare the impact of performed procedures. Coronary CFD simulations 
have been used to examine the effect of stent placement [91], the persistent stenosis after 
stenting [89], the effect of different types of stent [97] or the impact of the existence of stenosis 
at different location [88]. However, in most studies, the reported results seem to be detached or 
at least not directly connected to the main problem of CAD which is the possibility of 
complications. To the best of knowledge, only in three studies where there is an attempt to use 
CFD as a tool of assessment of the severity of the case with definition of appropriate indices and 
even these studies deal more with ischemia than the possibility of complications : (i)Chen et al 
[91] defined the computational flow stenosis index, a non-dimensional quantity calculated from 
the CFD results in order to express the reduction of the blood supply due to the presence of 
stenosis; (ii) Wellnhoffer et al [86] defined a set of non-dimensional indices based on a the 
geometrical features of coronary and shear stress distribution to be used for coronary 
assessment [86] (iii) Finally Morris et al [56] developed and validated an integrated method for 
virtual calculation of the fractional flow reserve (FFR) based on CT coronary images, the first to 
our knowledge actual connection of CFD with medical diagnosis. It can be said that although the 
CFD studies provide a detailed description of the flow field and calculate the flow quantities that 
 
Figure 2-9: WSS distribution in different coronary models with bifurcations for a normal (left) 
and a stenosed (right) case [86]. The differences in geometry lead to much higher values of 
WSS for the vessel with CAD. Although the view angle is different it is clear that the values 
of WSS are approximately three times higher in the right image. 
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are related to pathological situations in more detail than the medical examinations, there is no 
use of CFD as a diagnostic tool. The difficulty of the validation of the CFD under in-vivo 
conditions leads inevitably to mistrust towards these results in clinical practice. However the 
author of this Thesis is motivated from the potential of developing future diagnostic tools 
that may include validated CFD tools. Specific flow characteristics can be directly related to 
CAD deterioration and complications and also flow patterns that favour the formation of 
thrombus can be identified, as it is attempted in the current Thesis. Simulation of flow for a 
small number of cases with known outcome (stable CAD or ACS) and detailed processing of the 
results can lead to an arithmetic expression of these culprit flow patterns and produce 
quantitative criteria for the complication risk. These criteria can thereafter be tested and 
validated with application on a large number of patients. 
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2.2 Coagulation and thrombus formation 
2.3 Thrombus formation- The process 
The formation of blood clot is, in most occurrences, a physiological response of human body to 
vessel injury, necessary for the stop of bleeding. It is initiated when blood contacts certain 
substances like those exposed after the rupture of endothelium and also when pathological flow 
conditions prevail in a region [46]. At the same time, thrombus formation is involved in a 
number of life threatening situations like venous and venous thromboembolism, ischemic 
episodes at different sites of the vascular system and ACS (after rupture of atheromatous 
plaques in stenosed vessels [113]); it is often a result of the contact of blood with artificial 
materials and implants as mechanical heart valves. The occurrence of pathological clotting in 
the circulation is believed to be the result of the co-existence of three conditions, traditionally referred to as Virchowǯs triad. Virchowǯs triad was initially proposed in order to describe 
venous thrombosis, but it can be applied also in the cases of arterial thrombosis and coronary 
complications [114]. The first prerequisite for pathological clotting is the prevalence of 
abnormal flow condition in the area [115]. The second prerequisite is a pathological condition 
on the vessel wall, as in the presence of an injury or inflammation site certain substances (like 
TF and collagen) are exposed and make contact with the blood components initiating the 
coagulation process [116]. The presence of foreign materials from implants, as stents or 
artificial heart valves, can also possibly be considered as pathological condition on the vessel 
wall. The third prerequisite is the increased coagulability of blood, locally or globally. The exact 
chemical composition of blood of an individual favours or makes more difficult the clotting, as 
differentiation of the concentration or behaviour of several blood components has a decisive 
effect on the process [117]. The occurrence of thrombosis requires the synergy of all three 
conditions. However it has been shown that there is interaction among these factors, and that 
when one of these conditions exists can lead to the appearance of the others. Pathological flow 
conditions can influence the endothelium cell responses and create an abnormal condition on 
the vessel wall [118]; pathological values of shear stress can also stimulate platelets and lead to 
the initiation of coagulation [49]. However the use of Virchowǯs triad as an interpreting tool is 
still useful when approaching the problem of blood thrombus formation in vivo. As described in 
the following section, thrombus formation is a multi-scale phenomenon both with respect to 
time and space, involving a number of biochemical substances, blood circulating minerals and 
cellular responses. 
Between the initiation and the formation of a thrombus, a series of enzymatic reactions takes 
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place; this is traditionally referred to as coagulation cascade [119]. Some of the substances 
taking part in these reactions are known in the literature as coagulation factors, and they are 
named with Roman numerals. As a big part of the reactions involved in the coagulation are 
enzymatic activations, most of the coagulation factors while inactive in their blood circulating 
state (except from FVIIa)  take part in the process after obtaining their activated form. For 
example, fibrin is the result of the fibrinogen activation by thrombin. Fibrinogen is also known 
as factor I of coagulation and fibrin as activated factor I.  
Coagulation cascade is classically divided in three parts: (1) the extrinsic or Tissue Factor (TF) 
pathway, (2) the intrinsic or contact pathway and (3) the common pathway. In the extrinsic 
pathway the process is initiated when factor VII of coagulation is bound on TF and activated, 
forming the complex TF:VIIa. In the intrinsic pathway the triggering is the activation of fXII after 
contact with specific substances. The two separate paths, identified on the basis of the different 
events that cause the initiation, have been studied and reproduced in in-vitro experiments [120, 
121]. However, this distinction is not actually representative for the in-vivo process as the TF 
factor pathway activates part of the intrinsic pathway with the activation of factors XI and VIII 
by thrombin. Both pathways finally result to the activation of factor X, which is the first step of 
the common pathway. The final outcome of the process is the activation of fibrin and the 
formation of the fibrin mesh.  
The main concept of the cascade description is that in every step of the coagulation process a 
circulating zymogen is activated and the activation reaction is being catalysed by the products 
of the reactions of previous steps. Coagulation is a dynamic process that includes a number of 
feedback loops which may have amplifying, inhibiting or regulative role. The inhibition 
processes are partially due to substances that already exist in plasma, like tissue factor pathway 
inhibitor (TFPI) and antithrombin III (ATIII) and partially due to substances that are activated 
during the process, for example activated protein C (APC) is possible after the activation of 
protein C by thrombin. Also  there is a process that breaks up fibrin network aka as fibrinolysis. 
While for physiological haemostasis the TF pathway is considered more important [122] as 
patients with deficiencies of the intrinsic pathway do not suffer from bleeding disorders, it is 
possible that the intrinsic pathway has significant involvement in the thromboembolic 
complications [123], as in some cases the inhibition of fXII can protect from pathological 
thrombosis without bleeding complications [124]. 
The initiation of the coagulation cascade occurs mainly on the TF-bearing cells on the vessel 
wall [125, 126]. During the following steps of the process though, two of the involved 
substances, platelets and thrombin, have particularly important contribution. Thrombin 
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catalyses the final step of clotting converting fibrinogen to fibrin, activates factor XIII that forms 
bonds that crosslink the fibrin strands [127], causes the activation of platelets [128] and 
activates factors V, VIII, XI and the inhibitor protein C. Platelets (also thrombocytes) are blood 
circulating cell fragments that have the ability to adhere to the materials exposed after arterial 
damage [2] or plaque rapture such as collagen [129-131] and play a major role in thrombin 
formation [132, 133]. Platelets become activated when they contact thrombin and other 
chemical agonists or when they are subjected to mechanical stimulation [49, 134]. After 
activation, platelets are modified in order to support biochemical reactions on their membrane 
and release chemical substances and micro-particles [135] that in turn activate other platelets 
and promote blood clotting [126]. Finally after activation platelets obtain the ability to adhere to 
each other and form aggregates on surfaces or in flowing blood. Due to their important role, 
platelets and thrombin are the subject of most coagulation tests and the target of most anti-
platelet drugs and require special attention in the process of modelling thrombus formation. 
The scheme presented above has been used widely for the study and the interpretation of 
coagulation process in vivo. The cascade model has also inspired and guided a large number of 
laboratory experiments on coagulation. During these experiments the impact of different 
coagulation factor was studied, by adding all or some of the coagulation factors and plasma in a 
test tube and monitoring the change in the concentration of the different substances. A number 
of studies were performed in this manner have managed to identify the mechanism and to 
measure the reaction rate constants of each of the involved reactions [120, 136]. 
Table 2-1: Localization of some of the enzymatic activations of the coagulation process [126, 
132]  
Vessel wall surface Plasma  Platelet surface 
VII binding with TF 
VIIa binding with TF 
Xa activation of TF:VII 
TF:VIIa activation of X 
TF:VIIa activation of IX 
Xa activation of VII 
IIa activation of VII 
IIa activation of V 
Iia activation of VIII 
Xa activation of II 
 
Xa activation of V 
IIa activation of V 
Xa activation of VIII 
IIa activation of VIII 
VIIIa binding with IXa 
Va binding with Xa 
VIIIa:IXa activation of X 
Va:Xa activation of II 
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However, while the cascade model deals with all the processes as they were sequential bulk 
reactions, a large part of the enzymatic reactions involved in the coagulation process occur 
either exclusively or significantly faster when the enzymes are bound on cell membranes or on 
phospholipids [137, 138]. Additionally, a number of the activated factors (fXa, fIXa, fVIIa...) of 
the coagulation cascade can bind on TF-bearing cells or platelets even before the activation of 
platelets [132, 139] and avoid the action of the inhibitors in plasma. In more detail, the 
formation of the complex TF-VIIa with the activating ion     (extrinsic tenase) that causes the 
activation of fIX and fX occurs on the surface of TF bearing cells and TF-rich sites of the vessel 
wall. At the same time the complex IXa-VIIIa (intrinsic tenase) which also causes activation of fX 
acts on the membrane of activated platelets, so this step is cross-linking the two classical paths 
of coagulation. Finally, while the circulating activated fXa causes activation of small amounts 
(pM) of thrombin, the complex Xa-Va (prothrombinase) which also acts on the activated plateletsǯ membrane, causes a burst of thrombin generation as it has much higher activity than 
circulating fXa and also is less prompt to inhibition. Also the activation of protein C is faster on 
the cells of endothelium by the thrombomodulin-thrombin complex than in plasma [140]. The 
acknowledgement of the crucial role that cell membranes play on the coagulation process has 
led to a new perception of coagulation and the development of cell based models describing the 
process, without cancelling of course the importance of the previous works. 
According to the cell based approaches and models for blood coagulation [125, 126], the 
process is divided in three discrete but overlapping phases, initiation, amplification and 
propagation (see Figure 2-10). The initiation phase takes mainly place on the endothelium or 
generally the vessel wall, after the exposure of tissue factor. TF binds fVIIa and causes the 
activation of fVII. The formed extrinsic tenase complex activates fIX and fX. As mentioned 
before, these activated enzymes can bind on TF bearing cells and avoid inhibition by TFPI or 
other inhibitors in plasma. So their action is initially limited near the surface of the vessel wall. 
During the amplification phase small amounts of thrombin are formed on the surface or near 
the surface of TF-bearing cells by circulating fXa. This amount is not enough to trigger directly 
the formation of clot, but it is capable of activating platelets and other co-factors. At the same 
time, platelets adhere and tether at the reaction site by binding on von Willebrand factor [141]. 
At the final stage of the amplification phase, activated platelets bearing activated coagulation 
factors enter the circulation. During the propagation phase, the complex of fIXa:fVIIIa is formed on the activated plateletsǯ surface. This complex activates fX to fXa which forms complex with fV, 
fXa:fVa aka as prothrombinase. This complex converts prothrombin to thrombin in a rapid way  
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(>100,000 faster than the conversion in plasma [137]) that finally leads to activation of fibrin 
and formation of blood clots. The cell based models of coagulation can provide explanation for 
some specific clinical conditions like bleeding complications due to fXI, fIX, and fVIII 
deficiencies, where the cascade description fails. Additionally, the binding of activated co-factors 
of coagulation on cells explains two other parts of the coagulation process in vivo: (i) the small 
amounts of activated enzymes initially produced remain active for a time period 
disproportionally long compared to their half-life in plasma. This is because they escape the 
inhibition due to the protected environment that this binding provides for the enzymes. (ii) 
Localization of coagulation process as it is observed in in arterial flow conditions would not be 
possible without enzymes binding on the reacting site. Arterial wall shear rate values are high 
and flow would cause the abduction of the reacting substances, even if they were produced with 
 
 
Figure 2-10: The cell based model for blood coagulation, image from K.P. Papadopoulos et 
al 2014 [142] inspired from the work of Smith 2009 [126]. The different steps of the process 
(initiation, amplification and propagation) occur at different sites. The arrows show how the 
processes are lumped in a smaller number of reactions in the developed phenomenological 
model (Chapter 3)  
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rates much faster than the ones that have been reported for the coagulation reactions. 
Therefore the role of cells and the localization of the reactions have to be taken into account for 
the modelling of the coagulation in-vivo. 
2.4 Simulations of thrombus formation 
This section is divided in three parts: the first one reviews only the coagulation reaction models, 
the second reviews models used for simulating platelet aggregation and finally the third one 
reviews integrated models that attempt to reproduce coagulation in the maximum possible 
detail.  
2.4.1 Models for the coagulation process 
The basic idea of a model for blood coagulation is a set of differential equations that represent 
the temporal evolution of each of the involved substances. These equations are derived from the 
biochemical reactions that describe the generation or consumption of each substance. Modelling 
of enzymatic reactions leads finally to an expression of a source/sink term (Si) for all enzymes 
and chemical substances involved in the coagulation process. If a substance is produced or 
consumed through more than one reaction, the source/sink term is the sum of the quantity of 
this substance produced or consumed per unit time in each reaction. In the general case the 
reactions may also include binding and unbinding between substances or between substances 
and cells. For example in Equation 2.4a (hypothetical) source term for plasma circulating 
thrombin for a model that simulates thrombin generation as a bulk reaction is presented as:  
          [   ]([ ]  [    ]  [   ]) binding of thrombin molecules on the available 
binding sites (p) of platelet membrane 
      [    ] unbinding of thrombin molecules from the surface 
of platelets      [   ][     ] inhibition of thrombin by anti-thrombin III         [  ][     ] activation of thrombin by the complex Xa:Va         [  ][  ] activation of thrombin by fXa in plasma 
Equation 2.4 
In the case a model includes the spatial evolution of coagulation reactions the source terms 
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would take different forms for the different domains of the computational area. The previous 
term at a site of the computational domain without platelets would be reduced to the simpler 
form of Equation 2.5:           [   ][     ]         [  ][  ] 
 Equation 2.5 
The reaction speed can be modelled as first order or second order reaction or with the use of 
the Michaelis-Menten approach [143] as shown in Table 2-2. Note that most of the reactions are 
enzymatic activations of the form described in Equation 2.6:            
Equation 2.6 
The enzyme E (activator) binds onto the substrate B in order to produce A (activated form of 
enzyme B). The Michaelis-Menten expression actually includes under some assumptions the 
binding and unbinding of the enzyme and the substrate into the empirically derived constant km. 
The choice of the appropriate way of modelling each reaction of the system depends on the 
specific purpose the system is developed for, and the available computational resources.  
Table 2-2: Different ways for simplified modelling of enzymatic biochemical reactions. The 
specific way used in every case depends on the type of the reaction, the desired accuracy 
and the available data. 
Reaction 
kinetics 
Process Conversion rate 
First order        [ ] 
Second order          [ ][ ] 
Michaelis-Menten               [ ][ ]     [ ]  
 
The purpose of a coagulation model is to reproduce the concentration of the different 
substances versus time in accordance with experimental measurements. As the usual target is 
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to predict the evolution of thrombin (and sometimes also fibrin) concentration, a general 
problem is that the mathematical models of coagulation have disproportional ratio of input and 
output parameters. While the mathematical model includes a large number of substances and 
respective reactions, only a small part of the calculated data is reported in the results and used 
for evaluation of the model, usually the temporal evolution of the concentration of thrombin, 
fibrin and sometimes factor Xa [144, 145]. Therefore if a mathematical model for coagulation 
aims to reproduce the production of thrombin while including a detailed description of the 
involved reactions it is very possible that it gives correct final outputs for a number of different 
simulation setups. 
An ideal model for thrombus formation in flowing blood should incorporate a large number of 
parameters. The starting point is the system of biochemical reactions for both intrinsic and 
extrinsic path of blood coagulation up to the formation and lysis of fibrin, including the 
amplifying and inhibiting feedback loops that were mentioned earlier. If the model is to be used 
under flow conditions, or just in simulations were the substances that participate in the process 
are not homogeneously distributed in space the model should additionally include the 
localization of reaction on different sites (endothelium cells, platelets or plasma), the formation 
of enzyme complexes and the binding and unbinding of certain zymogenes and enzymes on the 
cell membranes. In the case the model intents to describe the formation of thrombus in flowing 
blood, it should also include the motion of the blood circulating cells RBC and WBC as these cells 
can also be trapped in the fibrin mesh [146]. In reality though, we have not found any of the 
published models that include all these factors in full detail.  
The actual evolution of the existing models was from very simple zero dimensional to complex 
three dimensional ones and it was boosted by two factors. First, since the initial mathematical 
models for thrombin and fibrin generation were introduced around 1990, our understanding of 
the coagulation processes has improved dramatically. There have also been published a number 
of experimental works on coagulation that provided detailed quantitative information on the 
involved reactions. All this new information was gradually incorporated in the proposed 
models. Second, the increase of the computational power and the emergence of new 
computational techniques have made possible the conduction of much more demanding 
computational studies that include more parts of or the whole process and in greater detail. 
More or less, the trend in mathematical models of coagulation and thrombus formation is to 
move towards higher complexity and computational cost.  
The first mathematical simulation of thrombin and fibrin generation in plasma consisted of 14 
reactions describing the activation and inhibition of four coagulation factors (fI, fII, fV and fX) 
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and the action of two inhibitors (AT-III and APC); exponential time functions have been used as 
fixed inputs for the concentration of fX [147]. The model actually reproduced the common 
pathway and the threshold for the explosive increase in thrombin generation was a critical 
value of fXa while most of the reactions were modelled using the Michaelis-Menten approach.  
The next model was based on an in-vitro study of TF-induced thrombin generation [120]. The 
reaction rate constants measured in this study were used for the development of a system of 20 
reactions describing the activation and inhibition of six coagulation factors, fII, fV, fVII, fVIII, fIX 
and fX. The reactions were modelled as second order, accounting separately for the formation 
and breakage of complexes, while there were no inhibition reaction and the activation of the factors was restricted by a Ǯmaximum velocity of productionǯ. That study mainly focused on the 
effect of variation of the concentration of different factors [148].  
A similar model was proposed for the intrinsic pathway including fibrin production (in total 
factors fI, fII, fV, fVIII, fIX, fX and fXI) and AT-III and APC inhibition mechanism, and was used to 
investigate threshold values for some enzymes and the spatial propagation of coagulation from 
the reacting site due to diffusion [121, 145]. Subsequent work on extrinsic path included more 
chemical substances and biochemical processes [144] up to thrombin production, resulting in 
an improved version of the model of Jones et al [148]. The system consisted of 27 reactions and 
42 reaction rate constants, included all factors involved in the TF-pathway (fII, fV, fVII, fVIII, fIX 
and fX) inhibiting action by TFPI and AT-III and the concentration of TF as triggering substance. 
The model was mainly used to investigate the effect of different concentrations for the involved 
substances.  
This model was also combined with a Monte Carlo simulation method, in order to detect 
changes to the coagulation initiation behaviour, due to small variation of the concentration of 
enzymes induced by the stochastic approach [149]. In a similar model but more detailed with 
respect to the number of substances (22 fluid phase, 19 lipid bound and 6 complexes) and 
reactions Bungay et al [150] included for the first time the effect of lipids (phospholipids) on 
thrombin generation. The presence of lipids in the model actually reduced the rate of the 
inhibition reactions (by TFPI and AT-III) while the increase of some activation reactions due to 
the presence of lipids was not considered. This model also included the action of APC as an 
inhibiting loop due to thrombin production  
At the same time some studies used simulations to investigate a specific part of the coagulation 
process, as the function of positive feedback loops and threshold concentrations for the 
initiation of the process [151], the triggering threshold with respect to Tissue Factor Pathway 
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Inhibitor (TFPI) concentration [152] or the inhibition mechanism of APC [153]. Closing this 
brief reviews of the coagulation models we must emphasize on three things: (1) Generally, the 
described models are sensitive to the concentration of the inputs and while they produce 
reasonable results for near-to-physiological concentrations when used for unusually high or low 
input (mainly high) concentrations can give controversial results as oscillating solutions [153]. 
(2) At the same time, the mismatch between the number of inputs and outputs makes possible 
the reproduction of the coagulation by a much simpler system of six reactions [154] and indeed 
in different ways, as much of the information included in the inputs is not reflected in the 
outputs -or rather there is overlapping in this reflection so small changes in one reaction can be 
compensated by small changes in others. (3) Last but not least, these models describe 
thrombin generation in a closed and actually non-dimensional system. The result is a 
number of curves describing the temporal evolution of the involved factors, assuming that the 
whole process occurs in a closed homogenous system. The used reaction rate constants and the 
experimental validation of the results are also based in closed reaction systems. In such a 
system, a factor that plays crucial role is the depletion of the initial reactants (fII for example). 
The reduction of the initial substances will control the curve of thrombin generation. On the 
contrary, when studying thrombin generation in flowing blood, there is a constant supply 
of the initial reactants due to convection, and there is also rapid removal of the produced 
substances due to flow motion. 
2.4.2 Models for platelet aggregation and deposition 
The major role of platelets in blood clotting is well established and thus, there is also a number 
of computational studies that focuses on platelet behaviour and responses (adhesion, 
aggregation and activation). These studies usually ignore or oversimplify the biochemical 
reactions of coagulation and deal with the behaviour of platelets in a mechanistic manner.  
Some of these studies examine only the formation of platelet aggregates in flow, using collision 
efficiency, disaggregation models and population balance equations [155-157] while others 
include the changes to the tendency of platelets to form aggregates due to the presence of 
biochemical stimulators [158]. From the last study, which were the first attempt to model 
platelet deposition on a surface an important conclusion was drawn regarding platelet 
disaggregation. It was demonstrated that the disaggregation process could be relatively easily 
modelled with success. At the same time it was shown that under flow conditions, 
disaggregation has an important role and cannot be neglected.  
Similar mechanistic studies –in the sense that the process is attributed to convection and 
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diffusion of platelets- have been published also for platelet deposition on surfaces in the case of 
stagnation flow [159] and stenotic vessels [160]; the effect of shear rate on the rate of the 
deposition of platelets was modelled as an increase to diffusivity due to shear rate. The 
enhanced platelet deposition on an adhesive surface due to increased shear rate can also be 
attributed to the presence of RBCs and was initially suggested by Brash et al [161]. This specific 
effect has also been reproduced in a simulation of primary haemostasis for arterial values of 
shear rate (1000 s-1), where Stokesian dynamics were used to describe platelet-platelet and 
platelet-wall interactions under flow [162]. 
The same approach for the influence of shear on deposition rate was used in a different model 
that was applied on predefined parabolic flow profiles, in order to examine platelet deposition 
on stenotic surfaces [163, 164]. This model used a constant reaction rate, took into account 
platelet chemical activation by agonists and considered the effect of thrombin generation, 
inhibition and heparin related reactions. The model was applied to simulate deposition 
assuming Poiseuille flow over collagen coated surface. In this model, a function for chemical 
activation of platelets was proposed, based on a threshold concentration for the agonists. This 
approach for chemical activation was used later in several models. Another interesting finding 
in this work was that the differentiation of the deposition rate between resting and activated 
platelets did not change significantly the results, probably due to the small number of activated 
platelets in flowing blood. 
David et al [165] in a study aiming to assess 
downstream activation and adhesion due to 
transport and diffusion of activators generated 
by adherent platelets have confirmed that the 
performance of platelet deposition models 
depends on flow conditions. Longest et al 
[166] applied different models for platelet 
deposition in pulsating flow conditions with 
streamlines deviating from the parabolic 
profile. Compared to experimental data, the 
better results were achieved with a deposition 
model including the residence time of platelets 
near the reacting surface. The inclusion of 
residence time in the platelet deposition time 
is actually the same as taking into account (but not explicitly modelling) the biochemical 
 
Figure 2-11: Lagrangian simulation of 
platelet aggregation in a tube of 50μm 
diameter and 500μm length (Pivkin et al 
2006) 
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reactions that lead to the binding of platelets on reacting surfaces and other platelets. The shear 
dependent diffusivity gave satisfactory results in these studies. It is important to keep in mind 
though, that shear dependent diffusivity has a direct impact on the aggregation rate. However, 
the experimentally observed dependence of the platelet aggregation rate on shear rate values 
could be attributed to a number of mechanisms: Shear rate influences the diffusivity of both 
platelets and activating factors; it causes increased platelet concentration values near the wall, 
especially in the presence of RBCs, and this increase depends on the volume fraction of RBCs; it 
regulates the supply of new platelets over the reacting site of the vessel wall; in a bio-chemical 
level, it changes the prevailing mechanism of platelet adhesion [167]. Therefore the shear 
dependent diffusivity or aggregation rate used in modelling may be lumping a number of 
different physical processes. 
Pivkin et al [168] performed 3D simulation of platelet aggregation inside a tube (Figure 2-11). 
The computational model included also the effect of the growth of thrombus on the flow field. In 
this study the platelets were allowed to be in one of three states: resting activated and triggered. 
It turned out that the transition time from triggering to activation was important for the growth 
of the aggregate, or in other words, that the fraction of activated platelets and their residence 
time near the reacting site was important for the growth rate. The same research group in a 
later study also reproduced again (numerically) the combined influence shear and the presence 
of RBCs on platelet distribution and deposition [169]. 
In almost all models described above the effect of shear rate on platelet binding was taken into 
account either using the enhanced diffusivity or by straightforward modelling of the collisions 
between platelets and RBCs. It has been shown though that, even when compared to in-vitro 
experiments, the success of the model depends on the flow conditions. It seems that there is 
no unique and generally accepted way to model the effect of shear on platelet 
aggregation that works equally well for any possible flow conditions Additionally, the way 
the platelet state (i.e. if they are activated or not) should be included in the modelling of 
these interactions is not clarified yet and it also seems that the simple distinction of 
platelets into resting and activated may be oversimplified. It is also still unclear how the 
demonstrated alteration of the behaviour of platelets due to shear is to be included. Therefore, a 
phenomenological model for thrombus formation that adopts a simplified way for 
modelling platelet aggregation on vessel wall and other platelets may overcome the lack 
of models required for simulating in detail the complex biochemical mechanisms.  
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2.4.3 Integrated models of thrombus formation 
When thrombus formation is modelled under flowing blood conditions, the source terms Si that 
come from the assumed biochemical reactions must be coupled with the equations describing 
the effect of blood flow on the concentration of blood transferred substances; the same also 
holds for the source terms referring to platelets. The equation that is usually used to describe 
the combined effects of production (or consumption) and flow on the spatial and temporal 
evolution of the concentration Ci of a substance i in a flow field is the convection diffusion 
equation with source term (Equation 2.7):             ⃗            
Equation 2.7 
In a more realistic approach, the growth of thrombus at a site of the vessel will affect the flow 
field, as the formed thrombus will restrict the flow. In the case that this effect is also considered, 
the equations that describe the formation of thrombus are coupled with flow (as the 
concentration of the substances will alter the local properties of blood); otherwise the equations 
for the evolution of concentrations are solved independently from the already developed flow 
field.  
Despite that the integrated models of thrombus formation are rather demanding in respect of 
computational power, the first studies of this kind were performed more than 25 years ago, 
with the production rates of substances mainly modelled as fluxes or with the use of few 
reactions [170, 171]. The model of Sorensen could also fit into this category [163, 164] although 
it mainly focused on platelet aggregation. There are also some more resent attempts to 
approach the effect of flow on thrombus formation in a phenomenological way, using a set of 
(only) three equations describing fibrin production and showing different patterns of fibrin 
formation for different flow conditions [172]. 
The increase of computational power has allowed more complicated multi-scale and multi-
phase models to be developed. These models include an integrated coagulation sub-model, a set 
of chemical reactions similar to the one proposed by Hockin et al [144] and additionally may 
incorporate the movement of the cells, the localization of equations and the change of blood 
properties due to blood clotting. Kuharsky and Fogelson [173] proposed an integrated model of 
thrombus formation under flow conditions, taking into account the localization of reactions on 
surfaces. The localization of reactions on endothelium and platelets was achieved with the 
inclusion in the model of binding sites on cell membranes for enzymes and zymogens. The 

62 
 
alterations in blood flow due to the presence of aggregated platelets [178]. The macro-scale 
model was tested in simulations with pulsating flow in an idealized two dimensional vessel 
bifurcation [179]. The continuous model, with coupling of flow with thrombus growth and 
including flow and transport within the thrombus, was used to demonstrate the effects of flow 
conditions and the quantity of TF exposed in thrombus growth [180]. As these models actually 
calculate the position of individual platelets, produce very realistic images of thrombus 
formation (Figure 2-12). 
Another multi-scale model was proposed by Xu et al [181], that included a cellular pot model 
[182] for discrete cells; cell movement was simulated through an energy-based stochastic 
process. The simulation involved differentiation of cell movements depending on fibrin levels 
and cell-cell or cell-surface interaction and bonds. The model was used to evaluate the role of 
fVII in venous thrombus formation due to vessel injury [183] and to examine the impact of 
pulsating flow and the non-Newtonian characteristics of blood on thrombus growth [184]. 
Anand et al [98, 185] presented another multi-process model that used a viscoelastic model to 
simulate flow for both free vessel lumen and clot. This model also incorporated the activation of 
platelets due to excessive shear stress and fibrin production and lysis. In a similar work, a model 
for the viscosity of blood depending on fibrin concentration was proposed and used in a three-
dimensional simulation of blood coagulation in a tube with a reacting site; in this study the area 
where fibrin concentration exceeded a specific value interpreted as the area occupied by the 
clot [99]. This model was applied in three dimensional geometries, on the contrary with most 
models of this category where the applications were restricted in small two dimensional 
domains (Figure 2-12). 
While the detailed description of coagulation included in these works makes them 
appropriate for studying the influence of different factors, at the same time it increases 
dramatically the computational cost; thus published applications mainly refer to small two 
dimensional regions (~100Ɋm) while the dimensions of computational regions for studying 
thrombus formation in a coronary artery or in mechanical heart valves are much larger 
(typically, the diameter of the coronary artery at the inlet is about 4mm while the diameter of 
the aortic root is of some cm) with the flow distribution being three-dimensional and strongly 
time dependent preventing use of simplified flow models.. Finally the models reviewed here 
do not have and probably cannot obtain patient-specific characteristics, as the use of 
reaction rate constants derived from experiments do not allow the significant variability of 
thrombin generation observed for different individuals [186]. Also it is difficult in practice to 
have detailed blood analysis for each individual in order to perform patient specific simulations.  
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Figure 2-13: Three dimensional simulation of fibrin concentration on vessel wall. Simulation 
of coagulation in rigid wall tube (D=6.2mm, L=31mm) using a fully developed velocity profile 
(Bondar and Sequeira 2007) 
As the process between the initial stimulation and the formation of thrombin consist the main 
part of the coagulation reactions, our motivation is to develop a phenomenological model for 
thrombin formation that would be Ǯlightǯ enough to be used with three dimensional 
Computational Fluid Dynamic (CFD) simulations while also being adjustable in order to reflect 
measured differences existing in data of different individuals. As the intention here is to 
combine the model with CFD simulations, it should also account for a rough localization of the 
different processes. A case-specific simplified model like this, though not including the full 
biochemical details of the process, could be used for comparison of different cases of clinical 
interest. The thrombin sub-model will be combined with a simple sub-model for platelet 
aggregation on the vessel wall and can be evolved in a useful comparative tool for thrombus 
formation in different cases. 
  
t=30s t=40s
t=50s t=60s
Vessel 
wall injury
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Chapter 3 The simplified thrombus model 
3.1 Introduction  
As mentioned earlier, blood coagulation is a process that involves a great number of 
substances and biochemical reactions, with some parts still being under investigation. In 
this chapter the development of a simplified-phenomenological model of coagulation is 
described. The model is light enough to be coupled with transient flow simulations in 
relatively large computational domains utilised in CFD. The development of the model 
can be separated into three distinct steps. The first step is a simplified sub-model for 
platelet aggregation on the reacting site. The initial calibration of the platelet sub-model 
is based on the experimental data reported from Badimon et al [2], and does not 
distinguish between activated and resting platelets. The second step is the development 
of a system of equations describing thrombin generation [142]. The validation of these 
equations is based on the thrombin generation assay results, an in-vitro test measuring 
the generation of thrombin in samples, under well determined conditions. The third part 
is the validation of the combination of the two sub-models under flow conditions. The 
initial thrombin model consisted by equations representing bulk reactions even for the 
processes that under flow conditions occur only on a part of the vessel wall. In order to 
convert these bulk reaction rate constants to surface reaction constants (actually surface 
flux terms similar to the ones used in Sorensen et al [163]) we used the threshold values 
for the initiation of coagulation under flow reported in Shen et al [3], modifying the 
surface reaction rate constants until the computational results agree with the 
experimental ones, i.e. until the threshold values for the flow and geometrical 
parameters of the problem in the simulations coincided with the ones reported in the 
experiments. As some of the experimental results used refer to the TGA and some others to the Ǯperfusion or flow chamberǯ, this chapter provides also some information on these 
processes and then moves to the detailed description of the three steps and finally 
provides some details on the programming technics used.  
3.2 Perfusion chamber 
Perfusion or flow chamber is a device mainly used for the in vitro study of biological 
phenomena that require flow of blood, plasma or other liquids over a biological 
substrate. It is generally accepted that the effect of shear stress on cells is not limited to 
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the obvious mechanical consequences [35] (cell membrane deformation etc) but can also 
trigger biochemical responses like the expression of certain glycoproteins on cell 
surfaces and even alter gene expression [187]. Specialized types of perfusion chambers 
have long been designed to investigate the subjects under discussion in this study 
[188].The device is able to produce controlled values of wall shear stress values within a 
range and create the appropriate flow conditions in order for the cell response to be 
studied. There are two main types: the parallel plate chamber and the tube chamber. In 
all types, the relationship between the applied mass (or volumetric) flow at the inlet of 
the chamber and the resulting shear rate or shear stress is obtained under the 
assumption of Poiseuille flow. The flow field is assumed to have a parabolic velocity 
profile similar to the one depicted in Figure 1-6. For the parallel plate chamber, the 
dynamic viscosity of the fluid Ɋ, the volumetric flow rate Q at the inlet of the chamber 
along with the geometric characteristics (height h and width w) determine the value of 
wall shear stress and wall shear rate (Equation 3.1):                      
Equation 3.1  In the case of cylindrical flow chamber with internal radius R, the wall shear stress 
and wall shear rate are given by Equation 3.2                        
Equation 3.2 
In all flow simulations performed in this chapter, when shear rate or shear stress is 
reported, the corresponding mass flow at the inlet of the chamber was calculated using 
the formulas above, and the resulting shear rate in the calculated flow field was 
compared to the reported one. In the cases of the platelet sub-model where a difference 
greater than 2% was observed, the boundary layer of the computational grid was refined 
in order to get more accurate results (less than 2% difference). 
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3.3 Exploiting the results of thrombin generation assay 
Because of the large number of enzymes involved in the 
process, the detailed modelling of the coagulation 
process (using values for the concentration of all 
involved substances and all the biochemical reactions) 
as exhaustively explained in the introduction is 
computationally extremely expensive. It also includes 
the risk of highly unstable models when applied to 
relatively large geometries. Additionally, the scope of 
this study is that the coagulation model should address 
patient specific data without demanding a great series of 
laboratory results regarding the possibly different 
species concentrations and reaction rates for each 
individual that lead to different rate of thrombin 
production (Figure 3-1).  
Instead, for a patient specific approach, it is preferable for the model calibration to be 
based on data obtained via clinical procedures that assess the differentiation of the 
coagulation process for each patient. For those reasons, the thrombin generation sub-
model calibration was based 
on the results of thrombin 
generation assays (TGA). The 
typical outcome of a TGA test 
is a curve of thrombin 
concentration versus time 
that is supposed to be 
indicative of the temporal 
evolution of thrombin 
generation in vivo. The results 
of such a test vary depending 
on the laboratory and the 
method used, but efforts are 
made for a standardization of 
both methods and results. In 
 
Figure 3-1: Variation of the 
temporal evolution of 
thrombin generation for 
different individuals [132] 
 
Figure 3-2: Typical thrombogram curve and the main 
parameters of the test (image from J.J. van Veen et 
al [189]) 
67 
 
general, the test provides five main parameters [189, 190] as shown in Figure 3-2 
1 The lag time (Tlag), i.e. the time until thrombin generation reaches the amplification 
phase, usually expressed in minutes.  
2 The time when thrombin concentration reaches its maximum value (Tmax or 
ttPeak) , usually expressed in minutes. 
3  The maximum concentration of thrombin (Cmax or Peak), usually given in nM.  
4 The endogenous thrombin potential (ETP) represented by the area under the curve 
of thrombin concentration over time, usually given in       .. 
5 The thrombin production rate is also considered an important parameter. However 
it is not an independent parameter as it can be calculated from the lag time, the peak 
and the time to peak (               ⁄ ). 
As it has been shown in previous studies, lag-time depends strongly on the concentration 
of the stimulator used for the initiation of coagulation (in most cases recombinant TF), 
while for concentrations above a certain value lag time is totally eliminated and the 
production of thrombin starts immediately. The concentration of the triggering 
substance affects also Tmax and Cmax, while the concentration of platelets affects all the 
parameters of the test [120, 191, 192]. Typical values of the parameters of a TGA test 
[191] using fresh PRP are shown in Table 3-1Error! Reference source not found. 
Table 3-1: Typical values for the 5 main parameters of TGA test 
parameter Typical value 
Tlag            
Tmax            
Cmax          
ETP                
Production 
rate 
60nM/min 
68 
 
As it will be shown in the next paragraphs, the thrombin generation sub-model was 
structured in such a way that its parameters can be modified appropriately using a 
method based on the four parameters of TGAs. The final result of this modification 
process is that the results of the model reproduce a wide range of curves of different 
TGAs while at the same time the reactions and substances used in the 
(phenomenological) model retain the connection with the physical properties of the 
process.  
3.4 Structure of thrombin generation sub-model 
The aims when developing the thrombin generation sub-model was to propose a set of 
equations that describe the thrombin generation in blood using the minimum possible  
number of parameters but which are able to describe with acceptable accuracy the 
whole process. The proposed model for thrombin production is based on the cell-based 
models of coagulation [126]; the full description of the biochemical processes are mainly 
 
Figure 3-3: Schematic of the reduced version of the cell based model of coagulation l 
shown in Figure 2-10 that was used for the development of the thrombin sub-model. 
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based on [125]. For a detailed modelling of coagulation, the localization of the different 
reactions makes the task more complicated, as it requires taking into account additional 
parameters such as the binding rate of the substances on cell membranes and the 
expression, concentration and availability of appropriate binding sites on the cell 
surfaces. 
For the development of a simplified model however, the fact that the different stages of 
the coagulation occur in different sites can function as an advantage, as the processes 
can be grouped in respect to the location they occur (on platelet surface, on the vessel 
wall or in plasma). This approach is rigorous in cases where the transport of reactants is 
mainly due to convection (such as arterial flow conditions), or in cases where the 
different species are well mixed.  
Table 3-2: The source terms for each substance of the thrombin sub-model, for zero 
dimensional simulations. 
As the proposed model used a reduced number of four species (thrombin, prothrombin, 
resting and activated platelets) and four reactions (see table), each reaction rate represents the integral effect of more than one actual process. Also, Ǯactivated plateletsǯ 
actually represent platelet activity, in the sense that 100% activated platelets implies  
Substance  Source term 
Thrombin [IIa] 
 [   ]                   [   ]               [  ]  [  ] 
Prothrombin [II] 
 [  ]                 [  ]  [  ] 
Activated Platelets 
[AP] 
 [  ]         [  ]  [  ]         [  ] 
Resting Platelets [RP] 
 [  ]          [  ]  [  ]         [  ] 
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Table 3-3: The values of the model’s constants and parameters that were used as a 
starting point for the calibration and the fine tuning of the model. 
maximum platelet activity rather than the fact that all platelets are activated. Figure 2-10 
illustrates the actual biochemical reactions that influence each constant of the model, 
while Figure 3-3shows the reduced model. The model is structured as follows: During 
the initiation phase thrombin generation is described by a slow first order reaction. This 
reaction, which is localized on the TF-bearing cells (when modifying the model for 
applying to 3D simulations), is used to describe the whole pro-coagulant activity that 
Process Constant 
symbol 
Initial value (S.I.)) Reference 
 
Thrombin generation 
by activated platelets 
                     [133, 163] 
Thrombin generation 
on reacting surface  
                 n/a 
Platelet activation by 
thrombin             [   ]  [   ]            [   ]  [   ]     [173] 
Platelet activation by 
activated platelets 
                   [173] 
Thrombin inhibition*                      [144, 180] 
Thrombin 
concentration 
threshold for platelet 
activation 
[   ]                        (0.5-1.2nM or 0.05-
0.12U/ml) 
[133] 
71 
 
occurs on the TF-bearing cells – formation of the TF-VIIa complex, activation of factors 
IX, X and V. In this reaction the inhibition of the amounts of IXa, Xa that leave the cell 
surfaces by TFPI in plasma are also included. The initial value for the reaction rate 
constant was estimated using the lag times reported in [120, 192]. Inhibition of 
thrombin during this phase is also modelled as a first-order reaction, with the value of the reaction rate constant for thrombin inhibition calculated from the ))a ∙AT))) 
inhibition reaction, using the initial bulk concentration of ATIII                                       ; this reaction is the major process of thrombin inhibition. 
Thrombin inactivation is 77% by anti-thrombin, 14% a2 macroglobulin and 9% by minor 
inhibitors [193]. 
With this setup for the initiation phase, the model describes the threshold behaviour of 
the initiation of blood coagulation in respect to TF concentration [3, 194], as there is a 
minimum value of activation constant capable of causing thrombin burst and, as this 
constant is related to the TF concentration, a threshold value for TF concentration. The 
threshold values used are within the range of thrombin concentration values that have 
been reported in Rosing et al [133] as being capable of causing platelet activation: 0.5 to 
1.2nM of thrombin (0.05 to 0.12U/ml). The equations (source terms) of the thrombin 
sub-model are shown in Table 3-2. The initial values for the reaction rate constants, 
shown in Error! Reference source not found. are taken either from already existing 
models or from experimental studies. 
Beyond the point that thrombin concentration has reached the threshold value, the 
conversion of prothrombin to thrombin is mainly attributed to platelets after their 
activation. This process is modelled as a second-order reaction, with the initial values for 
the reaction rate constant used from [133, 163]. Platelets can be activated either by 
thrombin, if its concentration is greater than the threshold value, or directly by other 
activated platelets. Thrombin in concentration about 1nM can initiate the activation of 
platelets [195], from 0.5nM for minimum activity to 1.2nM for maximal [133]. Platelet 
activation by thrombin is modelled as a first-order reaction that is initiated when 
thrombin concentration reaches the threshold value. The activation of platelets by 
activated platelets represents the activation by platelet-released substances and it is 
modelled as a second order reaction. The reaction rate constants for the activation of 
platelets used were found in [173]. In the case of TF induced coagulation, the 
contribution of the later reaction is negligible, but it can make the model capable of being 
used to describe shear induced coagulation. 
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Inhibition of thrombin during the propagation phase is again modelled as a first-order 
reaction. The reaction rate constant for the inhibition of thrombin in plasma is not the 
same as for the initiation phase; here it must be noted that this constant is significantly 
smaller than the one used by Leiderman et al [180] for modelling this reaction in the 
same manner, which was based on thrombin half-life in plasma. However, as the 
activation of protein C that acts as an inhibitor to the coagulation process mainly occurs 
on the endothelium cells, for the areas near the endothelium cells the value used for 
thrombin inhibition is larger. The exact value of the inhibition constants for the 
computational cells that are near the wall is derived from the adjustment of the model 
with the use of TGA results. 
3.5 Calibration based on TGA parameters 
By adjusting the values of the constants and parameters within Ǯphysiologicalǯ limits, 
based on the four main parameters of a thrombin generation assay (Tlag, Cmax,Tmax 
and ETP), the model can reproduce, to a good level of accuracy, actual thrombin 
production as it is depicted by the TGA for different patients. The initial attempts of 
adjustments were performed manually (on a Microsoft Excel sheet), but in general the 
adjustment can be done using the following procedure and assumptions. 
Platelet response is very fast compared to the other processes included in the model 
[196]. With the approximation that all platelets are activated as soon as thrombin 
concentration reaches the threshold value an approximate solution can be found for the 
system of differential equations, giving the equation that describes thrombin 
concentration through time. To get this approximate solution, we make the assumption 
that all platelets are instantly activated when thrombin reaches its threshold value. 
Under this assumption, concentration of activated platelets is zero when thrombin 
concentration is below the threshold value. When thrombin exceeds the threshold 
values, the concentration of activated platelets becomes instantly equal to the initial 
resting platelet concentration. In the general case thrombin concentration is given by 
Equation 3.3 while prothrombin concentration is given by Equation 3.4:  [   ]       [   ]       [  ] 
Equation 3.3 
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 [  ]         [  ] 
Equation 3.4 
Here ktot represent the total rate of prothrombin conversion to thrombin and includes 
both the production on the reacting site and on the platelet surfaces:                     [  ]      [   ]  [   ]   
Equation 3.5                                            [   ]  [   ]     
Equation 3.6 
The approximate differential equation (Equation 3.4) that describes prothrombin 
concentration can be solved analytically and provide an expression for the prothrombinc 
concentration vs time (Equation 3.7): [  ]    [  ]               
Equation 3.7 
The PDE describing thrombin concentration becomes:  [   ]       [   ]       [  ]            
Equation 3.8 
                                  [  ]              
Equation 3.9 
The equation can be rewritten as follows,                                
Equation 3.10 
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The last expression, after manipulation leads to an (approximate because of the 
assumption of instant platelet activation) analytic solution for the temporal evolution of 
thrombin concentration (X): 
           [(               )          ]     
Equation 3.11 
[   ]                    [ቀ          [   ]               [  ] ቁ                    [  ] ] 
Equation 3.12 
For [   ]         the equation acquires the simplified form: 
[   ]         [  ]                           
Equation 3.13 
This equation has the general form:  
[   ]                               ⃗   
Equation 3.14 
The term        ⃗   represents the approximate analytical expression for the temporal 
evolution of thrombin concentration for a given set of reaction rate constants    The 
equation is similar to the equation proposed by Wagenvoord et al [154] when applied to 
zero dimensional modelling of thrombin generation, but it can also be applied in cases 
where platelets and TF are not uniformly distributed in a sample and the results will 
vary in space. Here the constants A, B and C depend both on the model parameters and 
TGA results and they have different values for the initial phase and the propagation 
phase. 
In the case where only the four characteristic parameters of TGA are available the 
physical meaning of each parameter poses a mathematical condition that the function         ⃗   must fulfil. Tlag is the moment thrombin reaches the threshold concentration; 
Tmax is the time when thrombin reaches maximum concentration therefore the time 
75 
 
derivative of thrombin concentration for t=Tmax must equal zero; Cmax is the maximum 
concentration of thrombin, and it occurs when t=Tmax; ETP is the area under the 
thrombin concentration curve therefore it is equal to the integral of thrombin 
concentration over time. According to these, for the function F we obtain the equations 
shown in Table 3-4.From this set of equations, the reaction rate constants can be 
approximated numerically, making the resulting system of equations capable of 
reproducing the curve of the TGA with the given parameters.  
Table 3-4: Set of equations for tuning thrombin sub-model to reproduce the results of 
a specific TGA with the use of the four main parameters of TGA 
 
In the cases where the data from the whole curve are available, there is another –and 
more accurate- way for obtaining the model constants. The surface reaction rate is 
obtained by solving (numerically) Equation 3.15, which describes thrombin 
concentration during the initiation phase: 
[   ]         [  ]          (                      )    
Equation 3.15 
The activated platelet concentration is approximately, [  ]  [  ]   ቀ                  ቁ         
Equation 3.16 
Analytical expression can be obtained for prothrombin concentration versus time:  
    (      ⃗ )  [   ]    
     (      ⃗ )       
        (      ⃗ )    ∫     (   ⃗ )   ∫     (   ⃗ )                
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[  ]    [  ]                  
Equation3.17 
Therefore, for the differential equation describing thrombin evolution for t>Tlag    [   ]        [   ]          [  ]    
Equation 3.18 
In that case, the constants can be obtained numerically using an iterative process for the 
differential equation. In most of the results that will follow, only the constants related to 
thrombin production                 (Table 3-7) were adjusted. 
3.6 Results of thrombin sub-model 
We first applied the model using the 
initial values for the constants; while 
the resulting curve has the shape of a 
typical thrombin generation curve, 
the actual values of the TGA 
parameters were significantly higher 
than the typical experimental results 
for fresh platelet rich plasma as 
reported in [191]. Performing 
simulations for different time steps, it 
was found that the results of the 
model are identical for time steps 
below 0.5s (Figure 3-4: Time step 
independence test for the thrombin sub-model. For time-step values below 0.5s the 
results coincide.. As a whole heart cycle at rest conditions is about 0.8s (for 75 bpm), the 
maximum magnitude of the time steps for simulating pulsating flow is much smaller 
(about one order of magnitude smaller), thus in terms of temporal discretization, the 
coupling of the reaction system model with CFD simulations can be straightforward.  
  
 
Figure 3-4: Time step independence test for 
the thrombin sub-model. For time-step values 
below 0.5s the results coincide. 
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Table 3-5 : Brief description of the different cases simulated with appropriate 
modification of the model constants. 
Case 
number 
Description  
1 Reproduction of a TGA curve that corresponds to typical parameter values 
[191].  
2,3 Simulation of thrombin generation without inhibitors, in plasma with the 
addition of phospholipids [120]. The initiation was triggered using 5pM and 
100pM fVIIa and 5 pM TF for 1nM TF, 200ɊΜ phospholipids and the rest of the 
zymogens at the normal plasma concentrations. 
4 Reproducing an arbitrary TGA curve with different parameters compared to 
case 1 [197]. Platelet poor plasma with the addition of 1pM of TF. 
5-7  Simulations for different platelet concentration (100, 150 and 400 x 109 pl/L) 
using the same setup for the model [191]. The reported TF concentration was 
approximately 3pF. 
8 TGA curve corresponding to very low platelet concentration (75 x 109 pl/L) 
[198]. Clotting factors were close to the normal level, initiation was triggered 
by adding 0.2nM fVIIa and TF bearing monocytes at approximately 0.17pM. 
 
Subsequently, the model was applied in 8 different cases, denoted as Case1-8. In the 
corresponding plots, when both model and experimental results are represented, model results are named ǮC# modelǯ and the experimental results ǮC# expǯ.  
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Table 3-6: The experimental TGA parameters for all the cases used for the model 
testing and calibration and the resulting numerical ones 
 
 Tlag (min) 
Tmax 
(min) 
Cmax (nM) ETP (nM∙min) 
Case 1 
experiment 3.6 ± 0.8 7.4±1.8 164±50 1321±330 
model 3.7 6.8 165 1364 
Case 2 
experiment 1.5 3.5 (1.5∙103) n/a 
model 1.5 4 (1.5∙103) n/a 
Case 3 
experiment 0.67 2.25 (1.5∙103) n/a 
model 0.65 2.38 (1.5∙103) n/a 
Case 4 
experiment 3.5 4.8 199 735 
model 3.7 4.6 196 710 
Case 5 
experiment 5±0.5 11±2.7 161±38 1633±81 
model 5.8 9 190 1718 
Case 6 
experiment 5.5±0.5 11±0.2 98±40 1316±255 
model 6 9.4 91 1370 
Case 7 
experiment 5.8±0.7 13±0.9 72±38 1135±300 
model 6 9.6 62 1118 
Case 8 
experiment 15 27 101 2012 
model 13.3 25.3 102 1934 
 
The equations for the adjustment of the constants were solved in MATLAB, while the 
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adjustment of the platelet related constants was done manually using Excel and Systems 
Biology Toolbox 2 [199]. Case 1 represents the tuning of the constants in order for the 
model to give a thrombin generation curve that will match the typical values of the four 
TGA parameters as reported in [191] the resulting curve (C1 model) is shown in Figure 
3-5. Figure 3-8 compares curves representing cases with lower rate of thrombin 
generation. In the absence of inhibition (case 2 and case 3), the time interval between 
the end of the initiation phase and the moment that thrombin concentration reaches its 
maximum value, is 2-4 min depending on the constant for thrombin activation by 
activated platelets; the results match approximately the experimental thrombin 
production curves found in [120] (Figure 3-6).  
  
Figure 3-5:Curve matching the typical TGA 
parameters C1 and the curve that matches 
thrombin generation for low platelet 
concentration C8. 
Figure 3-6: Fitting of cases with added 
phospholipids in the absence of inhibitors. 
Triggering substance is r-TF:VIIa 
The next test (Case 4) involved adjusting the model constants in order to fit an arbitrary 
thrombin generation curve. The experimental curve was found in [197]. Figure 3-7 
shows that the model predicts the experimental curve with good accuracy. For future 
application of the model under flow conditions characterised by non-uniform 
concentrations of platelets, it has been considered important to test its behaviour with 
given constants for varying concentration of platelets near to the physiological values. 
The constants were adjusted so that the model approximated the TGA results for platelet 
concentration 150 x 109 pl/L (physiological values are 200-400 x 109 pl/L).Then the 
model was applied with the same setup for two other values of platelet concentrations; 
Cases 5-7 use the same values for reaction rate constants with platelet concentration 
400, 150 and 100 x 109 pl/L, respectively. The results shown on Table 3-6 are within the 
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range of values reported in [191] although the dependence of maximum concentration of 
thrombin on platelet concentration seems a little stronger than for the in vitro 
experiments. The resulting curves are shown in Figure 3-8. Further increase of platelet 
concentration resulted in higher values for maximum thrombin concentration and small 
decrease of Tmax, without significant effect on ETP. If the constants describing platelet 
activation are also suitably modified, the equations can match curves that depict slower 
thrombin formation like the ones reported in [198] for lower platelet concentrations (75 
x 109 pl/L) as shown in C8. 
The values of the model constants after modification, in order to fit different cases are 
shown in Table 3-6; it can be seen that for all cases the values are within a reasonable 
range and close to the initial estimations. The reactions related to platelet activation 
actually represent the transition from the initiation to the propagation phase. Although, 
as mentioned earlier, activated platelets in that model actually represent platelet activity 
compared to a maximum value rather than actual activated platelet count, it is 
interesting that the calculated time until platelets reach half of the maximum activity for 
Case 8 is 5-10 min, is in agreement with the findings of Allen et al [198]. As the curves 
used to reproduce a wide range of TGA results correspond to different experiments, 
these constants vary significantly between two groups of cases. In the experiments 
  
Figure 3-7: Adjustment of the model in 
order to reproduce a specific TGA curve. 
Experimental results from Hemker et al 
[197] 
Figure 3-8: Simulated thrombin 
generation curves for different platelet 
concentrations, C5-C7 and the typical 
curve C1.Values of the reaction rate 
constants are identical for cases C5 to 
C7 
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corresponding to cases 1-4, where phospholipids have been used as a substrate for 
enzymatic reactions, this transition is much faster than for cases 5-8 where human 
platelets have been used. For cases 5-8, the values of these constants have been adjusted 
manually. However, as shown in recent experiments [200], TGA results in whole blood 
resemble more the curves of case 1 and 4, (possibly because red blood cells that are not 
included in most TGA also contribute to thrombin generation [200, 201]), so this 
modification of the parameters related to platelet activation is not necessary for 
modelling thrombin generation in healthy whole blood; for these cases the model can be  
adjusted to reproduce thrombin generation without modifying the reaction rate 
constants related to platelet activation by thrombin.  
On the other hand, by modifying also the rate of platelet activation by thrombin, the 
model could also approximate pathological cases as haemophilia or results of patientsǯ 
blood analysis after anticoagulation treatment. Curves corresponding to pathological 
 
Figure 3-9: Simulation of thrombin generation for cases of haemophilia. In order for 
the equations to reproduce pathological cases the reaction rate constants have been 
significantly modified compared to their values with the use of the equations of Table 
3-4.  
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situations as severe haemophilia A [154] can be very well approximated as shown in 
(Figure 3-9). Haemophilia is fVIII deficiency. Thrombin generation curves shown in the 
Figure 3-9 were obtained by adding fVIII in the blood of haemophilic patient and 
performing measurements after specific time intervals. The concentrations of VIII 
reported have been calculated using 12.8 hours as half-life of fVIII [202]. In order to 
describe pathological TGA results, the same adjustment techniques described earlier 
were used. The parameters of the model obtained values that are significantly modified 
compared to the initial ones. However, that was expected as the pathological results 
correspond to different function of the coagulation system for the patient. In the specific 
case, factor VIII is mainly involved in the amplification and propagation of coagulation, 
as it is the co-factor of fIXa for thrombin activation on the membrane of activated 
platelets. In order to reproduce curves for different fVIII concentrations the constants 
related with the specific phases (                       required modification while the 
constant related only to the initiation phase remained unchanged.  
In contrast to the methods described and reviewed in [203] where the effect of the 
variation of each factor concentration and activity have been investigated, this model 
uses only the information included in the TGA curve; thus, it has some limitations. If the 
production rate of thrombin at the moment of the transition from the initiation to the 
amplification phase is close to the rate of inhibition      [   ]        [  ]) there is a 
possibility of oscillating solutions. This can be avoided either with the use of small time 
step or with a slight rearrangement of the involved parameters.  
The most significant inaccuracy of the 
model is recorded when the initial 
values of the parameters are used and 
refers to the time interval between the 
initiation of thrombin burst and the 
maximum concentration of thrombin. 
The time interval Tlmax-Tlag is smaller 
than the one reported in TGAs (2.8min 
compared to 2min predicted by the 
model) when adjusting only the three 
previously mentioned parameters. The 
increase of thrombin concentration 
 
Figure 3-10: Effect of the sampling 
frequency to the resulting curve after 
automated curve fitting on the results. 
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predicted by the model is sharper compared to the experimental data while the shapes 
of the two curves are different for this time interval. That can be fixed by adjusting 
manually the constants related to platelet activation as it was the case for cases 4-8. 
However, the experimental data, while in all studies are presented in the form of a 
continuous curve, usually correspond to measurements in discrete time intervals; the 
resulting curves are obtained through data fitting.  
In Figure 3-10 three curves are plotted for the time interval of thrombin concentration 
increase. The data points were using the same setup for the thrombin generation model 
so the data points for the three cases actually belong to the same continuous curve. The 
only difference among the three cases is the time interval between two consequent 
points. In one case labelled as Ǯdenseǯ, the time interval between two data points is 2s, 
while for the other two cases (labelled as sparse1 and sparse2), it is 30s and 20s, 
respectively. The time intervals between two consecutive data points for this test were 
chosen so as to be comparable to the time interval that intervenes between the 
extraction of two consequent samples from the investigated reacting solution; for 
example in the results presented by Lawson et al [120] the time interval between two 
samples is 7.5 to 30s. It can be seen that curve fitting on experimental values, that was 
used in studies prior to the introduction of continuous monitoring of thrombin 
generation, while making the results more presentable can also give incorrect 
information on the actual evolution of the process between two measurements. So 
differences between modelled and experimental curves do not necessary indicate 
inadequacy of the model. 
The constant that represents the initial thrombin production rate          (for a given 
value of the inhibition rate) is mainly calculated from lag time. While the reported 
experimental results seem to depend on the exact composition of the samples and the 
triggering substance used, (e.g. for the cases described in [191, 192]) in the results 
reported by Gerotziafas et al [191] there seems to be a clear relationship (R2=0.989) 
between TF concentration and lag time, and therefore         , for the same 
experimental conditions and for TF concentrations varying between 1 and 30pM: 
                          ቆ [  ][     ]ቇ  
Equation 3.19 
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The constant values are                    while for the aforementioned study 
the maximum calculated value for the rate of thrombin generation during the initiation 
phase is                      and the relationship can approximately be written 
as: 
                          ቆ [  ][     ]ቇ  
Equation 3.20 
Equation 3-18 gives good results when used for the estimation of          for other 
experimental studies where TF has been used for the initiation of the process. For 
experiments where recombinant TF:VIIa  has been used as triggering substance for the 
coagulation process, again a good correlation between          and trigger concentration 
can be established, (R2>0.98) but the resulting formulas are different, so equation 3-18 is 
valid only for cases where a quantity of TF is added to the reacting solution in order to 
trigger the  initiation of coagulation process. . Equation 3-18 can be used when there is a 
reference value for the initiation rate constant          for a known TF concentration, 
in order to estimate the value of the initiation rate reaction       for lower TF 
concentrations. It is mainly presented because it is possible that the TF concentration in 
atheromatous plaques is different than the TF concentration used in the TGA 
experiments, so the calculated value from TGA will require modification for applying 
under flow. 
As this thrombin sub-model was developed in order to be coupled with flow simulation 
techniques in three dimensional geometries, the initial and slow phase of thrombin 
generation that occurs on the TF bearing endothelium cells should finally be expressed 
as a surface reaction term. The reaction rate for the surface reaction can be calculated 
with the use of the reported surface TF concentration in atheromatous plaques 
(33pg/cm2) [204] and the molecular weight of (46,000Da approximately [205]). For a 
computational cubic cell of e.g. 100Ɋm this numbers would lead to a TF concentration of 
about 70pm resulting in                   . It must be noted that any value for the 
initiation constant obtained via TGA corresponds to bulk reaction in a stationary 
solution. Experimental validation for the value of the surface reaction rate constant      and the relation to the bulk reaction rate constant requires experiments on 
coagulation under flow. Perfusion of blood samples for different wall shear rate values 
over a surface with immobilized TF can lead to an independent deriviation of the value 
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of      , by measuring the lagtime. At the same time, if the TGA results for the examined 
sample are known, a more solid relationship between the bulk and the surface reaction 
rate constant can be established. It is preferable that the adjustment of the thrombus 
model for specific patients is based on TGA results rather than perfusion experiments. 
Perfusion experiments, while providing more accurate and direct information, require 
significantly larger blood samples and are harder to be repeated in an identical manner. 
Sub-threshold concentrations of thrombin actually represent also all the products of the 
previous steps of coagulation. At the same time, this approach allows a slow rate of fibrin 
production before the burst of thrombin and a realistic prediction of clotting time. As 
TGA results demonstrate inter-laboratory variation [189], this model, based on TGA 
results and with its simplified character, does not claim to reproduce with precise 
accuracy thrombin generation.  But it can offer a way to model thrombin generation that 
has some specific advantages: (1) can be adjusted to describe different rates of thrombin 
generation, and (2) can be easily coupled with CFD simulations as it will be 
demonstrated in the following sections. Finally, as the model describes the production of 
thrombin in blood in a phenomenological way, it does not require detailed information 
on the composition of blood for each patient. Instead of using detailed systems of 
biochemical reactions that require as input the concentration of all the involved 
coagulation factors, this model can be calibrated and applied directly for different 
patients using only the parameters or the curve of the TGA. 
3.7 Variation of the model parameters 
The proposed thrombin sub-model, although simplified compared to the actual process 
that is due to describe, still has an imbalance between the used parameters and the 
outputs. There are five independent reaction rate constants and three input 
concentrations that produce one output for which data for validation are available: 
thrombin concentration curve. Therefore, while the reaction rate constants could almost 
certainly be fitted directly without the use of a starting point for their initial values, it is 
possible that there is a large number of sets with different values for the fitted 
parameters that can satisfy the equations and reproduce a given thrombin concentration 
curve or the results of a given TGA; obviously most of this sets of values, while giving an 
output that fits the experimental TGA curves, have no connection to the actual processes 
at all and as a result of this would give big errors for different input parameters (platelet, 
prothrombin and triggering substance concentration).  
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Table 3-7: The variation of the reaction rate constants during the process of fitting the 
model to the different cases. In cases 2 and 3 there is no inhibitors in the 
experimental procedures and in cases 5-7, used to test the function of the model for 
different platelet concentrations the reaction rate constants were fixed. 
 
There were two ways to overcome this problem. The first one was to simultaneously fit 
the model in a number of cases with different inputs, and modify the parameters until 
optimum results are obtained. Unfortunately we could not find either a large number of 
cases or an appropriate method for this kind of fitting. The second way which has been 
used in this Thesis, was to look through the existing literature and establish an initial set 
of values for the parameters based on experimental results or previous computational 
models of coagulation. In this way the resulting Ǯlumpedǯ reactions are linked to the 
actual corresponding biochemical processes; at the same time, a range of accepted 
values for the parameters was obtained and used during the process of fitting. 
Additionally, it was checked whether the variation of the parameters was in agreement 
with the different conditions of each case. The results presented on Table 3-7 
demonstrate that at least quantitatively, the change of the parameters is the expected 
according to the different conditions. Cases 2 and 3 required modification of the 
initiation constant as different amount of the triggering substance was used while in 
cases 5-7 the results of TAGs that corresponded to different platelet concentrations were 
reproduced without modifying the parameters of the model. The initiation constant          is directly related to the amount of the triggering substance .It seems that the 
dependence of the initiation constant to the amount of the triggering substance can be 
Const.      Initial estimations Case 1 Case 2 Case 3 Case 4 Cases  5-7 Case 8  
         10-5 7.3∙10-6 9.ͳ∙10-6 1.5∙10-5 7.4∙10-6 7.2∙10-6 4.06∙10-7 
                0.73 2.8 4 1.55 0.53 3.6 
                 0.032 0 0 0.052 0.026 0.024 
               0.5 -  0.5 0.002 0.0018 
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described by a logarithmic relation. Note that the relationship between this constant and 
the lag time is approximately linear, as the reduction of prothrombin concentration 
during the lag time is very small and the amount of thrombin up to the threshold 
concentration increases linear with time. The variations of this constant were in 
agreement with the different concentrations of the triggering substance used in each 
case. At the same time, the case of haemophilia was successfully modelled without 
modification of the specific constant, in agreement with the alterations to the process 
caused by the disease. The only case where this constant was significantly lowered was 
the case with low (less than 20% of the normal) concentration of platelets. This indicates 
that in total absence of lipid surfaces, the initiation phase or at least the transition from 
the initiation to the amplification is also affected. This fact also supported by the small 
increase of the (experimentally derived) lag time for smaller platelet concentrations as 
reported in cases 5-7. So it is possible that the addition of a platelet concentration 
dependent term on the initiation would benefit the accuracy of the model. An overall 
comparison of the values of this constant has no meaning as different substances were 
used as triggering (human TF, r-TF and rTF:VIIa). 
Larger variations were observed in the fitted values of the reaction rate constant of 
prothrombin conversion to thrombin by activated platelets,      . The initial range of 
values for this process were extracted from the computational work of Sorensen et al 
[163] and an the experimental work of Rosing et al [133] that gives a large range of 
prothrombin activation rate by platelets for different experimental conditions. In the Ǯconstructionǯ of the reaction, the results for not stimulated platelets and platelets 
stimulated by thrombin were taken into account, but the rate of activation was kept 
constant. The results for cases 2 and 3 (although close to the predicted value) have no 
comparative value as in the specific experiments phospholipids were used instead of 
platelets. This variation for different cases was not surprising. This pseudo-reaction 
incorporates a large number of actual reactions therefore its variation may express 
altered function of several different parts of the coagulation process. Additionally, a 
small part of these reactions do not actually occur on activated platelets. Therefore the 
relationship between the platelet concentration and the activation rate of prothrombin 
by activated platelets was not expected to be accurately linear in the first place. The 
changes of the value of      .may reflect change of the non-used in the model real inputs 
of coagulation as fX, fV concentrations, different rate for one of the lumped reactions, but 
also big change in the platelet concentration. 
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The inhibition process was the most accurate part of the model. The minimum value was 
estimated using the ATIII inhibition at its maximum rate. All values used were within the 
predefined range with small variations; they were greater than the minimum value as 
they include inhibition of thrombin by other factors as well as all the other inhibiting 
reactions of the process that reduce the intermediate products of coagulation. The 
inhibition constant has almost the same value with the exception of the case where 
platelet poor plasma was used. That is feasible as thrombin that is bound on platelets is 
protected from inhibitors. Actually this would also justify allowing a small variation of 
the inhibition constant in cases 5-7 where platelet concentration varied, and possibly 
this would lead to better agreement of the simulation results with the experiments. The 
changes of the inhibition rate constant were applied only to the phase after the initiation 
in order to include the inhibiting feedback loops of the process. 
Finally the rate constant for the platelet activation by thrombin        had also large 
variations among the different cases. .As mentioned earlier, this term in most cases was 
modified manually. In the resulting thrombin generation curve this term is the main 
factor that determines the difference between lag time and the time of maximum 
thrombin concentration when the values of the parameters are within the accepted 
range. When the initial reaction rate was used for the process this difference,           ), was too small. This happened because the value for the constant, while 
taken from works where it represented only platelet activation, in this work is 
representing the whole process of transition from the initiation to the amplification 
phase of thrombin generation. This involves more processes and it is obviously slower. 
So for cases 5-8 the value of        was lowered significantly until the desired result was 
achieved.  
The presented model was developed in order to represent the temporal evolution of 
thrombin generation in a simplified manner while at the same time allowing the spatial 
distribution of the processes when applied to three dimensional cases. Each of the 
lumped reactions corresponds to a number of actual processes that occur in different 
sites and, with the exception of the inhibition, to a different phase of the coagulation 
process. Changes in one parameter of the physical system might require the modification 
of more than one constant of the equations. These modifications can be justified by the 
actual processes; the increase of the inhibition rate for lower platelet concentration is 
due to the reduction of the amount of the platelet-bound thrombin and the reduced 
platelet activity for lower fVIII concentrations can be attributed to the smaller amounts 
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of intrinsic tenase produced. However, the idea was to propose a system of equation 
that it would be able to reproduce the process as a whole rather than equations that 
independently describe different parts of the coagulation; therefore the variation of the 
reaction rate constants within a reasonable range was expected and does not require 
quantitative correlation with the experimental conditions of each case. 
3.8 Platelet adhesion sub-model 
The responses of platelets are modelled using a system of equations that is independent 
from the coagulation reactions. The platelet sub-model takes into account three different 
actions for platelets: binding on surface, binding on already bound platelets and 
unbinding from the surface. It is has been assumed that the corresponding three reaction 
rates for activated platelets are different, as one would expect them having more 
tendency to bind on the reacting surface or to each other and less tendency to 
disaggregate and return to the blood circulation. Therefore four different platelet-related 
states are required: resting platelets in flow     , activated platelets in flow       , 
bound resting platelets      and bound activated platelets       ; for each one of the 
possible platelet states corresponding source term for each state should be introduced. 
The model makes no distinction between platelets bound directly on the vessel wall and 
platelets binding on other platelets. The binding of platelets was introduced as a surface 
reaction term, similar to the one describing surface thrombin generation.  
In the equations of Table 3-8, the subscripts Ǯbiǯ and Ǯdissǯ refer to binding and unbinding 
respectively. The activation of platelets is not included in these terms. The binding of the 
platelets occurs only on the free part of the surface (the part not covered with platelets). 
The maximum platelets per surface was calculated based on the close packing ratio                    , a value close to the one used by Sorensen [163]             
or                after the unit conversion. Based on this value, the fraction of the 
surface that is available for platelet binding is calculated as: 
     [     ]  [     ]      
Equation 3.21 
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Table 3-8: Source terms for the four different states considered in the platelet 
aggregation sub-model:        corresponds to resting platelets in flow,        corresponds to bound resting platelets         represents the concentration of activated platelets in flow and        the concentration of bound activated platelets.          (                      [     ]          [     ])  [     ]          [     ]              (                      [     ]          [     ])  [     ]          [     ]  
        ((                      [     ]          [     ])  [     ]          [     ] )      
       (                      [     ]          [     ])  [     ]          [     ]  
The reaction rate constants are adjusted in order to function properly with the species in 
the units used in the model. The units for the bound resting and activated platelets 
are       and for the corresponding source terms are         while for during the 
implementation of the model the source terms for circulating platelets must be 
multiplied by a constant to convert their units to      . 
           
Equation 3.22 
Here       and ρ are respectively the reacting surface of the boundary cell, the volume 
of the cell and the fluid density. The reaction rate constants were adjusted in order for 
the model to be able to reproduce the results of platelet binding on sub-endothelium [2]. 
It was not possible to figure out a way to derive different reaction rate constants for 
resting and activated platelets for the specific experiment used for the calibration of the 
platelet sub-model. Therefore, the following approach was used: the constants of the 
model were adjusted to a single value, both for resting and activated platelets, using a 
system of only two species, circulating        and bound        platelets. So, for the 
development of the platelet aggregation sub-model only, the source terms that describe 
the change of the population of flowing and bound platelets presented in Table 3-8 are 
reduced to the ones described by Equation 3.23 and Equation 3.24, while the used 
species are also reduced to flowing and bound platelets. 
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         (                         [      ])  [      ]      
Equation 3.23 
        (                         [      ])  [      ]           [      ]   
Equation 3.24 
In this set of equations, platelets that disaggregate from the reacting site are not 
considered able to aggregate again or contribute in any way to the whole process. As 
described in the following sections, the different behaviour of platelet was included with 
the use of an additional constant,      , in a manner similar to the work of Sorensen 
[163]. The reaction rate constants for the transitions of activated platelets were set to be 
proportional to the reaction rates of resting platelets. For example the reaction rates for 
binding of resting and activated platelets on the surface of the vessel wall were related 
through the equation                            . 
3.9 Initial estimation of reaction rate constants  
An mentioned earlier, the verification-calibration of the platelet aggregation sub-model 
was based on the rate of platelet deposition on de-endothelized vessel segments [2]. The 
initial values of the reaction rate constants were based on some rational assumptions 
while fine tuning was performed after coupling the model with flow simulations, using 
the test cases described in the aforementioned study.  
An initial estimation of the reaction rate constant of platelets binding on the vessel 
surface can be obtained by using the conservation of mass for the platelets above the 
reaction rate, assuming that for the initial stages of the process the concentration of the 
platelets in that area will have a time-independent value [      ] . So the rate of platelet 
supply due to convection must be equal to the rate of binding. If a rectangular volume 
with dimensions ȟx, ȟy and h (x is the direction of the flow) is considered, then the 
previous assumption will lead to Equation 3.25: 
   [      ]                [      ]            ([      ]    [      ] )    
Equation 3.25 
92 
 
Here the height h is actually the depth of the reacting area. Platelets located outside this 
reaction zone, in a distance above h from the wall are considered unlikely to bind on the 
surface. The initial deposition rate can be approximated by:                [      ]  
Equation 3.26 
By combining Equation 3.25 and Equation 3.26 and substituting the velocity from 
Equation3.27: 
      
Equation3.27 
the approximation for the reaction rate constant shown in Equation 3.28 is derived: 
                     [      ]         
Equation 3.28 
The value that this relationship gives, using as reaction zone depth              
or in other words 3-5 times the diameter of a platelet, is of the order of              
As in all cases the quantity of bound platelets per surface reaches more or less a steady-
state value, it is reasonable to assume that at this point the aggregation and 
disaggregation rates are equal.  
 (                         [      ])  [      ]           [      ]  
Equation3.29 
As these values are well above the value where the surface is fully covered with platelets 
(    ), Equation3.29 gets the simpler form: 
 
          [      ]  [      ]           [      ]  
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Equation 3.30 
From that form one can get an initial estimation for the relationship between the 
disaggregation rate and the rate of platelets binding on other platelets, using the 
maximum value for bound platelets as shown in the graphs [      ]             and the initial concentration of circulating platelets. [      ]              
          [      ]           [      ]                                
Equation 3.31 
Additionally, as the difference in the initial rate is more obvious when the mass of 
aggregated platelets is less than 10% of the maximum, it was assumed that at this point 
the two processes must have comparable contribution to the increase of the quantity of 
aggregated platelets. This assumption provided a rough estimation for the ratio of the 
two reaction rate constants of these processes:           [      ]                  [      ]                              
Equation 3.32 
The initial values used as a starting point for the fine tuning of the model for the three 
constants were:                                        and                          . 
Time-step independence test showed that the results of the model when programmed in 
FLUENT were identical, even for large time-step values      . Also, while the 
boundary cells of the test geometry had low height to length ratio (0.1), the maximum 
value of bound platelets corresponded to a low volume (and mass) fraction of platelets 
in the cell (<0.07) one order of magnitude lower than the close pack ratio. 
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3.10 The fine tuning of the platelet sub-model 
As mentioned earlier the calibration of the model was based on the result reported by 
Badimon et. al [163]. A tube shaped geometry was constructed, with dimensions 0.04m 
×0.002m (length × diameter). A computational grid of 172,800 cells was constructed, 
with layers of denser grid near the near the walls. The reacting surface was defined as 
the part of the wall 0.025m stream-wise and 0.001 width, starting 0.01m downstream 
the entrance of the computational domain; this was similar to the dimensions of the de-
endothelized stripes described in the reference experiments. Flow simulations were 
performed for three different flow rates shown in Table 3-9. The actual values of wall 
shear rate were close to the reported ones, (<2% difference). The inlet length was 
enough to allow the development of a velocity profile identical to that of the outlet 
proximal to the reacting area (Figure 3-11). The flow conditions for these three cases are 
also reported in Table 3-9. The bulk platelet distribution was set to 0.0042kg/kg, or             according to the value reported in the experiment. Initially, only the flow 
field was solved as a steady state case and following that, the platelet deposition sub-
model was applied as a transient simulation. Wall shear rate values that were calculated 
 
Figure 3-11: The geometry used for adjusting the platelet deposition sub-model and a 
cut of the computational grid showing the dense cells of the boundary layer. The 
contour of the velocity profile corresponds to the case PLA1; the other cases had 
identical velocity profiles but the values of the velocity magnitudes were scaled 
according to the flow rate at the inlet.  
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from the simulation results were very close (less than 1% variation) to the reported 
ones. 
Table 3-9: Reported wall shear rate values and corresponding mass flow rate at inlet 
for platelet deposition cases. 
Case Shear rate(s-1) Inlet mass flow 
(kg/s) 
PLA1 106             
PLA2 212             
PLA3 1690             
The fine tuning of the model was mainly based on case PLA1 while the values of the 
constants used as a starting point for the fine tuning are shown in Table 3-10: Initial 
reaction rate constants for platelet deposition sub-model 
Table 3-10: Initial reaction rate constants for platelet deposition sub-model 
Process Reaction rate constant 
Platelets binding on surface                         . 
Platelets binding on platelets                   
Platelets unbinding                         
 
As shown in Figure 3-12 this setup of the model performed very well against the 
experimental values for the case with minimum shear. 
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As the shear value affects the 
platelet binding rate [206], 
probably by changing the 
diffusivity of platelets and the 
frequency of collisions 
between the platelets and the 
reacting site, the constants of 
the model regarding the 
aggregation should be 
somehow increased to 
reproduce the experimental 
results of cases with higher 
shear rates. The constants 
were multiplied by a shear 
dependent factor           . 
As shown in the related plots 
Figure 3-13 this modification gives good results for      , (case PLA2) while the 
results for        (case PLA3) show some deviation; in this case the model 
overestimates the maximum value of bound platelets, and it fails to predict the decrease 
of the quantity of bound platelets.  
  
Figure 3-13: Platelet deposition for cases PLA2 and PLA3. The introduction of shear 
dependent platelet aggregation rate captures the aggregation rate, but the model fails 
to reproduce the reduction of the quantity of aggregated platelets. However this 
occurs approximately 600sec after initiation, while the maximum simulation time for 
the realistic models was 480s. 
 
Figure 3-12:  Platelet deposition on de-endothelized 
vessel segments. Computational results against 
experimental for the PLA1 case. 
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The first insufficiency of the model is probably due to the influence of shear on platelet 
unbinding process. Thus, it was reasonable to assume that increased shear rate (and 
subsequently shear stress) will cause more platelets to disaggregate. The experimental 
values in Figure 3-13 indicate that high shear stress could cause large amounts of 
aggregated platelets to dis-aggregate after some time, perhaps due to stress 
accumulation. Such a prediction, platelet disaggregation after reaching the maximum 
value (and without any alteration in the flow conditions or concentrations) is not in the 
capabilities of the model, as under steady-state flow conditions the final stage of the 
process is achieved at an equilibrium state, where aggregation and disaggregation 
balance each other. It has also been reported that the dominant mechanism for platelet 
aggregation on a surface is not the same for all the range of wall shear rate (and wall 
shear stress) values [207]. 
3.11 Introducing the coagulation activation index (CAI) 
It has been reported [3] that the initiation of the coagulation process has a threshold 
behaviour with respect to the value of the wall shear rate and the size of the reacting 
surface. More specifically, for a given geometry and stream-wise length of the reacting 
surface, there seems to be a maximum value for the wall shear rate (γ), while for a 
determined value of wall shear stress there is a minimum threshold size of the stream-
wise length of the reacting area (L). This can be attributed to the lag-time of the 
thrombin generation that is shown in the TGA curve when the quantity of the triggering 
substance (usually TF) is below a threshold. In other words, it is possible that the 
substances that are involved in the initiation phase of coagulation are required to stay 
near the reacting surface for a minimum time interval in order to actually trigger the 
initiation. As the reactions occur due to the existence of substances on the surface (and 
not the whole mass of the flowing blood), these reactions must take place within a 
relatively small zone near the reacting boundary. For such a reaction zone with a given 
depth h, these two threshold quantities actually define a threshold for the actual 
residence time of chemical substances above the reacting zone: 
             
Equation 3.33 
Under the reasonable approximation that the reaction zone depth does not change, a 
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threshold value for the quantity         can be defined, describing the activation of 
the coagulation process. Actually, as diffusivity of platelets and other substances 
involved in the coagulation process is enhanced by the red blood cell motion, it will be 
increased for higher values of shear, possibly causing also a slight increase of the 
reaction zone depth. From the threshold values reported in the aforementioned study, 
the CAI threshold value was calculated              . Though it is highly unlikely 
that the threshold cases reported in the study to be able to represent the exact threshold 
conditions, the threshold value proposed is the minimum calculated (           ) 
provided that the geometry and the reacting surface is well defined. On the other hand, 
in a realistic geometry it will be impossible to calculate the Ǯstream-wise length of the reacting surfaceǯ with accuracy. Probably the value of shear has variations, so the 
maximum seems like a better choice. It is interesting that the in the following 
simulations for the calibration of the coagulation model under flow conditions, the 
maximum thrombin concentration in cases with sub-threshold conditions was exactly 
proportional to CAI. 
3.12 Coupling of the coagulation model with flow simulations 
In order to test the coagulation model (especially the thrombin generation sub-model) 
under flow conditions and to obtain a justifiable value for the surface reaction rate 
constant of initiation (        ), the experimental data concerning the threshold 
behaviour of the coagulation initiation with respect to the value of the wall shear rate 
and the stream-wise length of the reacting surface reported by Shen et al [3] were used. 
The geometries that correspond to the described experimental setups were 
reconstructed, the flow conditions were simulated via CFD and finally the coagulation 
model was applied.  
Two different geometries used for the adjustment of          were chosen from the ones 
described in the experiment of Shen et al [3] and they are shown in Figure 3-14; these 
will be referred to as SA and SB, respectively. The only geometrical difference between 
SA and SB is the length of the reacting wall (RWL). The reported wall shear rate and 
corresponding mass flow rate at the inlet are also different between the two geometries. 
The choice of the specific geometries was based on the values of CAI. The simulations 
should include mainly the two borderline cases: the case with minimum value of CAI 
where initiation of coagulation was observed and the case with maximum value of CAI 
where the initiation of coagulation did not occur. A computational grid (the same for 
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both geometries) with 227,200 cells with 10 layers of thin boundary cells was 
constructed. As CAI is lower for case SA, it can be expected that if the value of the          is set high enough to initiate the coagulation in case SA, there would be also 
initiation of the coagulation process in case SB. As the modelǯs behaviour was in 
accordance to that expectation, the calibration of          was actually the task of finding 
the minimum value of the constant capable of initiating the coagulation in case SA. This 
was done via a trial-and-error process. The range of the values tested were of the same 
order of magnitude as the predicted value reported in the thrombin generation sub-
model [142].  
The initial idea for an initiation criterion was to check whether the average surface 
concentration of thrombin in a cross section of the tube near the exit, exceeded the 
threshold value of the thrombin sub-model. After performing the initial simulations 
though, it was found out that the model under flow conditions had a very clear threshold 
response. The surface average of thrombin concentration in three cross-sections 
downstream the reacting boundary was calculated. It was interesting to discover that for 
sub-threshold setup of the model the concentration decreased as we moved 
downstream, while for above threshold setup the concentration increased. Therefore 
this was set as a criterion to decide on which cases initiation of the coagulation process 
took place. The result of the process gave a value of                            ; 
this is somehow lower than the value estimated earlier based on the cell size, but this 
was not a surprise, as this value was calculated using approximations from the constant 
of the bulk reaction, and was only used as a starting point; more importantly, there was 
no way to compare the TF concentration of the vesicles used in the experimental study 
for the surface activation to the bulk recombinant TF concentration.  
Although a large number of test simulations were performed until this result was 
achieved, in Error! Reference source not found. only 5 characteristic cases are 
presented. Cases SA and SB were the original cases, shown in Figure 3-14. Case SB was 
simulated just to show that the chosen value for the constant, based on case SA was also 
capable to initiate the coagulation in case SB, as expected. In the third case, SA_LC (lower 
reaction rate constant) the value of the reaction rate constant was a little lower,                            . However this small change (less than 1%) was 
enough to prevent the initiation of coagulation. For application of the model in real 
geometries, a slightly higher value was used                         , as it seems 
very unlike that the case SA is exactly the threshold case. The next cases, SA_HS (High 
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Shear) and SB_HS are presented to show that increased values of shear (that cause the 
CAI value to drop) prevent the initiation of coagulation. 
Table 3-11: Test cases simulated in order to adjust the rate constant for the surface 
initiation reaction.  
Case 
WSR 
(   ) Q(kg/s) RL (m)          
CAI 
(          initiation 
SA 25                             0.8 YES 
SB 40                             1 YES 
SA_LC 25                             0.8 NO 
SA_HS 30                             0.625 NO 
SB_HS 60                             0.667 NO 
The simulations for determining the reaction rate constant for surface thrombin 
generation were performed without taking into account the platelet activation due to 
contact with the reacting surface. In the final formulation of the model, a simple source 
term for contact platelet activation was added, applying only to bound resting platelets.                     [     ] 
Equation 3.34 
This term was added to the source term of bound activated platelets and subtracted 
from the source term of bound resting platelets. The reaction rate constant was 
estimated from the findings of Allen et al [198] for the time interval up to 50% platelet 
activation. The time interval reported for this process was about 7min, leading to an 
estimation of the reaction rate constant: 
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                                      Equation 3.35 
 
This constant actually includes the activation of platelets due to all possible mechanisms, 
as thrombin, agonists released from other activated platelets and direct surface 
activation; it is obtained under the assumption that the rate of activation is constant, 
something that contradicts with the behaviour of the thrombin generation sub-model. 
On the other hand, the presence of aggregated platelets on the vessel surface will 
probably cause locally increased residence time and augmented concentration of 
  
CASE SA CASE SB 
Figure 3-14: Geometric and flow characteristics for cases SA and SB. Note that in 
both cases the entrance length (upstream the reacting area) is sufficiently long for the 
development of velocity profile, which was identical with the velocity profile at the 
outlet. 
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substances, as they will induce a type of local surface roughness at sub-grid level.  
Therefore the value used in the final formulation of the model was a little bit augmented 
(2 x10-3s-1), but still has a significant role only in the coagulation pre-activation phase in 
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Figure 3-15: Comparison between the sub-threshold and the above-threshold cases. 
The X sign indicate the logarithm (base 10) of average thrombin concentration in the 
specific points, divided by the threshold thrombin concentration, while in the contours 
it is depicting the distribution of actual thrombin concentration in kg/kg. This 
distribution of thrombin concentration is after 300s of perfusion. 
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realistic models and flow conditions, when thrombin concentration levels are below the 
threshold value; at the same time, it is not causing significant changes in the simple test 
cases in tube geometries. 
In the following figure we compare the concentration and distribution of thrombin 
concentration for cases SA and SA_LC; these two cases have identical geometrical and 
flow characteristics, with only differentiation being in the value of the surface thrombin 
generation rate constant,         . It is obvious that for the cases with sub-threshold 
setup, the inhibition process reduces the concentration of thrombin downstream the 
reacting surfaces, while for the above-threshold cases, the concentration of thrombin 
continues to increase downstream the reacting surface. Thrombin concentration 
increases in areas away from the wall due to diffusion. It is interesting that, while at the 
point right after the reacting boundary, the difference in the average thrombin 
concentration is not very high, the above-threshold case presents one order of 
magnitude higher values downstream. 
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3.13 Overview of the model  
The final formulation of the model includes 6 different species as shown in Table 3-12. 
Prothrombin, thrombin and four different states for platelets. 
Table 3-12: The species included in the final formulation of the model, initial 
concentrations and diffusion coefficients. 
Name Symbol (Units) 
Initial 
concentration 
Diffusivity 
(        
Thrombin [IIa] (kg/kg) 0           
Prothrombin [II] (kg/kg)                      
Circulating resting 
platelets 
[     ] (kg/kg) 0.004           
Circulating activated 
platelets 
[     ] (kg/kg) 0           
Bound resting platelets [     ]       0 0 (surface bound) 
Bound activated 
platelets 
[     ]       0 0 (surface bound) 
 
There are additional processes occurring in the area and consequently the 
computational cells that lay near the wall of the vessel and this results in different forms 
for the source terms. Therefore, for circulating species there one part  of the source term 
represents the bulk reaction (Table 3-13). These terms are similar to the ones used in 
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the thrombin sub-model but they are presented again here because there are two 
important modifications: (i) the initiation term is not included, as it is presumed that TF 
is only present on the vessel wall and therefore the initiation takes place only at these 
sites; (ii) the added inhibition term is not included either, as the increased rate of 
inhibition is attributed to the APC and activated protein C is mainly found on the 
endothelium.  
 
Table 3-13: Source terms for the species of the model for the bulk reactions 
(reactions occurring in flowing blood and not at the cells near the vessel wall). 
[   ]       [   ]  (      [     ])  [  ] 
[  ]  (      [     ])  [  ] 
[     ]  (             [     ])  [     ] 
[     ]  (             [     ])  [     ] 
 
For the cells that included reacting boundary faces there are two additional species, 
resting and activated bound platelets and additional processes attributed both to the 
surface properties and to these species. Therefore there have been included extra terms 
that describe the binding and unbinding of both resting and activated platelets on the 
surface, the contribution of the reacting surface and activated bound platelets on 
thrombin activation and the activation of platelets due to contact with the reacting 
surface. For the resting and activated platelets source terms, part of the term in the first line ȋǮBindǯȌ refers to the binding and unbinding while the second line ȋǮactǯȌ contains the 
part of the source term related to the activation of platelets. The parts of the source 
terms referring to the activation of platelets by thrombin are active only when thrombin 
concentration is above the threshold value in the specific cell. In other cases the 
corresponding reaction rate is zero. Finally, the additional term for inhibition that refers 
to the thrombomodulin-APC inhibition loop is also active when thrombin is above 
threshold as protein C is activated by thrombin. As thrombomodulin is expressed on 
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endothelial cells without requiring any special pathological conditions, this term (the 
increase of inhibition rate) is also applied to all the computational cells that are attached 
to the vessel wall, provided the concentration of thrombin is above the threshold. The 
additional parts of the source terms for the reacting boundary cells are presented in 
Table 3-14. 
Table 3-14: Additional source terms for the model’s species for the computational 
cells that include reacting boundaries. [   ]        [   ]                 [     ] [  ] [  ]                 [     ] [  ] 
[     ] bind  ቀ(                      [     ]          [     ])  [     ]ቁ       [     ]  [     ] 
act 
[     ] bind  ቀ(                      [     ]          [     ])  [     ]ቁ       [     ]  [     ] 
act 
[     ] bind  ቀ(                      [     ]          [     ])  [     ]ቁ         [     ]        [     ]       ([     ]  [     ])  [     ]         [     ] act 
[     ] bind  ቀ(                      [     ]          [     ])  [     ]ቁ         [     ]        [     ]        ([     ]  [     ])  [     ]         [     ] act 
 
The values used for all the constants used in the model are summarized in the.Table 
3-15. As there are no available data for the different behaviour of resting and activated 
platelets in respect to binding and unbinding, a standard ratio between the constants 
referring to resting and those referring to activated platelets was used and denoted as      . For computational times up to 10 minutes, the addition of this term did not have 
any significant effects on the results of the model, as the activated platelets that were not 
bound on the vessel wall were washed down by flow. 
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Table 3-15: Values of all the reaction rate constants used in the model. 
 Symbol Order  Value  Process description 
T
h
ro
m
b
in
 g
e
n
e
ra
ti
o
n
 
         1                  Thrombin generation on the 
reacting boundary surfaces 
      2        Thrombin generation by 
activated platelets 
      1             Inhibition of thrombin in 
interior cells 
        1           Enhanced inhibition of 
thrombin due to the 
presence of ATH III in 
boundary cells 
P
la
te
le
t 
a
ct
iv
a
ti
o
n
 
       1 {      [   ]  [   ]            [   ]  [   ]      Platelet activation by thrombin 
      2           Platelet activation by other 
activated platelets 
        1           Platelets activated due to 
contact with reacting boundary 
surface  
B
in
d
in
g
 o
f 
re
st
in
g
 
p
la
te
le
ts
 
           1           Binding of resting platelets on 
reacting surface 
        2         Binding of resting platelets on 
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bound resting platelets 
        2         Binding of resting platelets on 
bound activated platelets 
        2         Disaggregation of resting 
platelets 
B
in
d
in
g
 o
f 
a
ct
iv
a
te
d
 p
la
te
le
ts
 
      0 1.0 Differentiation of the activated 
platelets in respect to binding 
           1                  Binding of activated platelets 
on reacting surface 
        2               Binding of activated platelets 
on bound resting platelets 
        2                Binding of activated platelets 
on bound activated platelets 
        2               Disaggregation of activated 
platelets 
In the function of the model there were also two very important parameters, the 
maximum amount of platelets per surface and the thrombin concentration threshold for 
platelet activation, with the last one also signalling the transition of the coagulation 
process from the initiation to the propagation phase and giving a boost to thrombin 
generation rate. The amount of platelets for full coverage of the surface was                       for all the simulations. The thrombin concentration 
threshold used in the thrombin generation sub-model was [   ]               ⁄  
and the same value was used during the calibration of the model under flow when a 
fixed grid was used. But as explained before, in order to apply the model on geometries 
with different grid cell sizes a different approach was used as explained below. 
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3.14 Some details on simulations and programming  
The initial testing of the model was performed in Microsoft Excel and Matlab for the 
zero-D cases. For the coupling of the model with simple flow fields a simple explicit code 
was developed that applied the model in very simple geometries with already dependent 
laminar flow field. For the coupling of the model with complex flow fields the 
commercial CFD software ANSYS FUENT was used. The results of FLUENT with the 
results of the custom code for the simple cases were identical. All the species of the 
model were introduced in FLUENT as user defined scalars (UDSs). While FLUENT 
provides the option of species with reaction terms, this was not applicable in that case as 
in the case of the species setup FLUENT calculates the concentration of the last species 
based on mass conservation. This would lead to added complexity and a number of 
possible errors for two reasons. Firstly, the circulating species concentrations were 
expressed in mass per fluid mass (kg/kg), while the surface bound species were in mass 
per surface( kg/m2);unfortunately there is no way to use two different concentration 
units for the same species in FLUENT. So all the bound species should be measured in 
kg/kg and converted to the correct units kg/m2 at the end of the calculations. However 
using this approach, the concentration of the surface bound species involved in the 
reaction rates would depend on the dimensions of each cell. Second, in the conversion of 
prothrombin to thrombin the resulting molecule has almost half the size of the original 
one, the molecular weights are 72kDa and 37kDa respectively, as the during the 
activation a part of the prothrombin molecule is cut-off. Thus in order to achieve mass 
conservation in the system of the reactions an additional species would be required, only 
to represent the cut-off part of prothrombin. 
According to FLUENT user manual (9.1.3), for each UDS named φi, FLUENT solves the 
convection diffusion equation with source terms,    :              ⃗             
Equation 3.36 
In all cases, the flow was initially solved (either as steady-state or time-dependent 
during the cardiac cycle) and the UDSs were applied afterwards. In the simple 
geometries, regarding the temporal discretization, all the terms of the reactions were 
treated implicitly; for example, the source term for thrombin for the tn-th time step was: 
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 [   ]             [   ]                    [     ]     [  ]     
Equation 3.37 
This approach gave correct results for the simple cases and made the model practically 
time-step independent (identical results for time-step values larger than 2.5 seconds or 
3 heart-cycles).But when it was used in the cases of complex geometries, it resulted in 
numerical generation and diffusion of substances in small quantities (of the order of      or ten orders of magnitude smaller than the lower produced amount by the 
reactions), a fact that for a simulation of a long time period (more than 500 heart cycles) 
had an effect on the results. In order to avoid this, terms of the reactions were treated as 
explicit. With this approach the source term for thrombin was changed to: 
 [   ]             [   ]                      [     ]       [  ]       
Equation 3.38 
This approach gave identical results with the fully implicit approach for the simpler 
cases, when relatively small (but still large enough) time steps up to 0.5s were used. 
Additionally, the explicit formulation of the source terms eliminated the numerical 
generation and propagation of substances in the more complex geometries.  
The surface reaction terms were actually programmed as surface fluxes and, as shown in 
Table 3-14 they were expressed as mass production per surface unit. So for the complete 
expression of a source term that included surface contribution, the surface-produced 
quantity of the substance had to be converted to match the units of the bulk production 
terms (kg/kg). So for the cells attached to the reacting boundary the source terms 
consisted of two parts the surface and the bulk reaction term: 
 [ ]       [ ]        [ ]               [ ]        [ ]                  
Equation 3.39 
Here    is the surface of the reacting boundary face,    and    the volume and the 
height of an approximately rectangular cell. It is obvious that it is impossible for the 
results to be completely mesh independent, as by increasing the height of the cells, the 
resulting concentration is inherently reduced. On the other hand, if for the surface 
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reaction terms is chosen another formulation that would express the products directly to 
bulk concentrations we would have the total amount of the produced (or consumed) 
substance depending on the grid. So using the first formulation there would be 
production of the correct amount of substance but the value of the concentration would 
be grid dependent while with the second formulation we would have correct bulk 
concentration values but the total amount of the produced substance would be time 
dependent. As the total amount of produced substances is generally considered more 
important than the local concentration values, the total amount of the species produced 
by surface reactions were calculated and the dependence on the cell dimensions was 
reduced with the use of refined mesh for the boundary layers. There was only one 
exception to that approach: the threshold value of thrombin concentration for the 
initiation of coagulation. In the calibration cases, the threshold value for bulk thrombin 
concentration was used was             ⁄ . However, as the initial rate of thrombin 
mass generation is due to surface reactions, the sub-threshold concentration of thrombin 
in the cells near the reacting boundary, as explained earlier, depends very strongly on 
the height of the computational cells. For the total amount of thrombin produced, this 
discretization error is corrected by diffusion and the choice of sufficiently small time-
step, as the gradient of thrombin concentration in the direction perpendicular to the wall 
is very high. The threshold value though requires more attention, as if for one time-step 
the thrombin amount exceeds this value, the source terms are different for the next time 
step. This could lead to serious error, as the transition of the coagulation process from 
the initiation to propagation phase which is an essential part of the model, would depend 
strongly on the grid. To prevent this, the threshold value for the computational cells that 
are attached to the wall was based on the amount of thrombin above the reacting 
surface. The boundary cells in the grid used for the calibration of the model under flow 
were purposely identical and had a cell volume                . The surface of the 
reacting face was                . So the Ǯsurface thresholdǯ of thrombin amount for 
platelet activation in the boundary cells used for the model in the realistic model 
simulations was: 
[   ]      [   ]                       ⁄  
Equation 3.40 
So after this modification, the triggering of the coagulation progress for the reacting 
boundary cells depended on the actual amount of thrombin above the reacting area. This 
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is equivalent to the physical assumption that the initiation reactions occur within a 
boundary layer of 3Ɋm.  
Finally in the simulations where the model of coagulation was applied to realistic 
geometries, the value of the wall shear rate (required for the shear-dependent adhesion 
rate) was calculated using the simplified formula of dividing the magnitude of the 
velocity at the centre of the boundary computational cell by the distance between the centre of the cell and the Ǯcentreǯ of the boundary face. In order to make sure that this 
method for the calculation of shear rate does not introduce significant error, we 
calculated the shear rate in one case in a more detailed way; we calculated the 
component of the velocity vector that was parallel to the boundary face and divided by 
the distance of the centre of the computational cell from the boundary face. As in all the 
geometrical models  refined boundary layers were used for the grid, the two methods for 
the calculation of shear rate gave the same results and therefore the simpler and less 
time consuming method was used. 
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Chapter 4  Flow simulations 
4.1 Introduction 
In this chapter it is examined whether computational simulations of flow field can 
indicate differences between geometrical models of LAD that are already statistically 
assessed as of different risk for CAD complications. Initially, it is described how the 
models of LADs corresponding to healthy individuals and stenosed LAD arteries were 
obtained. The data on which these arterial tree reconstructions were based are reported, 
while a short description of the techniques used for the reconstruction and the creation 
of the computational mesh are also given. Following, the formulation of a method for 
obtaining boundary conditions for coronary and LAD arteries based on the geometrical 
characteristics is described. The quantities used to characterize the disturbance of the 
flow field due to the stenosis are defined and finally the results are presented and 
discussed.  
4.2 Construction of the geometrical models 
As mentioned earlier, the comparison of a number of X-ray coronary angiographies of 
patients showed that the possibility of acute coronary syndrome can be related to the 
location of the stenosis [1, 30]. Based on that clinical finding, a total of 16 LAD 
geometries were constructed. The first one is a model without stenosis and corresponds 
to a healthy individual while all other 15 geometrical models had different degrees and 
  
Figure 4-1: (left) Typical image from X-ray angiography and (right) the centrelines of 
the main branch and the side branches used for the averaged LAD model. 
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location of stenosis. 
Initially the healthy model was developed, using the centrelines of the main branch and 
the major bifurcations and the diameter of the vessels at each point as these were 
extracted from X-ray angiograms of patients using the methods developed by Andriotis 
et al [105]. The three dimensional models for the main branch and the five side branches 
were constructed in Solidworks. These vessel shapes were used for the assembly of an Ǯaverageǯ LAD model. The information regarding the location of the bifurcations on the 
main branch and the angle between the main branch and the bifurcations were extracted 
from the statistical processing of the LAD geometries of 85 patients performed by 
Katritsis et al [1]. The models of the side branches were attached on the main branch and 
appropriately rotated in order to approximate the description of the average LAD 
(Figure 4-2).  
Instead of using a constant value of about 0.024mm/mm for the tapering of the main 
branch that resulted from the proximal distal and intermediated values of diameter of 
 
Figure 4-2: The data used for the construction of the average LAD model and the 
modifications on the tapering. 
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LAD (3.5mm-1mm/104mm), tapering was introduced only in the area of the 
bifurcations. For the calculation of the diameter of the main branch after a bifurcation 
Equation 4.1 was used [208, 209].                     
Equation 4.1  Here PMB, DMB and SB are the diameters of the proximal main branch, the distal main 
branch and the side branch, respectively (see Figure 4-2). For the side branches, a 
constant tapering of 2mm/100mm was used. The resulting geometry had a total volume 
of              and the total wall surface was         . Finally, a small fillet of 
radius 0.02mm, of the same order of magnitude with the X-ray pixel dimensions, was 
added at the point where each side branch meets the main branch. 
The stenosed models were constructed by Ǯaddingǯ stenotic lesions at the healthy LAD 
 
MI1 MI2 STA 
  
 
Figure 4-3: The sites of the stenotic lesions on the initial geometry and the model with 
maximum stenosis (90%) for each of three groups tested. 
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model on specific points (Figure 4-3). The position of the stenotic lesion for each case 
and the total length are shown inTable 4-1. The centre of each stenotic lesion is also the 
point with the maximum degree of stenosis. Based on the location of the stenotic lesion 
the stenosed models were divided in 3 groups, MI1, MI2 and STABLE. Each group 
included geometries with the centre of the stenotic lesion on a specific location and 
different degrees of stenosis 20%, 35%, 50%, 70% and 90%.  
Two of these groups are considered more likely to cause myocardial infarction (MI1 and 
MI2) while the third one is considered by far less dangerous (STABLE). More specifically, 
in MI1 and MI2 models at least one bifurcation was involved in the stenotic region. In 
MI1 the stenosis affected the second bifurcation of the model. The affected bifurcation 
was upstream the peak of the stenosis. In the MI2 models the stenosis mainly affected 
the third bifurcation, distal the peak of the stenosis, but there was a small change also at 
the second bifurcation, upstream the peak of the stenosis. In both of these groups the 
peak of the stenosis was located between the second and third bifurcation. In the models 
of the group STABLE, the stenotic region did not involve bifurcations and the peak of the 
stenosis was between the fourth and the fifth bifurcation. As seen in Table 4-1 the 
stenotic lesions in MI1 and MI2 groups were of greater length and the original diameter 
of the LAD in the stenotic lesion was greater than in the STABLE one. 
Table 4-1: The exact locations, beginning, ending and centre of the stenotic lesion for 
each group of the simplified LAD models. The centre of the lesion is also the point of 
maximum stenosis. All dimensions are given in mm 
 
By modifying the normal LAD model, the geometry with the maximum degree of stenosis 
(90%) was constructed for each group. The degree of stenosis is defined based on the 
relation between the diameter of the stenosed vessel at the point of maximum stenosis 
and the diameter of the healthy vessel (Equation 4.2): 
                                
group
position LAD diameter position LAD diameter position LAD diameter
beginning 29 1.47 31.8 1.45 61.2 1.12
center 38 1.38 40.8 1.375 68.7 1.1
end 47 1.29 49.8 1.27 76.2 1.12
length
MI1 MI2 stable
18 18 15
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Equation 4.2 
The reduction of the radius along the centreline of the vessel follows a sinusoidal law, a 
method that has also been used in previous studies [210, 211]. As the minimum radius is 
at the centre of the stenotic lesion, the radius of the stenotic vessel at the distance x from 
the beginning of the vessel was calculated using Equation 4.3: 
                         ቆ           ቇ  
Equation 4.3 
Here c is the centre and 2a the length of the stenotic lesion respectively, while R0 and Rs 
are the radii of the healthy and the stenotic vessel, respectively. The position x of each 
point of the main branch is defined using the length of the centreline from the inlet to the 
point. The final geometry was created by determining the value of the radius in some 
points of the centreline using Solidworks, while the exact formula used for the 
calculation of the radius did not have serious influence on the shape of the resulting 
geometry. In cases MI1 and MI2, the diameter of the second and third side branches from 
which they originate, are within the stenotic lesion; these, are lessened so that they can 
fit on the main branch. As a result of this, in these cases the second side branch is also 
 
Figure 4-4: Boundary layers near the wall 
surface as seen at the inlet of the 
computational domain. 
Figure 4-5: The denser grid at the areas of 
main interest (bifurcations and stenotic 
lesions) is shown 
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stenosed by approximately 20% (for MI1) and the third side branch is stenosed 
approximately 50% (for MI2).  
A computational grid with denser boundary layers (Figure 4-4) of about 1.5 million 
hexahedral cells was initially created for the non-stenosed geometry. Preliminary mesh 
independence tests with number of cells varying from 600 thousand to 2 million 
indicated that for grids with more than 1 million cells the simulation results were almost 
identical regarding wall shear stress, pressure drop, velocity profiles and streamlines in 
indicative locations of the geometry. The grid was constructed using the Hexa-Block tool 
of ANSA. With the use of this specific tool, the geometry was split to Ǯboxesǯ that were accurately fitted on the geometryǯs surfaces and created the grid and the boundary 
layers for each box. Special attention was paid in order to have denser grid in the areas 
of higher interest, near the bifurcations and the fillets at the inlets of side branches as 
well as the main branch at the stenotic lesions (Figure 4-5). 
 
Figure 4-6: Curves for the model without stenosis and the model with maximum 
stenosis (90%). The grid points for the intermediate models were obtained directly 
(without constructing new mesh) by interpolating the coordinates of the two extreme 
states.  
The topology of the grid boxes of the normal model was exported, along with their grid 
nodes. Following, three sets of curves were constructed (Figure 4-6), for the three 
models with 90% stenosis (one for each group). The curves defined both the boundary 
surfaces of each model and the boundary layer (Figure 4-6). The next step was to fit the 
hexa-boxes on the curves. For the parts of the geometry that not affected by the stenosis, 
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the hexa-boxes were obviously left as they were initially constructed. For the affected 
part, each edge of the hexa-boxes was fitted on the corresponding curve of the geometry. 
This process produced four identical computational grids with respect to the grid point 
number; one for the non stenosed model and three models with stenosis 90%, each one 
corresponding to the geometry with maximum degree of stenosis for each group. With 
the use of a script that was programmed within ANSA, it was possible to obtain directly 
the mesh for any intermediate geometry with stenosis between 0 and 90% by 
interpolating the grid point coordinates, without constructing the geometry for each 
model from the beginning. Giving as input a user defined parameter between 0 and 1, 0 
for normal model and 1 for 90% stenosed model, the script obtained the coordinates of 
the mesh nodes for any intermediate geometry as a linear interpolation of the 
coordinates of the nodes of the normal (xN) and the stenosed (xS) vessel. 
For example for the geometry with 35% stenosis, the user defined parameter was ɉ=0.3889 and the coordinates xA of a node of the geometry was given by the formula:                  
Equation 4.4 
However, a number of the intermediate geometries were also constructed in Solidworks 
independently, in order to place eccentric stenosis instead of symmetric (see Figure 4-7 
  
Figure 4-7: Symmetric stenosis (Case 
STABLE with 50% of stenosis) 
Figure 4-8: Eccentric stenosis (Case MI2 
with 50% stenosis) 
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and Figure 4-8). Finally all the models of the STABLE group had symmetric (to the 
centreline) stenosis, while the geometries of stenosis 20%-50% of the groups MI1 and 
MI2 were constructed in two versions, both with symmetric and eccentric stenotic 
lesions. 
 Here it must be noted that as the side branches are attached on the main branch based 
on averaged numbers (and not on the shape of a specific geometry) and the stenosis is 
artificially introduced onto the averaged LAD model, the resulting geometries might not 
correspond 100% to existing ones. 
4.3 Governing Equations 
Blood was modelled as a Newtonian fluid, using the incompressible Navier-Stokes 
equations (Equation 4.5); this was justified as for typical LAD dimensions the shear rate 
is well above the limit where blood exhibits shear–thinning behaviour for almost the 
whole of the cardiac cycle [58].                 ,       
Equation 4.5 
The viscosity was constant,              [88, 212, 213] and density                . The calculated Reynolds numbers were below 100 even when the maximum 
calculated velocity and the minimum diameter of the models with 90% stenosis were 
used. Therefore the flow was modelled as laminar and no turbulence model was used. In 
all simulations the vessel walls were considered rigid and stationary as it has been 
shown that at least for the flow rate and pressure distributions, wall deformability and 
movement have small influence [105, 112]. 4.4 Boundary Conditions 
4.4 Boundary conditions 
As already described, inflow and outflow boundary conditions for the coronary arteries 
exhibit some additional difficulties compared to other human vessels. While in literature  
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there are available at least indicative waveforms for the aortic pressure, there is very 
little information for the pressure or the mass flow rate at intermediate points of the 
coronary vessel system. The difficulty lies in the fact that there is no obvious way to 
know with acceptable accuracy the pressure or the flow rate at the flow outlets of the 
part of the coronary network that is used as computational domain for these 
simulations. As the coronary vessel system is located on the myocardium, there is 
pressure due to the heart contractions (intramyocardial pressure), which is also not 
 
Figure 4-9: Factors determining the coronary flow. As it can be seen, the 
‘operating’ pressure and the resulting flow rate are out of phase. The flow is 
mainly determined by the intramyocardial pressure, exerted on the coronary 
vessel network due to contraction. The vessels are coloured according to the 
intra-myocardial pressure [214] (blue is 0 red is 8kPa) at a random instance of 
the cardiac cycle. 
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uniformly distributed [214] on the vessel network; thus the final outlet pressure alone     ȋatrial pressureȌ is not of much use. Mass flow rate and coronary Ǯoperatingǯ 
pressure defined as the difference             , between the aortic minus the atrial 
pressure are out of phase; the mass flow rate waveform is mainly determined by the 
behaviour of the coronary vessel system and the intramyocardial pressure (Figure 2-6 
and Figure 4-9). The determination of the required for the simulations waveforms for 
the inlet and outlets of the computational domain is not straightforward and for the 
requirements of this Thesis it was achieved in two steps. The first step was the 
application of a method in order to obtain boundary conditions for the healthy vessel 
while the second step was to develop a method capable of providing boundary 
conditions for the stenosed vessels with an acceptable accuracy. 
4.5 Inlet and outlet for the normal LAD model 
The inlet and outlets for the physiological 
models were calculated with a simplified 
method that has already been used in 
previous studies [87, 213, 215]. For the 
left coronary inlet, the mass flow rate 
waveform available in the literature 
considered previously in other studies 
[90, 215, 216] has been utilised. For a 
healthy vessel it can be assumed that the 
value of wall shear stress is more or less 
constant, or to be more precise, it does 
not vary significantly in a small area, as 
the vessel walls are elastic and a sharp 
gradient of WSS would have as a result 
the change of the shape of the vessel up to the point where this gradient is somehow 
compensated. A typical value for the WSS in vessels is 1.5 Pa [34]. The distribution of the 
mass flow between the main branch and the side branches was determined under this 
assumption by employing the formulas that describe Poiseuille flow in a cylindrical tube 
of constant diameter (Equation 4.6). With the use of the equation that describes the WSS 
for a cylindrical tube, the wall shear stress is related to the mass flow rate in a branch, 
and this leads to a relationship between the mass flow and the radius of the two 
 
Figure 4-10: Mass flow rate inlet 
waveform for the healthy LAD model 
inlet. Waveforms for the six outlets are 
identically shaped but scaled according to 
the fi fraction factors. 
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branches: 
                              
Equation 4.6 
The last form of this equation has also been extracted from experiments of animal 
models [217]. Here     and  represent the mass flow in the i-side branch and the main 
branch past the i-th bifurcation, while     and      represent the radius of the i-th side 
branch at the bifurcation and the radius of the main branch after the i-th bifurcation  
Using this formula and the diameters of LAD and Left Circumflexing Artery (LCX), the 
mass flow at the inlet of the non-stenosed geometry of the LAD was calculated as 
constant fraction (0.52935) of the total mass flow rate at the inlet of the coronary artery. 
The resulting curve for the inlet of the computational domain is shown in Figure 4-10.  
The mass flow rate for each side branch was calculated using the same assumption, as a 
fraction of the total inflow. After calculating the mass fraction going into the first side 
branch, the same formula for the remaining mass flow of the main branch and the 
second side branch were used. Finally, the mass flow rate at the i-th outlet of the 
 
Figure 4-11: The distribution of the WSS on the walls of the healthy LAD model. For 
most part of the geometry, the WSS is between 1.5 and 2 Pa, confirming the 
assumption used for determining mass flow rates at the outlets. 
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geometry was a fixed fraction fi of the mass flow rate at the inlet, with the factors fi fully 
determined by the geometrical characteristics of the vessel:                             
Equation 4.7 
The fraction of the total mass flow rate for each side branch (SB) and each part of the 
main branch of the non-stenosed LAD geometry along with the radii used for the 
calculation are shown in Table 4-2 
The simulation of flow in the non-stenosed model actually showed small variation of 
WSS, with more than 99% of the vessel wall surface having TAWSS values 1-3Pa (Figure 
4-11), within the reported non-pathological arterial range [34] 
Table 4-2: Mass flow rate fraction for each side branch and the outlet of the main 
branch with respect to the mass flow rate at inlet 
Branch Branch diameter (mm) 
LAD diameter 
(mm) flow rate fraction 
proximal distal main outlet 
main 3.5 3.5 n/a 1 n/a 
SB 1 1.8 3.1 2.9 0.807 0.193 
SB 2 1.5 2.9 2.8 0.699 0.108 
SB 3 1.4 2.7 2.6 0.605 0.0945 
SB 4 1.2 2.4 2.34 0.533 0.0719 
SB 5 1.1 2.3 2.3 0.480 0.0526 
outflow n/a n/a n/a n/a 0.480 
A full validation of the flow distribution among the branches requires the knowledge of 
the structure or at least the overall behaviour of the vessel network that lies 
downstream the outflows of the computational domain and therefore it is very difficult 
to obtain. However an experimental setup where realistic pressure pulses are used as an 
input at the inlet while the outlets are connected to tubes with time varying resistance 
can be used to investigate the outcome of the method in in-vitro experiments. As the 
constant wall shear stress assumption is based on the deformability of the vessel the 
coronary or LAD geometry used should also have some elastic properties similar to the 
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vessels. By measuring the flow rates for different geometries it is possible to check how 
close the flow distribution described in Equation 4.7 is to the experimental results and 
probably add a correction due to the compliance of the elastic tubes. 
4.6 Inlet and outlet for stenosed LAD models 
In the case of a stenosed vessel, the mechanical properties of the unaffected vessel wall 
are different from the properties of the wall at the sites where the atheroma has 
developed. Probably the mechanical properties of the plaque itself would depend on its 
thickness and composition, so the assumption of constant or almost constant wall shear 
stress is no longer justified. Therefore, the previous method cannot be applied. On the 
other hand, there is no obvious reason to assume that the behaviour of the downstream 
vessel network will be seriously altered by the presence of the stenosis. The boundary 
conditions for the stenosed vessels were obtained under the assumption that both the 
cardiac output and the behaviour of the downstream vessel remain unaffected by the 
presence of the stenosis. As operating pressure for the coronary network the pressure 
drop between the aorta and the atrium (Figure 4-12) was used in most of the 
simulations. Some test simulations were also performed using only the aortic pressure 
as total pressure drop, while aortic pressure is actually the inlet pressure for the 
coronary network. The obtained resulting flow rates with the use of the two different 
pressure pulses, although not identical, had less than 1% difference. As aortic pressure is 
available on an individual-specific manner in the case a patient undergoes conventional 
coronary angiography the use of aortic pressure as operating pressure can lead to more 
consistent results. In a number of already published simulations of coronary flow, as 
well as for the calculation of the fractional flow reserve (FFR) for stenosed coronary 
vessels, the aortic pressure alone is also used as operating pressure [218], a 
simplification that introduces an average underestimation error of 8% of the operating 
pressure, with the maximum error being 18% (1.9kPa); this difference can be significant 
but probably of minor importance when compared to all other uncertainties involved in 
the problem. Additionally, as in our method the pressure drop is used to calculate the 
downstream resistance, this error is not transferred to the calculated flow rates for the 
stenosed vessels where the difference is much smaller (~1%). 
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The behaviour of the downstream 
network was described by a time 
dependent resistance (Figure 4-13). The 
value for this resistance is different at 
every instance of the cardiac pulse. It 
depends on the inlet (aortic) pressure and 
the flow rate of the healthy vessel and 
expresses, at each time instance, the 
total influence of the downstream 
network vessel to the flow rate in a 
linear manner. This means that at a 
given instance of the cardiac cycle   , the pressure drop         between the i-th outlet 
and the right atrium and the corresponding mass flow at the specific outlet       must 
fulfil Equation 4.8                                  
Equation 4.8 
In this equation, the value of       is the same for all the models for the specific 
outlet and time instance (but not the same for all time instances). In order to 
calculate the transient values of the resistance        the results of the simulation of the non-
stenosed coronary model were used. The value 
of the aforementioned variables (resistance of 
the downstream network for each outlet, mass 
flow rate and pressure at each outlet) and the 
total pressure drop at each moment must fulfil 
Equation 4.9. Using the outlet pressures 
obtained from the healthy model and the flow 
rate for each outlet, the time dependent outflow 
resistance for each outlet using as a total pressure drop the difference between aortic 
and right atrium pressure is calculated.                        
Equation 4.9 
 
Figure 4-12: The pressure waveforms 
used as inlet and outlet pressure for the 
whole coronary network. 
 
Figure 4-13: Simplified 
representation of the electrical 
circuit equivalent of the system 
considered for the extraction of the 
boundary conditions.  
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Here it must be noted that the time dependent resistance term that is imposed to each 
outlet of the coronary geometry, simulates the behaviour of the whole system 
downstream the outlet, both vessels and arteries, up to the right atrium; the main in this 
approach is that the vessels and arteries of the system are considered to have constant 
volume. As shown in Figure 4-13, the electrical equivalent to system assumed in order to 
obtain the boundary conditions neglects the changes in the total blood volume that is in 
the vessels (capacitance of the vessels) and the inertia of blood. If we denote   and   
the mass flow rate through the arteries and veins of the coronary vessel network, as 
there is no change in the total volume of blood, the flow rate must be the same for all the 
length of the one dimensional model, or       . Then, the equations relating the 
resistance with the pressure drop and the flow rate become:                                   
Equation 4.10 
And as the flow rate is constant, the relationship between the pressure drop and the flow 
rate for a given time instance is indeed linear:                    
Equation 4.11 
The main disadvantage of this method is that it is not able to reproduce the inversed 
coronary flow that occurs for a small time interval during the cardiac cycle, at the point 
of maximum pressure. 
During the application of this method it was found that, at least for this size of 
geometries tested here that do not include small vessels, the downstream resistance 
could be estimated without using the outlet pressures from the non-stenosed geometry, 
as follows: 
                                                                
Equation 4.12 
This approach obviously gives somehow greater values for the outflow resistances as it 
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does not take into account the pressure drop within the computational domain (during 
the estimation of the resistance from the healthy case); however the resulting outflows 
(and inflow) of the two methods have less than 2% difference, as the pressure drop 
between the inlet and the outlets of the computational domain is very small (>4% 
maximum difference) compared to the total pressure drop (see also Figure 2-4).  
The described boundary conditions, together with the values of the outflow resistance 
estimated using the geometrical features of the geometry were also tested in the healthy 
LAD geometry, both for steady and transient flow conditions. The shapes of the resulting 
the mass flow rate curves for the outlets were very similar to the ones calculated under 
the assumption of constant WSS. The actual values of the mass flow rate were slightly 
reduced. This was due to the over-estimation (of about 2%) of the downstream 
resistance described in previous paragraph. In the steady-state simulations, the fractions 
of the mass flow rate were the same for the two methods. In the transient simulations, 
the waveform for the inlet mass flow rate was identical for the two methods, but there 
some differences in the waveforms of the outlets. The distribution of mass flow rate 
under the assumption of constant wall shear stress leads to identical shapes for the 
waveforms of all outlets, with the only difference being the scaling, as each outlet has a 
different ratio of the total inlet mass flow. The method using the estimated resistance 
resulted in slightly different curves, as the side branches that were closer to the inlet had sharper changes and some Ǯspikesǯ; on the contrary, the outlet of the main branch and 
the outlets of the last two side branches were smoother than the inlet. The same 
differences between the outlet waveforms were observed when the method was applied 
to the stenosed models. It should be noted that this small differentiation of the mass flow 
rate waveforms at the outlet is similar to the experimental results for mass flow 
distribution in coronary tree reported by Boutsianis et al [90] after performing flow 
measurements in human coronary arteries. 
The advantage of this final simplification is that while introducing a minor error in the 
calculation of the resistance, it makes the method applicable to any arbitrary coronary 
geometry, without having to Ǯreconstructǯ the corresponding healthy model and perform 
additional simulations. It is easy to notice that the difference between the two methods 
will be larger for geometrical models that include a bigger part of the coronary vessel 
network. For significantly larger geometries, it is possible to reduce this error up to a 
point. This error is introduced because the resistance from the inlet to the outlet is 
partially ignored because it is considered very small compared to the resistance 
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downstream from the outlet. The result of this simplification is that the inside resistance 
is finally added in the downstream resistance. This added resistance though in cases of 
larger geometries, can be estimated based on the diameters of the main and the side 
branches and the analogy between electrical circuits and flow, and subtract it from the 
calculated value in order to correct it.  
All flow simulations were performed in FLUENT and the time-dependent-outflow-
resistance boundary conditions were applied using User Defined Functions (UDFs).The 
resistance and the total pressure drop were given as input as function of time. During the 
solution and at every time step the mass flow rate at the outlets was modified in order to 
fulfil the mass-flow and pressure relationship; at the end of every iteration, the mass 
flow at the inlet was corrected to satisfy mass conservation. This process was repeated 
for every iteration until flow rates were stabilized and convergence was achieved. 
The application of the previously described boundary conditions gave reasonable results 
for the flow rates in LAD main branch and side branches. The mass flow is reduced at the 
inlet and the side branches distal the peak of the stenosis. This effect is more intense for 
higher degrees of stenosis. For the side branches proximal to the stenosis, there is a 
small increase of the flow rate for small degree of stenosis while for severe stenosis 
(>70%) the flow rate is approximately the same as for the healthy LAD (Figure 4-14). 
Again, as in the healthy LAD model, the flow rate curve for the inlet is almost identically 
  
Figure 4-14: Normalized average mass 
flow for the inlet, the side branches distal 
and proximal to the peak of the stenosis. 
Results were similar for the three groups. 
Figure 4-15: Normalized waveforms of 
mass flow for the inlet and the side 
branches distal and proximal to the 
stenosis. Side branches proximal to the 
stenosis exhibit sharper variations of flow 
rate. 
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shaped with the one of the non-stenotic LAD, but in these cases it is significantly scaled 
down for high degrees of stenosis. It is interesting that for low and intermediate degrees 
of stenosis (up to 50%) the total blood supply is practically not affected by the stenosis, 
as the difference is less than 2%, and there is only a small reduction of the blood flow 
after the stenosis up to 5% depending on the case. The flow rate waveforms for the side 
branches in the stenosed models are similar but with small differences as the proximal 
side branches and in general the side branches that are closer to the inlet have more 
sharp variations and higher values at inversed flow point (Figure 4-15) with these 
differences being more obvious than the ones observed in the healthy model. The flow-
rate curves for the inlet and the outlets remained unchanged after simulating four 
cardiac cycles; the values from the last simulated cardiac cycle have been used for the 
specific plots. 
4.7 Processing of simulations results 
The results were processed using META post processor [219] and have included the 
time averaged wall shear stress vector and magnitude (defined as TAWSS (Equation 
4.13) and TAWSS(V) (Equation 4.14), respectively) the visualization of the flow field using 
streamlines and velocity profiles. In addition the oscillating shear index (OSI, Equation 
4.15) and relative residence time (RRT, Equation 4.16) also introduced in previous 
works [97, 220], have been plotted:         ∫ |   ⃗⃗⃗⃗ ⃗⃗ ⃗⃗  ⃗|       
Equation 4.13            |∫    ⃗⃗⃗⃗ ⃗⃗ ⃗⃗  ⃗    | 
Equation 4.14 
        ቌ  |∫    ⃗⃗⃗⃗ ⃗⃗ ⃗⃗  ⃗    |∫ |   ⃗⃗⃗⃗ ⃗⃗ ⃗⃗  ⃗|    ቍ   
Equation 4.15     [               ]   
Equation 4.16 
The last two surface quantities, OSI and RRT defined in Equation 4.15 and Equation 4.16 
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respectively have the following interpretation. OSI takes dimensionless values from 0 to 
0.5; it is an index of the variation of the direction of the velocity component parallel to 
the wall. OSI value equal to 0 denotes that the flow in that area is fully oriented in the 
direction of the average WSS vector for the whole time period, while OSI value equal to 
0.5 means that in that area there is no dominant direction of the flow. So high OSI values 
are possibly, but not necessarily related with the walls around a recirculation zone. RRT 
(units Pa-1) is an estimation of the residence time of the fluid components over the wall 
surface. As the actual residence time is not calculated, RRT can only be used as a means 
of comparison between two different cases. RRT is higher for larger values of OSI (so 
when the direction of the flow changes within one period) and when TAWSS (or the time 
averaged velocity magnitude) is small. So, increased values of RRT can be attributed 
either to great variation of the direction of the velocity vector, or to small velocity 
magnitude. Either way, the result will be an increased residence time of the fluid in 
that area, especially in the case that OSI is low and RTT is high. 
In addition, in order to assess the thrombogenic potential of each model, the coagulation 
activation index (CAI) was calculated for each model. In order to calculate this quantity in the realistic models, as there is no Ǯstream-wise length of reacting areaǯ, CA) was 
approximated as √     , where S is the area where average wall shear rate was below a 
certain value    ;this was set as AWSS<0.15 Pa. Indicative threshold value for CAI used 
were            , based on the results of the simulations for the normal model; the 
latter was approximately 10% higher than the value calculated for the normal case. It is 
interesting that this value is significantly closer to the one calculated from the 
experimental studies [3] in the previous chapter. In the case of realistic geometries a 
higher threshold value for CAI was used, based on two reasons. Firstly, the area with low 
WSS may be split in two or even more sites of the geometry. Secondly, the shape of this 
area is not rectangular; by elevating the threshold value the case of lower ratio of 
stream-wise length to surface was also represented. Note also that in these geometries 
there is no specific reacting surface, so the high values of CAI indicates just that there are 
areas in the model where,  provided that the appropriate triggering or substrate exists, 
can occur initiation of coagulation. It is also important to note that the threshold value 
calculated in the previous chapter agrees with the values calculated for the different 
models with the use of a totally different method. This agreement of values indicates that 
perhaps the CAI can be used as a risk index.  
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4.8 Results 
Besides the standard CFD plots which consist the usual detailed manner for the 
presentation of the results, quantities that can characterize each geometry with the use 
of one or a group of well-defined numbers have been also calculated. It seems that there 
are no generally accepted non-pathological values for the minimum and maximum 
TAWSS in coronary network. OSI and RRT indices are mainly used in computational 
studies the problem of non-pathological limits has not been addressed at all. Therefore 
the results of each model were compared mainly to the results of the non-stenosed 
model and the area of each model where the value of these quantities is well above the 
maximum value of the normal model have been plotted. This can be seen as an indication 
of the area most vulnerable to thrombus formation. Especially for TAWSS, as low values 
could increase the probability of causing the activation of blood coagulation, CAI was 
also used as an indication of the areas where flow conditions can allow the initiation of 
coagulation in flowing blood. It is interesting to note here that when the mathematical 
model for thrombin generation [142] was applied on the two cases extracted from the 
experimental work of Shen et al [3], the ratio of the calculated values of CAI for the two 
geometrical models (0.8) matched exactly the ratio of the maximum thrombin 
concentration (0.799) and was really close to the ratio of the average thrombin 
generation downstream the reacting area (0.759). This could indicate that CAI, a 
quantity that can be obtained via flow simulations and is directly related to flow 
conditions, although it does not take into account the shape or the exact location of the 
problematic surfaces, could be actually related to the thrombogenetic potential of 
pathological flow. Obviously, in order for such a correlation to be fully established and 
ready to be used in clinical practice it is necessary to apply the method in a relatively large number of real patientsǯ coronary geometries with known progress, to validate and 
possibly modify the range of non-pathological values of the quantities suggested here. 
4.9 Velocity field 
Regarding the velocity field, recirculation zones were observed distal the stenotic in all 
models with more than 20% stenosis, for some part of the cardiac pulse. The 
recirculation zones were not of the same size or duration for the models of all groups. In 
MI1 and MI2 these zones were longer in the stream-wise direction and lasted for a larger 
fraction of the cycle. Also, in the STABLE models, the recirculation zone was restricted to 
the main branch. On the contrary, in the models of the group MI1 mainly, but also in MI2, 
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part of the recirculating flow ended up in the side branch (magenta-coloured streamlines 
in Figure 4-16). In some cases a small recirculation zone in the side branch distal the 
stenosis is also observed. 
The disturbed velocities in the areas downstream the stenosis for some parts of the 
cardiac pulse have also impact on the average velocity profiles. As shown in Figure 4-17, 
the average velocity is reduced near the wall vessel for the cases with stenosis of 35% 
and higher, only on one side of the vessel. The velocity profiles for the normal LAD model 
are almost symmetric to the centreline of the main branch. A slight asymmetry is 
expected and it is due to the curvature of the geometry and the presence of the 
bifurcations. In the presence of the stenosis this image is significantly altered, as the 
velocity profile is no longer symmetric with respect to the centreline. 
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Figure 4-16: Recirculation zones downstream the stenotic lesion. Magenta-coloured 
streamlines indicate that part of the flow from the vortex area ends up in the side branch 
mainly in MI1 cases. Vortex stream-wise length is considerably larger for MI1 and MI2 
models. All snapshots correspond to the same instance of the pulse.  
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The point with maximum velocity is moved towards one side of the vessel wall and the 
maximum of the velocity is significantly increased despite the reduction of the flow rate. 
Additionally, at the side of the vessel with the high velocities, there is an increase of the 
spatial gradient of the velocity in the direction of the flow. At the same time, at the 
opposite side of the vessel, the average velocities are reduced and the increase of the 
velocity in the direction from the wall to the centreline is diminished.  
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Figure 4-17: Time averaged velocity profiles downstream of the stenotic lesion. Note 
that a small difference in the location of the stenosis (<3mm, less than 20% of the 
total length of the whole lesion) as it is between MI1 and MI2, changes significantly 
the location of the areas with inversed average flow velocity. 
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This asymmetry might have two possible effects. At the side of the vessel with high 
velocities and sharp spatial velocity gradients, the values of shear stress might be 
sufficiently high to cause activation of platelets and the coagulation process in general, as 
shear gradients are thought of being capable to initiate the coagulation process [49] 
independently of biochemical triggering. At the other side of the vessel, the small 
averaged velocities result to a prolonged residence times in this zone for any substances 
produced upstream in the stenotic lesion or at the side of the vessel with the high 
velocities, transported by the recirculation vortex. The effect of the stenosis to the 
downstream average velocity profile is more intense as we move to higher degrees of 
stenosis and at 70% stenosis for a part of the cross section of the vessel the time 
averaged velocity is opposite to the main direction of flow.  
4.10 TAWSS 
In the normal model there is a small variation of WSS due to the curvature of the 
geometry and possible imperfections of the model. The values are between 0.13 and 2.9 
Pa, but for the most part of the vessel wall (>99%) is between 0.5 and 2 Pa (Figure 4-11). 
The existence of stenosis had significant effect on the WSS distribution on the vessel 
walls (Figure 4-18). The stenotic lesion was characterized (as expected) by elevated 
values of wall shear stress that increase the surface average of TAWSS even for the cases 
with only 20% stenosis. This is more intense for all groups as we move to models with 
higher degrees of stenosis, with the TAWSS being higher than 3 Pa for the total of the 
stenotic lesion, while especially for the MI1 and MI2 cases there are zones of high TAWSS 
also distal the stenotic lesion. In the MI1 case there is also an area with high WSS at the 
entrance of the two side branches proximal and distal the stenosis and in MI2 case there 
is such an area only at the entrance of the side branch distal the peak of the stenosis, 
while in the STABLE models the WSS at the bifurcation is not significantly higher than 
the WSS in the normal case.  
As blood was simulated as a Newtonian fluid, WSS is proportional to wall shear rate. 
Thus, high and low values of TAWSS correspond directly to low and high values of time 
averaged wall shear rate. As already mentioned, low WSS is associated with the 
progression of the CAD and the growth of atheroma and coagulation is more likely to be 
initiated in areas with low wall shear rates. It is also possible that the initial products of 
coagulation and the activated platelets, existing as a result of high and sharply changing 
TAWSS in the stenotic lesion, will have a relatively high residence time in those areas, as  
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the lower values of wall shear indicate also smaller velocities near the wall. So, for all 
models, the area that seems of high risk (according to the TAWSS distribution) in terms 
of thrombus formation and progression of the disease is mainly the area distal the 
stenotic lesion. But as both areas of low and high TAWSS are larger in the MI1 and MI2 
geometries, and in these models the same flow pattern (from high to low TAWSS) is 
repeated in a smaller scale in the side branches involved in the stenosis, it could be 
claimed that for MI1 and MI2 models there is increased risk for deterioration and 
complications are higher. 
As wall shear rate values in the stenotic area are extremely high compared to the 
threshold values reported in by Shen et al [3], the results also show that in order to have 
initiation of the process inside the stenotic lesion, this can only happen due to surface 
reactions and surface bound substances and bound platelets, as any initial products of 
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 Figure 4-18: Distribution of time averaged wall shear stress for all geometry 
groups. Note that for groups MI1 and MI2 there are areas with high TAWSS 
after the stenotic lesion.  
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the coagulation process generated in flowing blood will be rapidly transferred 
downstream due to the high velocities above the vessel wall. At the same time, while 
values of TAWSS sufficiently high (>30 Pa) to be considered capable of causing platelet 
activation at a very short exposure time [221] were observed only in the cases of severe 
stenosis 70%, in all cases with stenosis higher than 35% there were areas with shear 
stress above 3.5-4 Pa, which can be considered capable of increasing platelet activation 
rate [134]. 
Table 4-3: Average values of TAWSS for the whole geometry and surface of the 
geometry with TAWSS>3 and TAWSS<0.15 (area in mm2). Coloured figures indicate 
that the specific value is more than 25% (orange) or more than 50% (red) than the 
lowest (green) value among the models with same degree of stenosis 
 
As shown in Table 4-3 and Table 4-4, the surface averaged values of the calculated 
quantities (TAWSS, OSI and RRT) for the whole wall surface of the models had small 
variations among the cases with different location or degree of stenosis, except from the 
OSI average value that was significantly higher for MI1 and MI2 geometries with stenosis 
more than 50%. Therefore, in order to examine whether there is a difference between 
the different groups that can be described by a set of numbers we calculated the area 
where each quantity (TAWSS, OSI and RRT) was above or below a selected value for each 
model. As mentioned earlier OSI and RRT have not been widely used so the only way to 
assess the resulting values is by comparing them with the results of the normal 
geometry. For TAWSS and wall shear stress in general, more literature data is available 
and it was co-estimated with the results of the healthy geometry, Special attention was 
paid to the plot in Gibson et al. [45] that correlates the WSS with the reduction of vessel 
radius, the results of Asakura et al [25], where WSS was measured experimentally in left 
and right coronary arterial trees obtained post-mortem where the minimum value 
reported was 0.12Pa. Here it must be noted again that although the correlation between 
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wall shear stress and deterioration of CAD and even thrombogenicity are considered 
established, it was not able to find specific threshold values or a generally accepted 
range of non-pathological values. However, the WSS values that were calculated in the 
non-stenosed model were in agreement with the values that were experimentally 
observed in previous studies [25, 45]. So, the results of the healthy LAD model that were 
used as a reference point for assessing the geometrical models based on the TAWSS 
distribution were in any case very similar to the previously published experimental data. 
Generally, the values in Table 1 and Table 2 indicate that there is a distinct difference 
between the models of different groups with the same degree of stenosis, but the only 
index that is of the same order of magnitude and therefore can be used for an overall 
comparison quantity is the area with low (<0.15Pa) TAWSS. 
The area averaged TAWSS for the whole vessel wall was 0.7-1.1Pa for all the models, 
within the range reported for in vivo measurements [222]. For the healthy geometry 
TAWSS was below 2 Pa except for some small areas (less than 0.5% of total area) of the 
side branches right after the bifurcation where TAWSS was between 2 and 2.9. This could also be attributed to differences in details between the Ǯaveragedǯ reconstructed 
model and a real LAD geometry at the specific points, as the averaging of the geometric 
parameters does not ensure that the final model will be 100% anatomically correct. The 
distribution of surface averaged TAWSS for cases with stenosis higher than 50% 
exhibited small differences between the three groups as in all cases there was a big area 
of high TAWSS (> 3Pa) in the stenotic region that caused an increase on the average 
TAWSS value. The surface average TAWSS for the whole geometry was more or less the 
same for the models of all three groups with the same degree of stenosis, (variation 
<2%), while the surfaces with high (> 3Pa) and low (<0.15) values were significantly 
larger (>50%) for the MI1 and MI2 groups. The results for the cases with small degree of 
stenosis though were more interesting, as only in cases MI1 and MI2 were observed 
areas with low AWSS (<0.15 Pa) and areas with high TAWSS (>3 Pa). Flow from areas 
with high shear stress, where platelet activation is more likely to occur, towards areas 
with low shear stress (Figure 4-18), where substances secreted by activated platelets, 
will have higher residence times and possibly boost the coagulation process.  
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4.11 OSI and RRT 
OSI and RRT values are expressing similar things as they are both quantities related to 
low average wall shear stress values, either due to small magnitude or high variation of 
the direction of WSS vector. Therefore, the contour plots for these two quantities were 
almost identical. OSI (Figure 4-19) had 
significant variation only in specific 
areas of the geometry, downstream the 
stenotic lesion and after the first 
bifurcation (Figure 4-19) at the area of 
the recirculation zones shown in Figure 
4-16. For models with stenosis 20% 
and for MI2 and STABLE with 35% of 
stenosis the values of OSI was low for 
the whole of the vessel wall indicating 
the absence of recirculation zones, 
while there was a small area with 
elevated values in MI1 model with 35% 
stenosis, in the recirculation zone near 
the bifurcation (Figure 4-16). In cases 
with 50% stenosis there is an area with elevated values right after the stenotic lesion 
while for the rest of the geometry the value is zero, meaning that for the rest of the 
geometry flow is fully oriented. The models with 70% stenosis had different distribution 
in the area where variation on the direction of the flow was larger (as the recirculation 
vortices are larger and occupy larger part of the cycle). As shown in Figure 4-19, the 
areas with high OSI were larger for MI1 and MI2 models (the images are in the same 
scale) and they are more or less next to the recirculation zones shown in Figure 4-16. 
For the RRT distribution again the results of the non-stenosed geometrical model were 
used as a reference point. The MI geometrical groups had elevated values of RRT starting 
from the geometries with 35% stenosis. Large areas with elevated RRT values were 
observed both in MI1 and MI2 models after the bifurcation. In MI2 model was also 
observed a zone with high RRT after the root of the side branch. The fact that OSI has 
values near zero in these areas implies that the flow is very slow. Increased values of 
RRT also appeared distal the stenosis in models of STABLE group with stenosis higher 
than 50% and for models of MI1 and MI2 groups with stenosis higher than 35%. In the 
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 Figure 4-19: Spatial distribution of OSI 
for the models with 50% and 70% of 
stenosis. 
140 
 
models of group MI2 there is also an area with high RRT values at the wall of the 
bifurcation after the stenosis. As we 
move to higher degrees of stenosis, the 
areas with high RRT and OSI as shown 
in Table 4-4 were larger. At the same 
time, these areas were moved 
downstream the vessel, probably 
following the growth of the 
recirculation zones and spread in a 
larger area of the vessel wall instead of 
being concentrated in specific points 
(Figure 4-16). 
Summarising, in order to compare the 
results among the different geometries, 
the same method as for TAWSS was 
utilised, but in this case the results have 
smaller absolute meaning as there are 
no known clinical or other threshold 
values regarding the non-pathological 
values of these quantities. For these 
quantities, comparisons have been 
performed relative to the value 
obtained for the healthy case. The 
magnitude of the surface where the 
value of OSI and RRT exceeded some 
specified values have been also 
calculated. For OSI a baseline value 0.25 
was used, as the values of the OSI for the normal model were below this value for almost 
the whole of the wall surface (less than 0.01% of the vessel wall exceeded that value). 
The areas with OSI greater than 0.25, 0.3, 0.35, 0.4 and 0.45 have been also calculated. 
Following similar considerations for RRT, a baseline value 5 Pa-1 corresponding to the 
healthy vessel was used .The areas with RRT greater than 5, 10, 17, 30, 50 and 100 have 
been calculated. The results, shown in Figure 4-21, indicate that the surface of the wall 
vessel with high values of OSI and RRT increases with the increase of the degree of 
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Figure 4-20: Contours of RRT. For great 
degrees of stenosis the areas with high 
RRT values are moved downstream. MI1 
and MI2 have larger areas with high RRT, 
and in MI2 models there is also an area 
with high RRT in the side branch after the 
stenosis. 
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stenosis for all groups but not with the same degree. Areas with high OSI occupy a 
significantly part of the vessel wall for the models of MI1 and MI2 compared to STABLE 
models. The MI2 models have more elevated values for intermediate degrees of stenosis 
(35% and 50%) while for the maximum degree of stenosis these two groups have almost 
identical distribution of OSI. It should be noted that Table 4-4 the area with OSI higher 
than 0.3 is double for the MI1 and MI2 models relative to the STABLE model. The results 
are similar for RRT, with MI1 and mainly MI2 models having more elevated values than 
STABLE. 
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Figure 4-21: Surface of the vessel wall with OSI and RRT above certain values.  The 
areas with high RRT and OSI are definitively higher for MI2 and MI1 geometries 
compared to STABLE for the same degree of stenosis, but the change of these 
values is mainly determined by the degree of stenosis rather than the exact location 
of the stenotic lesion. 
The contours of OSI and RRT show that while in terms of WSS values (mainly low) the 
effect of the stenosis is more intense for the models of the group MI2, MI1 and MI2 
models are characterized of equally disturbed flow. Again, the effect of stenosis on flow 
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was remarkably smaller for the models of STABLE group with stenosis less than 50%. In 
the models of the three groups with high degree of stenosis (>50%), there are distinct 
differences between them. The areas with elevated values of OSI and RRT are larger for 
MI1 and especially MI2 models and especially for OSI and even the surface averaged 
values are significantly higher. At the same time though, the results for all these models 
seem very close to each other when compared to the results of the healthy LAD or even 
to the results of the models with 35% of stenosis. So if these quantities are to 
characterize the risk of each case, it could be claimed that MI1 and MI2 are of higher risk 
compared to STABLE, while all of these cases are of very high risk compared to an LAD 
with low degree of stenosis. In any case, these quantities currently cannot be used as an 
absolute assessment of a stenosed LAD artery without further investigation in real 
geometries, but it is also possible that these quantities should be normalized according 
to the degree of the stenosis before used for assessment. 
Table 4-4: Average values of OSI and RRT for the whole model and surface of the 
geometry with OSI>0.3 and RRT>5 (area in mm2). Coloured figures indicate that the 
specific value is more than 25% (orange) or more than 50% (red) than the lowest 
(green) value among the models with same degree of stenosis 
 
4.12 Coagulation activation index (CAI) 
Of very high interest were the results regarding CAI for the different models. As CAI was 
related to low TAWSS, some similarity was expected. But the threshold values used for 
CAI, partially derived from the results of the healthy LAD were also close to the 
values suggested in the previous chapter, that were based on experiments 
investigating threshold conditions for the initiation of coagulation. The geometries 
of the MI2 group with low or intermediate degree of stenosis had CAI values clearly 
above the healthy geometry (        ) and the threshold value defined in the previous 
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chapter (        ). The same holds for geometries with intermediate degree of 
stenosis for the MI1 group while all the STABLE cases and the MI1and MI2 cases with 
70% stenosis have CAI values lower or near the threshold as shown in Figure 4-22. This 
means that, even if further investigations are required for establishing a threshold value, 
stenosed LADs similar to MI1 and MI2 with intermediate degrees of stenosis (30%-50%) 
may be more likely to cause activation of the coagulation process, which could 
subsequently lead to thrombus formation. Additionally, as low values of TAWSS alone 
are also related to faster progression of atheroma [223] and high CAI values are related 
to areas with low TAWSS, high values of CAI may indicate that these cases may also 
deteriorate faster.  
As it is reasonable to assume that the triggering for 
the initiation of coagulation will occur somewhere 
in the stenotic lesion, some estimations for the 
value of CAI in these areas has been performed, 
regardless of the fact that the shear in these areas is 
at least one order of magnitude larger than the 
threshold values reported. The stenotic lesions 
have maximum length of 16mm while wall shear 
rate in these areas varies depending on the case. 
For the cases with 50% and 70% stenosis, the 
average values of wall shear rate in the stenotic 
lesion are around 2000s-1. So the value for CAI, even in the extreme estimation with the 
whole stenotic lesion considered as reacting surface, is below the suggested thresholds 
(less than          , showing that initiation of coagulation in the specific area can occur 
only if surface processes and surface reactions occur.  
4.13 Grouping of the results 
If we conclusions of this study were to be limited to the models used in this study, this 
would be that the group MI2, the one corresponding to geometries with a 
bifurcation involved in the stenotic area downstream the peak of the stenosis, 
exhibits more disturbed flow and it is more likely to cause complications relevant to ACS. 
This statement is more intense for the intermediate degrees of stenosis between 20%-
50% for MI2. Similar were the trends that have been observed in MI1 group for stenosis 
between 35-50%.  
 
Figure 4-22: The variation of CAI for all 
groups and degrees of stenosis. . 
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Low values of WSS have been related to the progress of CAD [25, 45] but there is no 
definite lower non-pathological value for WSS in the relevant literature. As WSS all 
varies along vessel walls, there should be a surface area with low shear stress in order to 
consider a specific case of high risk. At the same time, low values of wall shear rates have 
been shown to allow the initiation of coagulation over a surface with TF, but the WSS 
values reported are much lower compared to the arterial flow conditions. Combining the 
data found in the literature with the results of the healthy LAD model (which is 
considered of no risk) and keeping in mind that the initial assumption was that STABLE 
models were of lower risk, it can be concluded that a geometry where TAWSS is lower 
than 0.15 Pa for a surface bigger than 0.4 mm2 could be considered of intermediate risk; 
when this surface becomes larger of 0.5mm2 then it can be considered a case of higher 
risk.  
Regarding the areas with high values of WSS, a value of 3Pa has been chosen as reference 
value. High values of shear stress are related to platelet activation. However it seems 
that it is stress accumulation that causes their activation rather than an instant or local 
high value of shear stress [134]; therefore, it is more important whether the platelets are 
exposed to high shear stress value for relatively long time interval. In terms of spatial 
distribution this is equivalent to having elevated shear stress values along the 
streamlines. So the effect of high stress on platelets is better expressed if the areas with 
high shear stress values are considered instead of the local values of shear stress. 
High WSS may also trigger plaque rupture but the evidence on that is weak [224, 225]. In 
any case, at least for the examined model the index related to high TAWSS does not seem 
to give any useful information for comparison, as the value depends strongly on the 
degree of the stenosis and extremely high values of shear stress (>30 Pa), capable of 
causing platelet activation [221] were observed only in the cases of severe stenosis 
(>70%) and in a very small part of the vessel surface. In respect to platelet activation it is 
possibly of more interest to examine also whether there are values of high shear stress 
within the flow and not only on the surface. 
The increased residence time and the recirculation in the post stenotic region is 
expressed via the RRT index. RRT is definitely related to the recirculation zones as it has 
clearly higher values (>3) in all cases where recirculation occurs (Table 4-5 and Figure 
4-16). OSI has similar variation to RRT (Table 4-4 and Figure 4-21) and with the 
proposed threshold which is based on the results for the healthy model does not give 
any additional information. RRT and OSI indexes have distinctively higher values for the 
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cases where recirculation zones were observed and the variation of their values is in 
accordance to the different size and duration of the vortices. 
Previous studies also showed that slowly recirculating flow due to core jet flow patterns 
through a stenosis promote aggregation of platelets and platelet-activating factors and 
that blood stagnation occurring at areas with disturbed flow may facilitate the 
accumulation of blood thrombogenic factors near the wall [226]. Since adhesion of 
platelets to a surface is greatly enhanced by prior activation [227], this mechanism offers 
an explanation for the increased platelet deposition at the recirculation zone: platelets 
that are already activated by the high shear stresses at the throat and along the shear 
layer between the jet and the slow vortices, are brought for a considerably large time 
interval close to the vessel wall at the slower side of this shear layer. In terms of the 
calculated quantities and indices, this condition can be expressed using the combination 
of TAWSS and RRT. This scenario is more likely to occur in the cases with high values of 
TAWSS and large areas with elevated RRT. 
With the aforementioned criteria, the models are clearly divided in two categories: all 
models with stenosis above 50% and only the model MI2 with 20% exhibit high risk 
index. The difference in the extent of the surface with high TAWSS between the two 
groups is at least of one order of magnitude. This difference makes it possible to extract 
safely an exact threshold value as there is a big difference between the cases that are 
considered of high complicated risk and the cases that are considered safe. However, 
taking into account the results of all cases we used as a threshold condition for high WSS 
the existence of an area with 5mm2 magnitude with TAWSS higher than 3Pa. 
For OSI and RRT, non-pathological values or non-pathological distributions do not exist 
in literature; thus, absolute calibration of these indexes is not possible. The limits were 
set according to the results of the healthy model and the models that were considered o 
lower complication risk. For the OSI the limit was 5mm2 total area with OSI above 0.25 
and for RRT 2mm2 area with RRT above 5 Pa-1. The threshold values for CAI were 
explained in the previous section. In the following table the indices above the risk value 
for each case are summarised with + or - while in the parenthesis the ratio of the value of 
the index to the specific model is also given. 
While the demonstrated indexes could obviously undergo further statistical 
manipulation and result to an overall index for each model, or for each group, or even for 
each degree of stenosis, as the examined cases were somehow limited, the extraction of 
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more general results may not correspond to real cases. 
Table 4-5: Flow-based risk indexes for models with stenosis up to 70%. Overall the 
MI2 appears to be of higher risk, followed by MI1. Each risk index is based on the 
extent that the specified condition (stated in the first row) is present in each model. 
 
 group Low 
TAWSS 
High 
TAWSS 
OSI RRT CAI 
2
0
%
 
STA -(0.0) -(0.0) -(0.0) -(0.63) -(0) 
MI1 -(0.18) -(0.014) -(0.0) -(0.53) -(0.59) 
MI2 +(1.3) +(1.4) -(0.010) +(1.1) +(1.6) 
3
5
%
 
STA -(0.28) -(0.00011) -(0.0) (-0.66) -(0.72) 
MI1 +(4.2) -(0.098) -(0.0) +(3.2) +(2.8) 
MI2 +(2.1) -(0.18) -(0.11) +(1.55) +(2.0) 
5
0
%
 
STA -(0.41) +(5.0) -(0.91) +(6.3) -(0.88) 
MI1 +(1.3) +(6.3) +(1.36) +(9.1) +(1.6) 
MI2 +(2.6) +(6.4) +(3.0) +(9.9) +(2.2) 
7
0
%
 
STA -(0.88) +(5.11) +(1.7) +(8.2) +(1.3) 
MI1 -(0.088) +(7.2) +(3.27) +(12) -(0.41) 
MI2 -(0.73) +(7.2) +(3.28) +(14) +(1.2) 
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In Table 4-5 it can be seen that in terms of disturbed flow there is a gap between the 
cases with 35% or less stenosis when compared to cases with 50% and above. The 
appearance of recirculation zones causes a sharp increase in the quantities related to the 
variation of the velocity vector above the walls of the vessel OSI and RTT. While in most 
indexes the difference between MI and STABLE cases is clear for the same degree of 
stenosis, it is possible that for geometries with high degrees of stenosis there should be 
defined different limits for the calculated quantities, especially for OSI and RRT. 
However, RRT seems capable of indicating the existence of recirculation zones without 
plotting more complex visualization requiring the velocity vector.  
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Chapter 5 Applying the thrombus model to realistic geometries 
5.1 Method of application 
The thrombus model developed in chapter 3 was applied to the realistic LAD models, 
using the time dependent flow fields that were calculated in chapter 4. More specifically, 
the geometries with 35%, 50% and 70% of each group were used, as the sharpest 
change of the characteristics of the flow field was observed between these cases. the 
geometries with stenosis of 20% were classified as of less interest because the 
alterations of flow compared to the healthy vessel was negligible. Additionally, the 
assessment of models with 20% stenosis was considered of no practical use, as the 
resulting geometries after the introduction of the stenosis would not be classified as 
stenosed vessel when seen in a coronary angiography. The initial intention was to show 
the results of the model under steady-state flow conditions, in order for the method to 
be easier to apply. Unfortunately, the steady-state state simulation results were found to 
depend strongly on the choice of the specific time instance of the flow or more 
accurately, on the pressure drop and the resistance values corresponding to the specific 
time instance, as the recirculation zones appear in a part of the time steps. An alternative 
could have been the use of the average flow field, but this totally eliminates the effects of 
recirculation for the cases with less than 70% stenosis and does not demonstrate areas 
  
Figure 5-1: The discrete steps used for the 
application of the thrombus model, shown on 
the mass flow rate pulse corresponding to 
the healthy model. The resulting flow rate 
pulse that was used is described by the 
dashed lines. 
Table 5-1: The time instances used for the inlet 
pulse for the application of thrombus formation. 
The flow rates and inlet masses correspond to 
the inlet of the healthy vessel. The values of 
mass flow correspond to the flow rate pulse 
used for the healthy model. 
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where the velocity vector is opposite to the dominant direction of the flow. For these 
reasons, the application of the coagulation model under flow was performed using a. a 
number of flow instances much smaller than the 100 timesteps that consisted each pulse 
during the flow simulations. 
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Figure 5-2: The defined reacting boundary (RED) for all the geometries on which the 
model was applied. The images are in the same scale. The reacting area has the 
same stream-wise length for all models, approximately 6mm while the middle is at the 
point of maximum stenosis.  
In more detail, for each one of the tested geometries the flow field (velocity and pressure 
drop) was exported for 9 time instances of the heart pulse as shown in Table 5-1 and 
Figure 5-1. The flow fields used were the ones obtained via the transient flow 
simulations presented in chapter 4. The time instances were chosen in a way that they 
include moments where there is reversed flow in the areas of recirculation for all models 
that exhibited recirculation zones as well as instances where the flow rate value is close 
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to the maximum value of the cycle. As the time scale of thrombus models was in the 
magnitude order of minutes and the used heart pulse duration was 0.75s (80 bpm) the 
sufficient period of time for such a simulation is about 3-5 minutes or 350-400 heart 
pulses; this corresponds to about 4000 time steps for each case. As mentioned earlier, 
the use of more dense time steps made the process extremely time consuming, as at each 
time step the program loads the new flow field and applies the model again. Some 
preliminary tests for the model MI1 with 35% degree of stenosis performed with more 
time steps (20) within a heartbeat for a small (>10) number of heart pulses did not show 
any significant differences in the monitored quantities (thrombin concentration, 
thrombin production rate, bound platelets and activated platelets). As shown in Table 
5-1 the time instances used for the flow fields were chosen so as the resulting average 
mass flow rate and the total mass flow of the discretized pulse are close to those of the 
original pulse while the difference is approximately 0.8%.  
In order to apply the thrombus generation model to the realistic geometries, a reacting 
area on the vessel wall had to be defined. No experimental data regarding the exact 
location where the initiation occurs is available. The size of the reacting area is also 
unknown. The reacting boundary for the scope of this Thesis was defined as the part of 
the stenotic lesion. The reacting boundary was symmetric to the peak of the stenosis 
with respect to the direction of flow and ,as shown in Figure 6-2, it has had 
approximately the same 6mm stream-wise length for all the geometries. 
5.2 Results 
The behaviour of the coagulation numerical model on different geometries appears 
strongly related to the findings of chapter 4, as the results depend strongly on the degree 
of the stenosis while there are also differences among the different groups of geometries. 
The results showed that the evolution of the process, at least as it is described by our 
model, depends strongly on the distribution of wall shear rate, especially on the reacting 
part of the vessel wall. The wall shear rate distribution on the other hand depends 
mainly on the degree of the stenosis. As a result of these the process had similar –but not 
identical- temporal evolution on the geometries with the same degree of stenosis rather 
than the geometries of the same group.  
The time interval between the beginning of the simulation and the moment when 
thrombin concentration exceeded the threshold value in sites downstream the reacting 
area varied significantly between the models (2s to approximately 5min) but in all cases 
151 
 
was small compared to the time scale of human life. The emergence of thrombin in above 
threshold concentration in the area distal the reacting boundary was utilised as the 
event that signals the initiation of the clotting process; from this point onwards these 
locations will be referred to as downstream propagation. The time interval between the 
initiation of the process and the initiation of downstream propagation, Tp. increases 
about one order of magnitude with higher degree of stenosis. At the same time, for 
models with higher degree of stenosis, downstream propagation requires a bigger 
amount of bound activated platelets in order to occur. Note that according to what has 
been described for the thrombus model in chapter 3, activation of platelets actually 
occurs during the transition from the initiation to the propagation phase of coagulation, 
so bound activated platelets represent also added surface bound activity. 
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Figure 5-3: The different temporal evolution of the process for different distributions of 
wall shear rate (WSR) with the time (Tp) and the amount of bound activated platelets (AP(b)) required for downstream propagation. It is clear that the cases with low values 
of WSR do not require the presence of bound activated platelets (additional surface 
bound activity) for downstream propagation.  
In Figure 5-3 the distributions of time averaged WSR for each model along with the time 
between the initiation and the downstream propagation and the amount of bound 
activated platelets Tp and AP(b), respectively, are demonstrated. The minimum value of 
the contour is the average WSR of the normal geometry (200s-1). The total mass of bound 
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activated platelets was normalized by dividing with the average platelet mass. As mean 
platelet volume is about 6.5fL [228] and platelets are considered non-buoyant particles 
(density ρ=1060kg/m3), an approximate value for platelet mass is          , so AP(b) is 
approximately the number of bound activated platelets. Due to this differentiation of the 
behaviour of the model for different degree of stenosis the results are presented in three 
different groups, corresponding to different degrees of stenosis.  
Indicative values for thrombin concentration of 1.15nM (or           ⁄ ) in the 
thrombin production sub-model has been utilised as a threshold for the transition from 
the initiation to the propagation phase. This value of concentration of thrombin, besides 
being the threshold value in the thrombin production sub-model, is considered capable 
of igniting the fibrin activation and clotting [229]. From the typical result of TGA [191] 
one can obtain a reference value for the thrombin generation rate:  [   ]                        ⁄                ⁄  
Equation 5.1 
As in most parts of the computational domain thrombin generation rate is negative, 
implying that inhibition process dominates, the legend for thrombin production rate 
includes also negative values. It must be noted that, as the typical thrombin generation 
curve is not symmetric with respect to the maximum of thrombin concentration, the rate 
of production (absolute value) is significantly greater than the rate of inhibition; this 
means that values for thrombin concentration change rate smaller than               ⁄  should be considered as significantly high rates of inhibition. The average 
concentration and production/inhibition rate for IIa that are presented above have been 
calculated for the area near the vessel surface as the concentration away for the vessel 
walls was near zero for all the cases. As the area distal the reacting boundary (   ) is not 
the same for all models, the average concentrations ( [   ]       that were calculated 
for the total surface of the geometry (    ) were corrected to correspond to the average 
for the area downstream the reacting site ( [   ]    ). As the concentration upstream 
the reacting site is zero, the correction was performed using the following formula: 
 [   ]      [   ]              
Equation 5.2 
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Finally, in all the cases presented, the spatial distribution of thrombin concentration one 
minute after the downstream propagation (Figure 5-6, Figure 5-10 and Figure 5-14)and 
the temporal change of thrombin concentration ( [   ]   ⁄ ) one and two minutes after 
the downstream propagation (Figure 5-7, Figure 5-11 and Figure 5-15) are presented. 
5.3 35% stenosis 
In the geometries with stenosis of 35% the downstream propagation is almost 
immediate after the initiation of the triggering, as shown in Figure 5-3. Besides that 
common characteristic, the results of the coagulation model varied significantly among 
the three cases.  
 
Figure 5-4: Temporal evolution of thrombin 
concentration near the vessel wall within two 
minute time interval after the downstream 
propagation.  
Figure 5-5: Temporal evolution of thrombin 
generation/inhibition rate near the vessel 
wall –excluding the surface production- 
within two minute time interval after the 
downstream propagation  
As shown in Figure 5-4, a sudden burst of thrombin exists in the STABLE model followed 
by one also sudden fall. On the MI1 model, a relatively smaller production rate is 
observed, which is positive only for a small period of time; it is to be noted that there is 
also production of thrombin before the moment of downstream propagation so the fact 
that the rate of the [IIa] change is mostly negative is reasonable. Finally in the MI2 model 
both average concentration and production rate have very small values, negligible 
compared to the other two cases. However, the average values do not completely 
describe the situation as the quantities of thrombin are not uniformly distributed. 
For the MI1 and the STABLE models, above-threshold values of thrombin concentration 
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are present in a large area of the downstream vessel wall, while in the MI2 model this 
phenomenon is localized in a specific site (Figure 5-6). The maximum calculated values 
of thrombin concentration downstream the reacting sites were similar for the three 
models and approximately 20 times higher than the threshold value 
(                    ⁄ ; but at the same time, these values are more than five 
times lower than the typical maximum values of TGA (160nM) and remained almost 
unchanged during the last 30 seconds of the simulation as their increase was less than 
less than 1%. 
MI1 MI2 STABLE 
Figure 5-6: The distribution of thrombin concentration for the three models with 35% 
stenosis, 1 minute after the downstream propagation. While in MI1 and STABLE 
models there is a large area with above threshold values for thrombin concentration 
in the MI2 models high thrombin concentration is localized in a specific site. 
Finally as shown in Figure 5-7, generally the rate of production of thrombin decreases at 
the area downstream the reacting site after the downstream propagation in all cases. In 
the MI1 geometry inhibition dominates 2min after the downstream propagation, with an 
exception at a small area at the root of the side branch. As it has been demonstrated in 
chapter 4 (Figure 4-16), a recirculation zone was observed in the MI1 model with 35% 
stenosis, located at the end of the reacting zone where thrombin is initially produced. 
The inhibition of thrombin is more rapid at the cells near the wall due to the action of 
protein C, which is included in the coagulation model with an increase of the inhibition 
rate constant. This spot of increased activity observed in MI1 model with 35% of 
stenosis is probably due to activated thrombin that is transferred at the root of the side 
branch via the recirculation vortex and escapes the action of APC.  
 MI1 MI2 STABLE 
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In the MI2 case the areas with high rate of IIa production are small and coincide with the 
areas with high [IIa]. As shown in chapter 4, this area has smaller flow velocities (Figure 
4-17) but not significantly low WSS (between 0.5 and 1Pa) while the area with very low 
WSS (Figure 4-18) and high RRT at the root of the side branch does not exhibit any 
noticeable differentiation in terms of thrombin production. Finally, in the STABLE case, 
there is a dramatic drop at the rate of IIa production, with inhibition dominating at the 
most part of the vessel walls but with certain areas -root of the side branch and the wall 
of the main branch opposite to the main branch- where the rate of production of 
thrombin is positive and indeed above the maximum of the scale. These areas were also 
characterized by relatively low WSS (in most area below 0.5Pa) and high RRT. It must be 
noted that in the STABLE model, while of smaller risk regarding to thrombosis is 
expected (according to the initial hypothesis and the flow based assessment), there is a 
significantly large area where production of thrombin exists and takes values above 
threshold concentrations, even 2 minutes after the downstream propagation, making it 
of higher risk based on the evolution of the coagulation model. 
Overall it can be said that the thrombin model indicates areas of elevated thrombin 
concentration and thrombin production is generally different from the ones indicated by 
the flow risk assessment indexes. If the different geometries with 35% stenosis were to 
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Figure 5-7: The spatial distribution of the rate of change of [IIa] one and two minutes after the 
downstream propagation for 35% stenosis. In all cases the rate of production decreases and it 
is interesting that for the MI2 geometry the areas with high production rate coincide with those 
of high concentration. 
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be classified based only on the behaviour of thismodel, probably the one of higher risk 
would have been the STABLE geometry, followed by the MI2 and the least dangerous 
would be the MI1 case. Additionally it is clear that after the downstream propagation the 
process in MI1 and STABLE geometries advances with similar pace while the evolvement 
in MI2 geometry is quite slower and significantly different. However as it can be seen in 
Table 4-5, the flow conditions prevailing in the STABLE model with 35% of stenosis do 
not favour the progress of CAD or the initiation of thrombin as the calculated indices are 
below the suggested level for all the involved factors.  
5.4 50% stenosis 
Average thrombin concentration had similar temporal evolution for all three models of 
50% stenosis as it can be seen in Figure 5-8. The maximum values of thrombin 
concentration were the same with the models of 35% (                    ⁄  and 
also obtained a constant value after 1.5 minutes after the downstream propagation. 
However, in terms of production/inhibition rate the findings for the MI2 model differ 
from the other two, as the average rate of production of thrombin for the whole area 
downstream is nearly 0 for the two minutes after the downstream propagation. 
Obviously, these two facts indicate that in MI2 geometry thrombin generation and high 
thrombin concentrations are restricted to a small part of the downstream area. The 
areas with elevated thrombin concentration in MI1 model are more or less the same 
with those of the MI1 geometry with 35% stenosis. High thrombin concentration values 
are observed at the part of the main branch starting opposite the side branch and at a 
part of the side branch starting from the root part closest to the stenosis (Figure 5-10). 
These areas are characterized by low WSS (below 0.5Pa and one part below 0.15Pa, 
Figure 4-18 and Figure 4-20, respectively) and high RRT (in some parts above 10 Pa-1 
Figure 4-20) which, at the same time, is the area of a large recirculation vortex (Figure 
4-16). Thrombin concentration above the threshold value was also observed at the 
bifurcation.  
The areas with high thrombin concentration in the MI2 model were also restricted in 
specific areas, in a manner similar to the MI2 model with 35% stenosis, but these areas 
were in slightly different locations and were significantly larger. Elevated thrombin 
concentrations were observed in a small area at the root of the side branch, at two 
stripes of the reacting area and at the wall of the vessel downstream the reacting site and 
opposite to the side branch (Figure 5-10). In both the main and side branches the areas 
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of elevated thrombin concentration include the areas of recirculation and the areas with 
high RRT and low WSS, with an exception at the root of the side branch which is an area 
with high WSS. 
In the STABLE model, the above-threshold values of thrombin concentration were 
observed in the same area of the main branch as for the model with 35% stenosis. This 
areas are also characterized by low WSS values (below 0.5Pa, figure) extremely high RTT 
compared to the values observed in the healthy vessel (in most parts above 15 Pa-1, 
Figure 4-20) and also partly recirculating flow motion. On the contrary, the 
concentration in the side branch downstream the stenosis was nearly zero, unlike what 
was observed in the STABLE geometry with 35% stenosis. 
The MI1 model has an area with high thrombin concentration opposite the side branch. 
The size of this area is slightly reduced and displaced downstream after 2 minutes but it 
remains considerably large. This area is a part of the area with thrombin concentration 
above threshold value and therefore it has the same flow characteristics, low WSS, high 
RRT and recirculation. In the MI2 model the area with elevated thrombin production 
rate increases its size with time, and after two minutes it includes most part of the area  
 
Figure 5-8: Temporal evolution of 
thrombin concentration near the vessel 
wall during two minutes after the 
downstream propagation for models with 
50% stenosis. The three geometries 
have similar images. 
Figure 5-9: Temporal evolution of 
thrombin generation/ inhibition rate near 
the vessel wall –excluding the surface 
production- during two minutes after the 
downstream propagation. There is an 
increase of the inhibition rate for MI1 and 
STABLE while MI2 exhibits very small 
values. 
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 with elevated thrombin concentration, while after two minutes an area of thrombin 
production has also appeared at the root of the bifurcation. It is also important that for 
the rest of the geometry the rate of production after two minutes is approximately zero, 
meaning that while we have production at specific site this is not balanced by the 
domination of inhibition at the rest of the vessel. Finally, in the STA geometry while the 
MI1 MI2 STABLE 
 
Figure 5-10: The distribution of thrombin concentration for the three models with 50% 
stenosis, 1 minute after the downstream propagation. While in MI1 and STABLE 
models there is a large area with above threshold values for thrombin concentration 
in the MI2 models high thrombin concentration is localized in a specific site. 
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 Figure 5-11: Thrombin production rate for 50% stenosis. The rate of production for the MI2 
model is significantly increased near the reacting site while there is not increased inhibition 
rate downstream.  
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average production rate is reduced with time, or rather the inhibition rate is increased, 
the situation moves from a state with zero production/inhibition almost for the whole 
downstream area to a state where there are areas of rapid production and rapid 
inhibition. The areas of high production in this case are also part of the area with 
elevated thrombin concentration; they are also inside the recirculation zone and have 
high values of RRT and low values of WSS. 
Summarizing, for all the geometries with 50% of stenosis, the areas of high susceptibility 
(elevated concentration and production rate) almost always coincide with the 
recirculation zones. In the MI2 model seems to be an increase of production rate with 
time in areas with already high thrombin concentration, while in MI1 and STABLE there 
are also susceptible areas.  
5.5 70% stenosis 
In the MI1 and MI2 models, the average thrombin concentration is changing slowly, and 
it has in general a low value of approximately two orders of magnitude lower than the 
threshold value of thrombin concentration for the transition from the initiation to the 
propagation phase. The maximum values are approximately                ⁄  and 
they are also lower than the ones observed in the models with lower degrees of stenosis, 
but well above the threshold value. This fact indicates again that the elevated thrombin 
concentration areas are restricted in specific locations. In the STABLE model with 70% 
of stenosis. The temporal evolution of the average thrombin concentration has 
similarities to the model of 50%. There is an increase up to approximately           ⁄  (sub-threshold value) but this increase is sharper, starting approximately 
one minute after the downstream propagation (Figure 5-12Figure 5-15). The maximum 
value is higher than the ones at MI1 and MI2,                   ⁄ , close to the 
maximum values of the models with lower degree of stenosis.  
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The rate of production has also similar temporal evolution for the MI1 and MI2 models, 
with a slow increase of the inhibition rate, while for the STABLE model there is a fast 
increase of inhibition rate one minute after the downstream propagation (Figure 5-13).  
The average inhibition rate in all cases is much slower than the typical inhibition rate of 
the TGA (                         ⁄ . In the STABLE model, initially the inhibition 
rate has similar evolution to the MI1 and MI2 models. One minute after the downstream 
propagation the inhibition rate increases; still it remains much lower than the values 
 
Figure 5-12: Temporal evolution of thrombin 
concentration near the vessel wall during two 
minutes after the downstream propagation. 
Figure 5-13: Temporal evolution of thrombin 
generation/ inhibition rate near the vessel 
wall –excluding the surface production- 
during two minutes after the downstream 
propagation 
MI1 MI2 STA 
 
Figure 5-14: The distribution of thrombin concentration for the three models with 70% 
stenosis, 1 minute after the downstream propagation. While in STABLE model there 
is a large area with above threshold values for thrombin concentration in the MI1 and 
MI2 models high thrombin concentration is localized in a specific sites. 
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observed with the 35% and 50% stenosis and the average rate of TGA.  
In MI1 and MI2 models the distribution of the areas with elevated thrombin 
concentration and increased production rate resembles the image from the MI2 models 
with lower degree of stenosis (Figure 5-15, Figure 5-11 and Figure 5-7). 
In both models, the areas with high production rate are within the area of high thrombin 
concentration, and do not change with time (Figure 5-15) while inhibition dominates in 
the rest of the geometry. On the contrary, in the STABLE model there is a definitively 
larger area with high thrombin concentration. This area includes the area of the 
geometry where we have production of thrombin (figure); however this area changes 
with time.  
 
 In general, the three models have lower values of thrombin inhibition rate and average 
thrombin concentration than the ones with lower degrees of stenosis. However, in terms 
of spatial distribution, the three models have similar images, with localization of 
thrombin in specific spots. It has been mentioned that in models with higher degree of 
stenosis the downstream propagation requires a greater amount of bound activated 
platelets (or additional surface activity). In the models with 70% stenosis, the areas 
where we have thrombin production (and not inhibition) are restricted within the area 
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Figure 5-15: Thrombin production rate distribution for the models with 70% stenosis. In MI1 and 
MI2 models thrombin production is localised in specific sites that do not change with time. In 
STABLE model the area with high thrombin production rate is larger and changes with time.  
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of the reacting boundary, while it seems that outside the reacting boundary zone 
inhibition takes over. It is possible that if simulations with longer time interval had been 
performed, one could get a different image, but this time interval is impossible to be 
determined and additionally, as the amount of bound platelets increases with time, that 
in fact would also cause alterations in the geometry of the models.  
5.6 Comments 
As the thrombus model focuses mainly on thrombin production, it was decided to 
identify the susceptible areas based on the thrombin concentration and thrombin 
concentration rate, claiming that when elevated thrombin concentration is calculated 
while at the same time there is increased rate of production at the same area, then this 
area can be considered as of high risk for thrombus formation. Maximum thrombin 
concentration was used only as an index of stabilization of the phenomenon, as at the 
end of the two minutes after the downstream propagation, in all geometries it showed in 
the worst case a very slow increase. Maximum physical time for the simulations was 8 
minutes and it was necessary only for the MI2 geometry with 70% of stenosis. 
Nevertheless, the possibility that if simulations had been performed for longer time 
interval, the behaviour might be different cannot be excluded, as the average surface 
concentration of bound platelets was below 5% of the maximum. Unfortunately, there was no method to estimate the Ǯproperǯ maximum time interval for the simulations. It 
was necessary though to set an end point, since the method was extremely time 
consuming (each case was running for more than one week). More importantly, while 
coagulation is progressing, certain occurring processes as local alteration of viscosity 
due to fibrin polymerization, change of the vessel wall properties and shape due to 
bound platelets and fibrinolysis become too important. As these processes have not been 
yet incorporated in the used coagulation model, it was chosen to stop the simulations at 
a point that they seemed to reach to a steady state solution. Continuing beyond that 
point has extremely high computational cost while at the same, with the current setup 
for the coagulation model neglects important parts of the process. 
In general, the model of coagulation has different behaviour in each geometry and there 
seems to be no general rule capable of describing all cases. In the STABLE cases, 
downstream propagation occurs faster compared to the MI cases with the same degree 
of stenosis. Again the degree of stenosis is a very important factor regarding how fast the 
process progress but the models of MI2 group seem to follow a similar pattern, with 
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localization of thrombin generation in small areas. The whole process seems to reach a 
steady state after 2.5 minutes in the cases of 35% stenosis for all geometries. For higher 
degrees of stenosis this time interval increases and varies among the different groups. 
The cases can be divided into two clearly distinct groups. In some of the geometries (all 
the groups of MI2 and MI1 model with 70% of stenosis) the areas with high 
concentration and high production rate are restricted in specific sites in a small distance 
downstream the reacting area and the average thrombin concentration was low and 
below the threshold value and at the same time the production rate had small absolute 
values (| [   ]   ⁄ |               ⁄ ). In the rest of the geometries (all the STABLE 
cases and the MI1 cases with 35% and 50% of stenosis) there are areas with high 
thrombin concentration and production rate in great distance downstream the reacting 
site and the inhibition has larger variations (| [   ]   ⁄ |               ⁄ ). 
There is also differentiation regarding the side branch downstream the reacting site. In 
some cases (MI1 and STABLE with 35% and MI1 with 50% stenosis) we have thrombin 
transportation via the side branch, while for the rest of the cases (all MI2 cases, 
STABLEwith 50% stenosis and STABLE and MI1 with 70%) the side branch has almost 
zero thrombin concentration (and zero rate production). Among the cases with high 
thrombin concentration in the side branch only in the case STABLE with 35% stenosis 
there is positive production rate in the side branch and therefore only in that case we 
can identify a high risk area in the side branch downstream the bifurcation and 
additionally a possibility of propagation of the coagulation process towards smaller 
vessels downstream.  
Another interesting general conclusion is the relationship between the shear rate and 
the surface activity required in order for the downstream propagation to occur. While 
there is not accurate one-to-one pairing of wall shear rate values and the amount of 
bound activated platelets, it is clear that geometries with higher degree of stenosis and 
therefore areas with higher shear rate require much larger amount of bound platelets or 
in other words increased surface activity. This means that the flow field prevailing in 
the reacting area might change the significance of the different processes involved 
in the coagulation process. In more detail, as some of the reactions occur both in 
plasma and on surface bound cells, it is possible that while in areas with low wall shear 
rate the reactions occurring in plasma are capable of initiating the coagulation process, 
in areas with high wall shear rate the processes occurring on surface cells have a more 
essential role.  
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The big difference between the time intervals required for the transition from the 
initiation to the propagation phase has an additional interpretation. The results show 
that, at least for the tested flow conditions, the surface processes have major importance 
all the active components that are not surface-bound are washed away by flow. Provided 
that in an area there is a triggering for the initiation of coagulation the effects, during the 
time interval between the initiation and the propagation the quantity platelets in the 
reacting site increases, and the majority of them are not yet activated. The burst of 
thrombin concentration during the propagation phase will cause the activation this large 
amount of platelets that will remain immobilized near the reacting site. Therefore a big 
time interval between triggering and propagation may enhance locally the 
coagulation process. 
The connection between the downstream propagation time and the amount of bound 
platelets at the beginning of the propagation phase can lead to another conclusion. The 
propagation time, except from the geometric characteristics of each case, is also related 
to the TGA results of a patient. The rate constant for the surface related initiation in the 
used coagulation model is mainly determined by the lag time of thrombin generation 
curve. This means that increased lag time in the TGA results will lead to increased 
downstream propagation times for coagulation under flow conditions and larger amount 
of bound platelets at the beginning of the propagation phase. So, it is very possible that 
this large amount of bound platelets at the beginning of the propagation phase 
enhances the coagulation locally in patients with increased lag time in the TGA and 
therefore these patients have increased risk for thrombotic complications 
compared with patients with smaller thrombin lag time. 
Compared to the flow-based assessment presented in the previous chapter, the 
application of the coagulation model on the same flow fields indicated different areas as 
of high risk with more characteristic the case STABLE with 35% degree of stenosis, in 
which almost all flow related risk indexes were lower than the suggested threshold 
while the application of the model showed revealed a large area of high risk, where both 
thrombin concentration and production rate had high values. This was somehow 
expected, as the two methods actually focus on different things. The flow-based 
assessment criteria, mainly WSS related, indicate areas that are prompt to cause the 
initiation of the coagulation process either due to extremely low values of WSS and 
alteration of the endothelium properties, either due to high or oscillating values of WSS 
that could lead to a rapture of the atheromatous plaque. On the contrary, the coagulation 
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model is supposed to describe the progress of the phenomenon once the triggering 
is present. Therefore the two methods are meant to complete each other rather than 
contradict. It is important though that the thrombus model indicated as high risk 
areas the part of the wall that was near the recirculation vortex and specifically 
near the site of the vortex where the flow was inversed compared to the dominant 
direction of the flow.  
The average values of thrombin concentration and production rate, although corrected 
in order to take into account the different downstream length from the reacting site to 
the outlets which is significantly smaller for STABLE geometries still contain an error 
that cannot be corrected. The time interval between the moment blood passes the 
reacting site and the moment it reaches the exit of the computational domain is different, 
smaller for the STABLE geometry. So the production and inhibition reaction (except for 
the surface production terms) occur in different extend within the different geometries. 
Unfortunately, although this error was identified, it was not possible to find a way to 
correct it, so the only correction performed was based on the downstream surface 
magnitude. Therefore, the comparison of the average values (and possibly maximum 
value as well) between the MI models and the STABLE models is somehow risky. 
However it is believed that a minor commentary is allowed. The average value of 
thrombin concentration was for all degrees of stenosis higher for the model which had 
the minimum amount of bound activated platelets at the moment of downstream 
propagation. This indicates that when the initial surface activity is more or less enough 
to cause downstream propagation, larger quantities of thrombin are transported 
downstream the reacting area, while the surface activity due to bound activated platelets 
has more local effects. The average production rate was negative for the whole time 
interval after the downstream propagation with only exception of MI1 and STABLE cases 
with 35% degree of stenosis where it also had positive values for a time interval. As in 
this number are summed up both production and inhibition, so actually a small value can 
be either due to very small or due to very high production and inhibition rate, in theory 
the interpretation is controversial. In the studied cases though, small absolute values of 
average production rate were always combined with restriction of high concentration of 
thrombin to small regions of the vessel wall. 
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Chapter 6 Overview, conclusions and future work 
The main idea behind this work was to investigate whether it is possible to perform an 
assessment of the thrombogenic risk of different LAD geometries and more generally 
coronary artery geometries with the use of computational methods. For that purpose 
were constructed a number of geometries that were previously assessed as of different 
risk for CAD complications in other works with the use of statistical methods. So, one 
main hypothesis behind this work was that the geometries of the group named 
STABLE were less prone to lead to complications compared to the geometries of 
the MI1 and MI2 groups. Consequently, one of the main questions this work had to 
answer was whether this different risk was mirrored somehow in the results of the 
simulations and if it was possible for the risk to be expressed in a quantitative arithmetic 
manner.  
The work in its final form consisted from two almost independent parts. Initially, a 
phenomenological thrombus model was developed. Then a method for simulating the 
flow in LAD arteries was developed and some complication risk indices were proposed , 
based on identified physical mechanisms that are related to the progression of CAD and 
thrombus formation. Finally, these two independent tasks were combined in the last 
chapter where the coagulation model was applied under transient flow conditions. As a 
general conclusion, CFD results had significant differentiation between the different 
groups; the flow related complication indices were in agreement with the initial 
hypothesis. This result indicated that the use of CFD for the assessment is feasible. The 
coagulation model had also different behaviour for the different geometrical models but 
in a manner that made it hard to extract general conclusions. 
6.1 Thrombus modelling 
6.1.1 Overview of model development 
In Chapter 3 a simplified model was proposed that simulates the coagulation process up 
to the activation of thrombin. The development of the model was performed in three 
steps. As most part of the biochemical reactions involved in the coagulation process 
occurs between the initial triggering and thrombin formation, the first step was to 
propose a set of equations describing that part of the process. As the final purpose of the 
model was to be appropriate for coupling with CFD simulations of relatively large scale, 
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the minimum number of substances (prothrombin, thrombin, resting and activated 
platelets) and equations (one differential equation for each substance) was used. At the 
same time the model was built in such a way that would enable the differentiation of the 
processes with respect to the location they occur (plasma, activated platelets or vessel 
surface) according to the cell-based models of coagulation rather than following the 
cascade models. The cell based models divide the processes of coagulation to three 
distinct parts: initiation, amplification and propagation. In this work each part is actually 
related to the different parts of thrombin generation curve in TAGs. Each of the modelǯs 
reactions represented a number of actual processes. Therefore, there were no available 
constants for the reaction rates of each source term from previous experimental works. 
To obtain values for the reaction rate constants initially a rough estimation was 
performed using calculations and values from previous computational works (which 
alone gave reasonable results). The estimated initial set of values for the reaction rate 
constants of the model was necessary as a starting point for the fitting of the model as it 
provided a reasonable range for the value of each constant. Following that, the initial 
values of the reaction rates were corrected and fine-tuned using the results of thrombin 
generation assays (TGA), by modifying each one of the constants within the range that 
the initial estimations determined. TGAs provide a curve that represents thrombin 
concentration versus time in vitro, after stimulation with tissue factor, a substance that 
is also exposed when there is endothelium or plaque rapture.  
The second step was the development of a model for the aggregation of platelets on a 
reacting surface. This was done by using experimental data for the aggregation of 
platelets on a reacting part of a tube shaped flow chambers for different values of (wall) 
shear rate. In the initial form the platelet aggregation sub-model did not distinct 
between resting and activated platelets, so it was formulated using two species 
(circulating and bound platelets) and three different processes, platelets binding on 
surface, platelets binding on bound platelets and unbinding of bound platelets. The 
reaction rate for the binding of platelets was shear-dependent. Initial values for the 
reaction rate constants of the processes were again obtained using previous works and 
rough estimations. The model was applied to three different cases (for different values of 
shear rate) and the reaction rate constants were corrected using the trial and error 
method, until the results of the simulations matched with acceptable accuracy the 
available experimental results. The method gave good results for the three different 
cases with the use of a shear dependent reaction rate constant for the aggregation with 
the main insufficiency being that due to its structure it was unable to reproduce the 
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reduction of the amount of bound platelets.  
The third step during the development of the coagulation model was the calibration 
under flow conditions. The constants of the thrombin sub-model were obtained using 
data from TGA which is steady state (in terms of flow) experiment where also the 
reacting substances including the triggering one (TF) are well mixed and the reaction 
rate constant for the initiation reaction was calculated for this conditions. However, 
when the process is initiated in a vessel under flow conditions, the triggering substance 
is expressed only on the reacting site of the vessel wall, so the source term describing the 
initiation of coagulation needed to be converted from a bulk to a surface one. The 
correction was based on experiments describing the threshold behaviour of the 
coagulation process in respect to the stream-wise length of the reacting area (a TF 
bearing patch) and the shear rate. The reaction rate constant for the surface source term 
of the initiation (which replaced the bulk term) was changed using again a trial and error 
method until we had agreement with the results reported (initiation or no-initiation) for all the cases. As Ǯinitiationǯ we identified the appearance of high thrombin ȋabove 
threshold) concentration downstream the reacting site. This process was performed 
without the terms describing the aggregation of platelets as the substances involved on 
platelet aggregation were not present or active in the experiment. It was interesting that 
the resulting value for the reaction rate of the surface initiation obtained with the use of 
this method was close to the one estimated by the size of the computational cell and the 
surface density of TF in atheromatous plaques. The main conclusions drawn from the 
process of thrombus modelling are the following: 
 
 The simplified thrombin sub-model was proved capable of reproducing TGA 
results for different cases (including haemophilia) while at the same time the 
results of the model with a fixed setup of the constants followed the changes in 
initial conditions (mainly platelet concentration) with acceptable accuracy. 
Therefore it was showed that it is possible to reproduce the part of the 
coagulation reactions up to thrombin generation using only 4 substances 
and 4 equations. Additionally, although the development of the thrombin sub-
model was zero dimensional, it is structured in such a way that it can account 
for processes occurring at different locations.  
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 The proposed set of equations has a case specific character as with appropriate 
modification of the constants it is able to reproduce different TGA results that 
may correspond to different patients.   Platelet aggregation can be modelled with the use of shear dependent 
aggregation rate constants and reproduce the initial aggregation rate and 
maximum concentration of bound platelets.   The disaggregation of platelets that is observed for high values of wall shear rate 
(after ~10 minutes) of perfusion is not captured. As this disaggregation is 
possibly due to stress accumulation, requires a different approach that would 
model the temporal evolution for the whole aggregate in order to be captured.   The exact concentration of TF on the reacting surface might not change 
significantly the constant of the initiation for the phenomenological model 
a reasonable result as TF acts as a catalyst for the initiation .   The experimental data on the threshold behaviour of coagulation reported a 
minimum size for the stream-wise length of the reacting surface for a given value 
of the wall shear rate and a maximum value for wall shear rate for a given size of 
the reacting area. Exploiting these findings, we introduced coagulation 
activation index (CAI), a number that indicates whether coagulation is 
initiated under specified flow conditions for a given reacting area, and using 
the available data we proposed a threshold value for the initiation. It test 
simulations with steady flow the process was indeed initiated when CAI 
exceeded the threshold value, while for sub-threshold setup maximum 
concentration of thrombin was proportional to the value of CAI.   The initiation and also the amplification of the coagulation was limited in a small 
depth near the reacting wall. This finding was confirmed also by the application 
of the model on the realistic geometries.   It was observed that the modelǯs results under flow were sensitive to small 
changes of the reaction rate constants, especially with respect to the initiation 
and the inhibition. This finding demonstrates that patient specific conclusions 
require taking into account the different coagulability of each individual. 
The model in its final form had some additional species (compared to the sub-models) in 
order to make the distinction between bound and circulating platelets that can be either 
in resting or activated state. In a last step two more aspects were incorporated into the 
model. The first one was the addition of a term that altered the behaviour of the 
activated platelets compared to the resting platelets. With this modification activated 
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platelets were more prone to bind and more unlikely to unbind. Although based on a 
reasonable assumption and estimations from experimental data, this change had minor 
effect on the model behaviour under flow for the time interval of the simulations. The 
second one was the addition of a very slow term of platelet activation due to contact 
with the reacting site. The overall of the binding-unbinding in at different rates 
depending on whether the platelets are activated or resting and activation due to contact 
are used to mimic the transition of platelet behaviour from tethering to forming 
permanent bonds. 
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6.1.2 Discussion and suggestions for future work on coagulation model 
The proposed phenomenological model for blood coagulation focuses mainly on 
thrombin generation, as in this work we did not want to include processes that alter the 
flow conditions. However it is possible and probably useful as a next step to make 
additions to the model in order to include the processes that describe the final 
step of coagulation, fibrin activation and cross-linking and fibrinolysis. 
Additionally, in order to capture the effect of thrombus formation on the local flow 
conditions, the spatial development of the clot, the entrapment of circulating 
platelets and in the fibrin mesh should be included. As the most part of coagulation 
reactions are already included in the model the next step could be added independently, 
with the only interaction with the existing model being the binding of thrombin on fibrin 
strands which has effect on the inhibition rate of thrombin. Finally the platelet 
aggregation model could possibly be improved (if appropriate experimental data exist) 
as the distinction made for the behaviour of resting and activated platelets is somehow 
oversimplified.  
Thrombin sub-model was based on clinical rather than laboratory information. It is 
intended to maintain this characteristic for the further additions to the model. So the 
platelet aggregation equations should be re-calibrated according to the results of clinical 
platelet function assays. This modification will provide to the function of platelets a 
patient specific character. The same concept will be used for fibrin polymerization and 
lysis. The results of the thromboelastography can be used to model the last steps of 
 
Figure 6-1: (left) The variation of prothrombin concentration. The snapshot is from STABLE 
model with 35% stenosis, and one of the moments with lowest [II] concentration yet the 
maximum variation is approximately 0.5%.(right) The variation of resting platelet 
concentration. The case is different compared to prothrombin as in some areas the 
concentration falls to the 25% of its initial value. 
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thrombus formation in a phenomenological and patient specific manner, similar to the 
methods used for thrombin in this Thesis. 
The application of the model under transient flow conditions revealed that there was 
room for some simplifications and probably some improvements as well. First of all, the 
concentration of prothrombin seems to have very small variations when the model is 
applied under flow. While during the calibration of the thrombin sub-model the initial 
concentration of prothrombin had crucial role as it influenced all the parameters of TGA, 
under flow conditions the case is different. The maximum variation is 0.5% (figure) 
which respectively causes a 0.5% reduction of the thrombin production source terms, 
where prothrombin concentration is involved. As this change is small compared both to 
the approximations of the model but also the accuracy of the experimental techniques 
measuring thrombin concentration and the inter-laboratory variation of TGA tests, the 
species corresponding to prothrombin may be omitted on the model and the 
initial prothombin concentration value can be merged into the reaction rate 
constants. Unfortunately the case is not the same for resting platelets, as there is 
significant variation of the concentration.  
Another interesting conclusion when applying the model under flow conditions was the 
crucial role of shear. Under conditions of increased shear similar to what prevails in 
coronary artery (        ) any quantities of thrombin produced due to surface activity 
are abducted by flow. In the proposed model this is compensated by the binding and 
activation of platelets, which increase the activity of the reacting surface and probably 
also by the extremely large size of the reacting area. As several coagulation factors 
actually bind on endothelium cells and on platelets it is possible that the model would 
become more realistic if it included a term for bound thrombin, similar to the term 
for bound platelets. Unfortunately we have not come across any experimental data that 
would allow us to include such a term in the model in a reliable way. This could be 
possibly achieved by performing coagulation experiments under flow conditions, using a 
solution of coagulation factors over immobilized activated platelets and measuring the 
amount of the coagulation factors in the area of the activated platelets. Repeating the 
same process without the presence of activated platelets and possibly correcting for any 
extra amount of coagulation factors produced, the amount of coagulation factors that are 
bound on the reacting substrate can be estimated. 
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6.2 Flow simulations and risk factors 
6.2.1 Overview of simulation results  
In chapter 4 a flow based assessment of LAD geometries in respect to complications or 
rapid deterioration of coronary artery disease was introduced. The first step was the 
construction of 16 different LAD geometrical models, one healthy and three groups with 
induced stenosis (MI1, MI2 and STABLE). Each group consisted of 5 geometries with 
different degree of stenosis (20%, 35%, 50%, 70% and 90%) with the stenotic lesion 
located at a different site in each model. According to previous works these geometries 
were considered of different risk. After performing indicative mesh independence tests a 
computational mesh of approximately 1.5 million cells with refined boundary layer was 
constructed for each model. 
Following that, we developed a simplified method in order to obtain boundary 
conditions for the inlet and the outlets of each model. The method uses as inputs the 
geometric features of the model (diameters of main branch and bifurcations) and the 
pressure (aortic pressure) and the mass flow rate at the inlet of healthy coronary. For 
the inlet we used average waveforms for mass flow rate and aortic pressure throughout 
one cardiac cycle under resting conditions. The method can be easily applied on any 
arbitrary coronary artery geometry. 
Transient numerical simulations of the flow were performed for each case. Blood was 
modelled as Newtonian fluid and the flow was considered laminar. The results were 
periodic after the first cardiac cycle of simulations and the resulting waveforms for mass 
flow rates resembled waveforms obtained by in-vitro and ex-vitro experiments. The 
resulting flow field was processed for the geometries with stenosis up to 70% and 
average wall shear stress, oscillating shear index and relative residence time were 
calculated over the time of one heart circle as well as coagulation activation index with 
the use of average wall shear rate value and an estimation for the reacting area. We 
identified the sites of the models where wall shear stress had very high or low values 
and where oscillating shear index and relative residence time had very high values. The range of Ǯnormalǯ values for these quantities was basically based on the results obtained 
for the healthy geometry while especially for the wall shear stress we also took under 
consideration the values reported in previous studies. The findings of this part can be 
summarized as follows: 
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 The culprit flow patterns as recirculation zones and areas with low and high 
TAWSS were present to a greater extent in geometries of higher complication 
risk when comparing models with the same degree of stenosis.  The complication related flow patterns were expressed via arithmetic indices 
and non-pathological limits were proposed for each index. This makes possible 
the assessment of an arbitrary coronary geometry.  Most indices showed that in general, the properties of the flow field are strongly 
influenced by the degree of the stenosis but the location of the stenosis has also 
a very important impact.  The geometries of the group MI2 (two bifurcations involved in the 
stenosis) had higher values of the risk indices followed by the models of 
MI1 group(one bifurcation in the stenosed lesion), with STABLE group (no 
side branches affected) having lower values for stenosis up to 50%. For the 
models with 70% stenosis the indices had similar values for all groups.   CAI had exceeded the suggested safe value only for the cases MI1 and MI2 
with stenosis 35% and 50% while the rest of the models had clearly lower 
values. This shows that only in the models of high risk the areas where local 
flow conditions favour the initiation of coagulation were sufficiently large.  
6.2.2 Suggestion for improvement of flow based assessment method 
A simple method for simulating blood flow, both in respect to viscosity model and 
boundary conditions was chosen. This approach, except for the fact that it reduces the 
computational cost, it makes the method repeatable in an identical manner on any 
coronary geometries.  
Boundary conditions are obtained with a method that can be further evolved in order to 
include more of the actual factors that determine the flow field in coronary artery 
(counter pressure from myocardial contractions, changes of the volume of the 
downstream vessel network etc) while still applied in the same manner. However, while 
such additions in boundary conditions might change the mass flow rate distribution  
among the vessel branches, there is no reassurance that they would also lead to 
improved accuracy of the method or to a more patient specific character. The use of 
more complicated methods for the application of boundary conditions leads inevitable to 
a large number of assumptions, regarding mainly the downstream vessel network and 
introduces an additional number of parameters that are not accessible in a patient 
specific manner. Therefore, I considered more important to propose a method that can 
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be directly applied on any coronary geometry. This approach makes any obtained results 
consistent and directly comparable. The proposed method also allows the modification 
of the pressure and flow waveforms used for the inlet according to the size of the vessel, 
the patient weight or in order to simulate hyperaemic blood flow.  
In all cases, the assessment based on flow simulation results is possible to overlap with 
assessment based purely on the geometrical characteristics of the coronary, similar to 
what is proposed by Wellenhoffer et al [230, 231]. It is also possible that in several cases 
the results of the two different methods of assessment might be similar, as the areas 
with extreme values of WSS and other quantities are actually determined by the shape of 
the vessel. To go one step further, it is almost impossible to reproduce the exact flow 
conditions in an fully individual specific manner, as the heart cycle has variations, 
so even this so called flow based assessment is actually geometry assessment 
based on flow simulations, as it cannot be argued that the applied flow conditions 
can represent the real conditions in each individual. Nevertheless, the use of flow 
 
Figure 6-2: MI1 (orange) and MI2 (grey) models with 20% degree of stenosis. The 
differences between the two geometries are hard to distinguish and although these two 
models are supposed to be classified in different groups it is doubtful if a performed-
from-scratch geometrical classification would make that distinction. The flow fields 
however have noticeable differences, as shown in chapter 4. 
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simulations in chapter 4 revealed that small differences between two geometries can 
lead to significant alterations on the characteristic quantities of the calculated flow field. 
For example, between the cases MI1 and MI2 with 20% of stenosis (Figure 6-2) and also 
the STABLE geometry with the same degree of stenosis (not shown), the differences in 
geometry are hard to distinct. On the other hand, the indexes related to low and high 
TAWSS are approximately one and two orders of magnitude higher respectively for MI2 
model (the exact ratios are 7.22 and 99). This indicates –provided that we accept the 
relationship of flow with CAD progress and we trust the CFD results of course- that 
geometrical assessment cannot substitute the assessment via flow simulation as 
probably there is no geometrical criterion that would classify two real geometries with 
such small differences in different category. Indicative, the remodelling index               ⁄  proposed by Wellenhofer et al [86] calculated for the models 
presented in Figure 6-2 with the use of the minimum diameter  in the stenotic lesion 
and the inlet diameter    is 21.43 for the MI1 geometry and 21,7 for the MI2 geometry. 
The only justification for the fact that MI1 and MI2 geometries with 20% belong to 
different groups in this Thesis are the statistically derived criteria used for the 
reconstruction of the LAD geometrical models. 
The main drawback of the method is that it was applied in a small number of geometries that additionally were derived using the same initial Ǯaverageǯ healthy model. The 
establishment of the physiological range of the risk indexes was thus based only on a 
number of simulations on a group of models with very similar geometrical 
characteristics (except for the stenosis location and degree). So, while based on the 
results it is demonstrated that it is possible to assess the risk of a LAD or coronary 
geometry based on CFD simulation, the exact limits for the physiological range that 
we propose for the risk indexes except for CAI are rather indicative and further 
investigation in real coronary geometries with known progress is required before 
they can be actually be used as diagnostic tools (from follow-up studies on CAD 
patients). 
6.3 Thrombus model under transient flow conditions 
In the last chapter the thrombus model was applied on the realistic models of stenosed 
LAD arteries under transient flow conditions. This part of the work exhibited certain 
(expected) difficulties. Obviously, there are no experimental data for the temporal and 
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spatial evolution of blood coagulation in vivo, so there is no way to validate the results of 
the simulations and perform any correction to the method. Besides that there are also 
additional information missing. The probable size and position of the reacting areas are 
unknown. The actual time scale of the phenomenon is also unknown and assumed to be 
in the order one day, and there is also big difference between the timescale of the heart 
pulse (approximately one second) and the time scale of thrombin and platelet 
aggregation sub-models (approximately five minutes). As one minute of simulation 
corresponded to 80 pulses or 8000 time instances of the flow, performing simulation for 
time interval of the order of days (about 10 million time instances) as a test was out of 
the question.  
So we had to compromise in respect to the accuracy for all these aspects of the problem. 
We used a simplified pulse of 10 time instances (9 time intervals), and we restricted the 
simulation time up to 8 minutes. The simulation time was not the same for all cases, as 
we used as a criterion the downstream propagation of elevated thrombin concentration, 
and continued the simulation for two more minutes. As a reacting surface we used a part 
of the stenotic lesion, of the same stream-wise length for all cases, approximately 6mm. 
We made that choice, knowing that the total size of the reacting surface would be smaller 
for higher degrees of stenosis, because the experimental data used in Chapter 3 
emphasized on the significance of the stream-wise length. As we applied the exact same 
method for all the cases we believe that our results can be trusted for a first comparison 
on how coagulation evolves in different cases, but we cannot guarantee that they depict 
the actual evolution of the process as it would be in –vivo. The results showed that: 
 Similar to the flow simulations in Chapter Ͷ, the modelǯs behaviour was strongly 
influenced by the degree of stenosis and especially the models with 70% stenosis 
of all three groups exhibited similar but not identical results..   Downstream propagation required more time and larger amount of bound 
activated platelets for higher degrees of stenosis. For the same degree of stenosis 
STABLE cases were the faster ones followed by MI1 cases with MI2 having the 
slowest evolution. Thrombin concentration downstream the reacting area 
reached concentrations much higher than threshold value, but lower than the 
typical peak concentration of the TGA.   In order to distinguish the areas of higher risk for thrombus development we 
sought for sites where both thrombin concentration and thrombin production 
rate had elevated values. In MI2 cases those areas were small and localized, 
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while in STABLE group there were large areas with high thrombin concentration 
which in the 35% model also included some smaller areas with rapid thrombin 
production. MI1 models had an intermediate behaviour, with the geometries 
with low degree of stenosis behaving similarly to the STABLE model and the 
geometry with 70% similarly to the MI2 models. However as stated earlier the resultsǯ variation did not allow the extraction of some generalized conclusions on 
the behaviour of thrombus formation. 
  A prolonged lag phase of thrombin generation in a thrombin generation assay is 
mainly related to hypocoagulable states. Increased lag time is observed in cases 
with reduced stimulation or increased inhibition of thrombin [232]. On the 
contrary, the application of the coagulation model under flow shows that a 
prolonged initiation phase leads to increased accumulation of a platelets at the 
reacting site. These bound platelets will become activated during the 
propagation phase and contribute locally to thrombin generation. The observed 
mechanism indicates that it is very possible that the prolonged lag phase 
indicates increased risk for thrombotic complications in vivo, provided that an 
initiation stimulus is present.. 
This work includes both zero dimensional simulation of thrombin production and 
simulation of thrombin production under flow. Modelling of thrombus formation, 
besides reproducing the clinical tests, can also be used for studying the formation of clot 
under flow conditions.  Coagulation in vivo occurs under flow and this fact can change 
the importance of each parameter in respect to the steady state system. For example, it 
was demonstrated earlier while initial prothrombin concentration plays a major role in 
closed, zero dimensional systems, itis of minor importance under flow. Also, in all cases 
where the thrombus model was applied under transient flow conditions in the whole 
process was localized near the vessel wall. The vast majority of the related experimental 
data though, are derived from steady state experiments with the reactants being in 
solutions with uniform spatial concentrations. . This is probably due to the fact that the 
experiments under flow are more difficult to standardize and require much larger 
quantities of samples. Generally in the literature there is a lack of experimental data, 
especially quantitative, referring to the coagulation process under flow conditions. In 
order for more reliable and accurate detailed or simplified models for coagulation 
under flow to be built, is required experimental data focusing on what happens 
under flow conditions (no depletion and stagnation of reactants) and paying special 
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attention on the surface related processes near the vessel wall. A good example of the 
type of  work required is the experimental study of Reininger et al [130], where material 
from human atheromatous plaques was exposed to blood and thrombin generation and 
platelet aggregation was measured under steady and flow. Performing a similar 
experiment for a larger variety of samples (TF, zymogen and platelet concentrations) 
and a wider range of flow conditions can correlate the results of the currently used 
coagulation assays with coagulation under flow. 
To the best of my knowledge, this is the first attempt of applying even a simplified model 
of coagulation on a large number of realistic geometries under pulsating flow conditions. 
The comparison of the results, although they did not provide clear conclusions, showed 
that there are big differences in the behaviour of the model among different geometries. 
The huge volume of the result files is an additional obstacle in the process of extracting 
specific conclusions. As this study has mainly comparative character, as a next step I 
intend to apply the same method under average steady flow conditions, for different 
sizes and location of the reacting areas including the sites of low shear rate identified 
with the use of flow simulations. This might provide more clear differentiation of the 
results and maybe the extraction of some arithmetic indexes similar to the ones 
extracted for the flow conditions in chapter 4. 
The supplementary character of the two methods used for the assessment of flow effect 
on thrombus formation must be emphasized. The flow-based assessment focuses both 
on the possibility of deterioration of the case and on the possibility of thrombus 
formation, as the progression of coronary artery disease is also related to wall shear rate 
and wall shear stress distribution. It deals with the possible growth of the atheromatus 
plaque and the identification of sites where pathological flow conditions may alter the 
behaviour of the endothelium, triggering the initiation of coagulation. On the other hand, 
the application of thrombus model is focusing on what happens after this triggering 
occurs, and whether the initiation leads to elevated thrombin concentration and 
thrombin production rate. Therefore an integrated assessment of a case requires the 
combined application of both methods, and the total risk for each patient should come 
from the co-estimation of the results.  
 Considering the differentiation of the conditions among patients (coronary shape 
diversity, blood coagulability and flow conditions)it is possible that the optimum 
treatment is not the same for all patients and that the problem cannot be answered using 
only the statistical approach. The use of different clinical scenarios cannot indicate the 
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preferable treatment for all cases where acute symptoms are absent. In this work it is 
supported that the problem can be approached in a more patient specific manner using 
computer simulations. A method that uses as input the images from coronary 
angiographies and the blood coagulation test of a patient and estimates the risk of 
thrombotic complications is presented. Unfortunately, the small number and variety of 
the geometrical models used does not allow a safe definition of the non-pathological 
values of the calculated quantities. However, this first application showed that the 
results of the simulations can be correlated with the complication risk. In order for these 
methods to be used in clinical practice, the application on a large number of real patient 
cases with known outcome is required, in order to have a statistical confirmation (and 
possibly correction) of the indices calculated for each case. The vision for the future of 
this work is to apply the developed method on a relatively small number (~20) of real 
cases including cases with stable CAD, ACS, wide range of TGA results and, if possible, cases, where acute syndromes Ǯwere not expectedǯ. After detailed examination of the 
results the non-pathological limits of the risk indices that are proposed here will be 
reconsidered and it will also be specified whether the risk is due to pathological flow or 
different coagulation potential for each case. After a final test on a larger number of 
patients I believe that the method will be appropriate to be used in clinical practice as an 
assessment tool. 
  
181 
 
References  
1. Katritsis, D.G., et al., Anatomic Characteristics of Culprit Sites in 
Acute Coronary Syndromes. Journal of Interventional 
Cardiology, 2008. 21(2): p. 140-150. 
2. Badimon, L., et al., Influence of arterial damage and wall shear 
rate on platelet deposition. Ex vivo study in a swine model. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 1986. 6(3): 
p. 312-20. 
3. Shen, F., et al., Threshold Response of Initiation of Blood 
Coagulation by Tissue Factor in Patterned Microfluidic 
Capillaries Is Controlled by Shear Rate. Arteriosclerosis, 
Thrombosis, and Vascular Biology, 2008. 28(11): p. 2035-2041. 
4. Go, A.S., et al., Heart Disease and Stroke Statistics—2013 Update: 
A Report From the American Heart Association. Circulation, 
2013. 127(1): p. e6-e245. 
5. Rayner, M., et al., Cardiovascular disease in Europe. European 
Journal of Cardiovascular Prevention & Rehabilitation, 2009. 
16(2 suppl): p. S43-S47. 
6. Allender, S., et al., European cardiovascular disease statistics. 
European Heart Network, 2008. 3: p. 11-35. 
7. Mozaffarian, D., et al., Heart Disease and Stroke Statistics—2015 
Update: A Report From the American Heart Association. 
Circulation, 2015. 131(4): p. e29-e322. 
8. Uren, N.G., et al., Relation between myocardial blood flow and the 
severity of coronary-artery stenosis. New England Journal of 
Medicine, 1994. 330(25): p. 1782-1788. 
9. Head, S.J., et al., The rationale for Heart Team decision-making 
for patients with stable complex coronary artery disease2013. 
10. Simoons, M.L. and S. Windecker, Controversies in Cardiovascular 
Medicine Chronic stable coronary artery disease: drugs vs. 
revascularization2010. 
11. Yusuf, S., et al., Effect of coronary artery bypass graft surgery on 
survival: overview of 10-year results from randomised trials by 
the Coronary Artery Bypass Graft Surgery Trialists Collaboration. 
182 
 
The Lancet, 1994. 344(8922): p. 563-570. 
12. Schömig, A., et al., A Meta-Analysis of 17 Randomized Trials of a 
Percutaneous Coronary Intervention-Based Strategy in Patients 
With Stable Coronary Artery Disease. Journal of the American 
College of Cardiology, 2008. 52(11): p. 894-904. 
13. Trikalinos, T.A., et al., Percutaneous coronary interventions for 
non-acute coronary artery disease: a quantitative 20-year 
synopsis and a network meta-analysis. The Lancet, 2009. 
373(9667): p. 911-918. 
14. Boden, W.E., et al., Impact of Optimal Medical Therapy With or 
Without Percutaneous Coronary Intervention on Long-Term 
Cardiovascular End Points in Patients With Stable Coronary 
Artery Disease (from the COURAGE Trial). The American Journal 
of Cardiology, 2009. 104(1): p. 1-4. 
15. Boden, W., et al., Title LM, Gau G, Blaustein AS, Booth DC, Bates 
ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optimal 
medical therapy with or without pci for stable coronary disease. 
N Engl J Med, 2007. 356(15): p. 1503-1516. 
16. Jeremias, A., et al., The Impact of Revascularization on Mortality 
in Patients with Nonacute Coronary Artery Disease. The 
American Journal of Medicine, 2009. 122(2): p. 152-161. 
17. Hueb, W., et al., Five-Year Follow-Up of the Medicine, 
Angioplasty, or Surgery Study (MASS II): A Randomized 
Controlled Clinical Trial of 3 Therapeutic Strategies for 
Multivessel Coronary Artery Disease. Circulation, 2007. 115(9): 
p. 1082-1089. 
18. Kappetein, A.P., et al., Comparison of coronary bypass surgery 
with drug-eluting stenting for the treatment of left main and/or 
three-vessel disease: 3-year follow-up of the SYNTAX trial. 
European Heart Journal, 2011. 32(17): p. 2125-2134. 
19. Mohr, F.W., et al., Coronary artery bypass graft surgery versus 
percutaneous coronary intervention in patients with three-vessel 
disease and left main coronary disease: 5-year follow-up of the 
randomised, clinical SYNTAX trial. The Lancet, 2013. 
381(9867): p. 629-638. 
20. Hachamovitch, R., et al., Comparison of the Short-Term Survival 
183 
 
Benefit Associated With Revascularization Compared With 
Medical Therapy in Patients With No Prior Coronary Artery 
Disease Undergoing Stress Myocardial Perfusion Single Photon 
Emission Computed Tomography. Circulation, 2003. 107(23): p. 
2900-2907. 
21. Stone, G.W., et al., A Prospective Natural-History Study of 
Coronary Atherosclerosis. New England Journal of Medicine, 
2011. 364(3): p. 226-235. 
22. Patel, M.R., et al., ACCF/SCAI/STS/AATS/AHA/ASNC 2009 
Appropriateness Criteria for Coronary Revascularization. A 
Report by the American College of Cardiology Foundation 
Appropriateness Criteria Task Force, Society for Cardiovascular 
Angiography and Interventions, Society of Thoracic Surgeons, 
American Association for Thoracic Surgery, American Heart 
Association, and the American Society of Nuclear Cardiology 
Endorsed by the American Society of Echocardiography, the 
Heart Failure Society of America, and the Society of 
Cardiovascular Computed Tomography. Journal of the American 
College of Cardiology, 2009. 53(6): p. 530-553. 
23. Patel, M.R., et al., ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 
2012 Appropriate Use Criteria for Coronary Revascularization 
Focused UpdateA Report of the American College of Cardiology 
Foundation Appropriate Use Criteria Task Force, Society for 
Cardiovascular Angiography and Interventions, Society of 
Thoracic Surgeons, American Association for Thoracic Surgery, 
American Heart Association, American Society of Nuclear 
Cardiology, and the Society of Cardiovascular Computed 
Tomography. Journal of the American College of Cardiology, 
2012. 59(9): p. 857-881. 
24. Ku, D.N., et al., Pulsatile flow and atherosclerosis in the human 
carotid bifurcation. Positive correlation between plaque location 
and low oscillating shear stress. Arteriosclerosis, Thrombosis, 
and Vascular Biology, 1985. 5(3): p. 293-302. 
25. Asakura, T. and T. Karino, Flow patterns and spatial distribution 
of atherosclerotic lesions in human coronary arteries. Circulation 
Research, 1990. 66(4): p. 1045-1066. 
26. Friedman, M.H., et al., Relationship between the geometry and 
quantitative morphology of the left anterior descending coronary 
184 
 
artery. Atherosclerosis, 1996. 125(2): p. 183-192. 
27. Krams, R., et al., Evaluation of Endothelial Shear Stress and 3D 
Geometry as Factors Determining the Development of 
Atherosclerosis and Remodeling in Human Coronary Arteries in 
Vivo: Combining 3D Reconstruction from Angiography and IVUS 
(ANGUS) with Computational Fluid Dynamics. Arteriosclerosis, 
Thrombosis, and Vascular Biology, 1997. 17(10): p. 2061-2065. 
28. Stary, H., et al., A definition of the intima of human arteries and 
of its atherosclerosis-prone regions. A report from the Committee 
on Vascular Lesions of the Council on Arteriosclerosis, American 
Heart Association. Circulation, 1992. 85(1): p. 391. 
29. Zhu, H., et al., Cataloguing the geometry of the human coronary 
arteries: a potential tool for predicting risk of coronary artery 
disease. International Journal of Cardiology, 2009. 135(1): p. 
43-52. 
30. Katritsis, D.G., et al., Ruptured versus stable plaques in human 
coronary arteries. Coronary Artery Disease, 2011. 22(5): p. 345-
351 10.1097/MCA.0b013e3283471f95. 
31. Virmani, R., et al., Lessons From Sudden Coronary Death: A 
Comprehensive Morphological Classification Scheme for 
Atherosclerotic Lesions. Arteriosclerosis, Thrombosis, and 
Vascular Biology, 2000. 20(5): p. 1262-1275. 
32. Caro, C.G., J.M. Fitz-Gerald, and R.C. Schroter, Atheroma and 
Arterial Wall Shear Observation, Correlation and Proposal of a 
Shear Dependent Mass Transfer Mechanism for Atherogenesis. 
Proceedings of the Royal Society of London. Series B. Biological 
Sciences, 1971. 177(1046): p. 109-133. 
33. Tzima, E., et al., Activation of integrins in endothelial cells by 
fluid shear stress mediates Rho-dependent cytoskeletal 
alignment. The EMBO Journal, 2001. 20(17): p. 4639-4647. 
34. Malek, A.M., S.L. Alper, and S. Izumo, Hemodynamic shear stress 
and its role in atherosclerosis. JAMA: the journal of the American 
Medical Association, 1999. 282(21): p. 2035-2042. 
35. Davies, P.F. and S.C. Tripathi, Mechanical stress mechanisms and 
the cell. An endothelial paradigm. Circulation Research, 1993. 
72(2): p. 239-45. 
185 
 
36. Yin, W., S.K. Shanmugavelayudam, and D.A. Rubenstein, The 
effect of physiologically relevant dynamic shear stress on platelet 
and endothelial cell activation. Thrombosis Research, 2011. 
127(3): p. 235-241. 
37. Hoffmann, U., et al., Noninvasive Assessment of Plaque 
Morphology and Composition in Culprit and Stable Lesions in 
Acute Coronary Syndrome and Stable Lesions in Stable Angina by 
Multidetector Computed Tomography. Journal of the American 
College of Cardiology, 2006. 47(8): p. 1655-1662. 
38. Motoyama, S., et al., Computed Tomographic Angiography 
Characteristics of Atherosclerotic Plaques Subsequently Resulting 
in Acute Coronary Syndrome. Journal of the American College of 
Cardiology, 2009. 54(1): p. 49-57. 
39. Schroeder, S., et al., Noninvasive detection and evaluation of 
atherosclerotic coronary plaques with multislice computed 
tomography1. Journal of the American College of Cardiology, 
2001. 37(5): p. 1430-1435. 
40. Pundziute, G., et al., Evaluation of plaque characteristics in acute 
coronary syndromes: non-invasive assessment with multi-slice 
computed tomography and invasive evaluation with 
intravascular ultrasound radiofrequency data analysis. 
European Heart Journal, 2008. 29(19): p. 2373-2381. 
41. Motoyama, S., et al., Multislice Computed Tomographic 
Characteristics of Coronary Lesions in Acute Coronary 
Syndromes. Journal of the American College of Cardiology, 2007. 
50(4): p. 319-326. 
42. Arbab-Zadeh, A., et al., Acute coronary events. Circulation, 2012. 
125(9): p. 1147-56. 
43. Slager, C.J., et al., The role of shear stress in the generation of 
rupture-prone vulnerable plaques. Nat Clin Pract Cardiovasc 
Med, 2005. 2(8): p. 401-407. 
44. Samady, H., et al., Coronary Artery Wall Shear Stress Is 
Associated With Progression and Transformation of 
Atherosclerotic Plaque and Arterial Remodeling in Patients With 
Coronary Artery Disease. Circulation, 2011. 124(7): p. 779-788. 
45. Gibson, C.M., et al., Relation of vessel wall shear stress to 
186 
 
atherosclerosis progression in human coronary arteries. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 1993. 
13(2): p. 310-5. 
46. Jackson, S.P., W.S. Nesbitt, and E. Westein, Dynamics of platelet 
thrombus formation. Journal of thrombosis and haemostasis : 
JTH, 2009. 7 Suppl 1: p. 17-20. 
47. Hathcock, J.J., Flow Effects on Coagulation and Thrombosis. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 2006. 
26(8): p. 1729-1737. 
48. Siediecki, C., et al., Shear-dependent changes in the three-
dimensional structure of human von Willebrand factor. Blood, 
1996. 88(8): p. 2939-2950. 
49. Nesbitt, W.S., et al., A shear gradient-dependent platelet 
aggregation mechanism drives thrombus formation. Natural 
Medicines, 2009. 15(6): p. 665-673. 
50. Sheriff, J., et al., High-Shear Stress Sensitizes Platelets to 
Subsequent Low-Shear Conditions. Annals of Biomedical 
Engineering, 2010. 38(4): p. 1442-1450. 
51. Peterson, D., et al., Shear-induced platelet aggregation requires 
von Willebrand factor and platelet membrane glycoproteins Ib 
and IIb-IIIa. Blood, 1987. 69(2): p. 625-628. 
52. Moake, J., et al., Shear-induced platelet aggregation can be 
mediated by vWF released from platelets, as well as by exogenous 
large or unusually large vWF multimers, requires adenosine 
diphosphate, and is resistant to aspirin. Blood, 1988. 71(5): p. 
1366-1374. 
53. Chow, T., et al., Shear stress-induced von Willebrand factor 
binding to platelet glycoprotein Ib initiates calcium influx 
associated with aggregation. Blood, 1992. 80(1): p. 113-120. 
54. Ruggeri, Z.M., et al., Activation-independent platelet adhesion 
and aggregation under elevated shear stress. Blood, 2006. 
108(6): p. 1903-1910. 
55. Taylor, C.A., T.A. Fonte, and J.K. Min, Computational Fluid 
Dynamics Applied to Cardiac Computed Tomography for 
Noninvasive Quantification of Fractional Flow ReserveScientific 
187 
 
Basis. Journal of the American College of Cardiology, 2013. 
61(22): p. 2233-2241. 
56. Morris, P.D., et al., Virtual Fractional Flow Reserve From 
Coronary Angiography: Modeling the Significance of Coronary 
LesionsResults From the VIRTU-1 (VIRTUal Fractional Flow 
Reserve From Coronary Angiography) Study. JACC: 
Cardiovascular Interventions, 2013. 6(2): p. 149-157. 
57. Pijls, N.H.J., et al., Fractional Flow Reserve: A Useful Index to 
Evaluate the Influence of an Epicardial Coronary Stenosis on 
Myocardial Blood Flow. Circulation, 1995. 92(11): p. 3183-
3193. 
58. Baskurt, O.K. and H.J. Meiselman. Blood rheology and 
hemodynamics. in Seminars in Thrombosis and Hemostasis. 
2003. New York: Stratton Intercontinental Medical Book 
Corporation, c1974-. 
59. Yilmaz, F. and M.Y. Gundogdu, A critical review on blood flow in 
large arteries; relevance to blood rheology, viscosity models, and 
physiologic conditions. Korea-Australia Rheology Journal, 2008. 
20(4): p. 197-211. 
60. Pries, A.R., T.W. Secomb, and P. Gaehtgens, Biophysical aspects 
of blood flow in the microvasculature. Cardiovascular Research, 
1996. 32(4): p. 654-667. 
61. Wells Jr, R.E. and E.W. Merrill, Influence of flow properties of 
blood upon viscosity-hematocrit relationships. Journal of Clinical 
Investigation, 1962. 41(8): p. 1591. 
62. SCHMID-SCHöNBEIN, H., R. Wells, and J. GOLDSTONE, Influence 
of deformability of human red cells upon blood viscosity. 
Circulation Research, 1969. 25(2): p. 131-143. 
63. Berezina, T.L., et al., Influence of Storage on Red Blood Cell 
Rheological Properties. Journal of Surgical Research, 2002. 
102(1): p. 6-12. 
64. Pries, A.R., D. Neuhaus, and P. Gaehtgens, Blood viscosity in tube 
flow: dependence on diameter and hematocrit. American Journal 
of Physiology - Heart and Circulatory Physiology, 1992. 263(6): 
p. H1770-H1778. 
188 
 
65. Picart, C., et al., Human blood shear yield stress and its 
hematocrit dependence. Journal of Rheology, 1998. 42(1): p. 1-
12. 
66. Eckstein, E.C. and F. Belgacem, Model of platelet transport in 
flowing blood with drift and diffusion terms. Biophysical Journal, 
1991. 60(1): p. 53-69. 
67. Aarts, P.A., et al., Blood platelets are concentrated near the wall 
and red blood cells, in the center in flowing blood. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 1988. 8(6): 
p. 819-24. 
68. Heinrich Joist, J., J.E. Bauman, and S.P. Sutera, Platelet adhesion 
and aggregation in pulsatile shear flow: Effects of red blood cells. 
Thrombosis Research, 1998. 92(6, Supplement 2): p. S47-S52. 
69. Aarts, P., R. Heethaar, and J. Sixma, Red blood cell deformability 
influences platelets--vessel wall interaction in flowing blood. 
Blood, 1984. 64(6): p. 1228-1233. 
70. Goldsmith, H., et al., Effect of red blood cells and their aggregates 
on platelets and white cells in flowing blood. Biorheology, 1999. 
36(5-6): p. 461-468. 
71. Turitto, V.T., A.M. Benis, and E.F. Leonard, Platelet Diffusion in 
Flowing Blood. Industrial & Engineering Chemistry 
Fundamentals, 1972. 11(2): p. 216-223. 
72. Xu, C. and D.M. Wootton, Platelet near-wall excess in porcine 
whole blood in artery-sized tubes under steady and pulsatile flow 
conditions. Biorheology, 2004. 41(2): p. 113-125. 
73. Tilles, A.W. and E.C. Eckstein, The near-wall excess of platelet-
sized particles in blood flow: its dependence on hematocrit and 
wall shear rate. Microvascular research, 1987. 33(2): p. 211-
223. 
74. Yeh, C. and E.C. Eckstein, Transient lateral transport of platelet-
sized particles in flowing blood suspensions. Biophysical Journal, 
1994. 66(5): p. 1706-1716. 
75. Lowe, G.D., et al., Relation between extent of coronary artery 
disease and blood viscosity. BMJ, 1980. 280(6215): p. 673-674. 
76. Yilmaz, F. and M.Y. Gundogdu, Analysis of conventional drag and 
189 
 
lift models for multiphase CFD modeling of blood flow. Korea-
Australia Rheology Journal, 2009. 21(3): p. 161-173. 
77. Jonghwun Jung, A.H., Three-phase CFD anaytical modeling of 
blood flow. 2006. 
78. Jung, J. and A. Hassanein, Three-phase CFD analytical modeling 
of blood flow. Medical Engineering & Physics, 2008. 30(1): p. 
91-103. 
79. Huang, J., R.W. Lyczkowski, and D. Gidaspow, Pulsatile flow in a 
coronary artery using multiphase kinetic theory. Journal of 
Biomechanics, 2009. 42(6): p. 743-754. 
80. Johnston, B.M., et al., Non-Newtonian blood flow in human right 
coronary arteries: steady state simulations. Journal of 
Biomechanics, 2004. 37(5): p. 709-720. 
81. Shibeshi, S.S. and W.E. Collins, The rheology of blood flow in a 
branched arterial system. Applied rheology (Lappersdorf, 
Germany: Online), 2005. 15(6): p. 398. 
82. Razavi, A., E. Shirani, and M.R. Sadeghi, Numerical simulation of 
blood pulsatile flow in a stenosed carotid artery using different 
rheological models. Journal of Biomechanics, 2011. 44(11): p. 
2021-2030. 
83. Johnston, B.M., et al., Non-Newtonian blood flow in human right 
coronary arteries: transient simulations. Journal of 
Biomechanics, 2006. 39(6): p. 1116-1128. 
84. Jonghwun Jung, R.W.L., Chandrakant B. Panchal, Ahmed 
Hassanein, Multiphase hemodynamic simulation of pulsatile flow 
in a coronary artery. 2005. 
85. Wellnhofer, E., et al., Flow simulation studies in coronary 
arteries—Impact of side-branches. Atherosclerosis, 2010. 
213(2): p. 475-481. 
86. Wellnhofer, E., et al., Non-dimensional modeling in flow 
simulation studies of coronary arteries including side-branches: A 
novel diagnostic tool in coronary artery disease. Atherosclerosis, 
2011. 216(2): p. 277-282. 
87. A. Theodorakakos, M.G., A. Andriotis, A. Zifan, P. Liatsis, and 
E.P.E. I. Pantos, D, Katritsis, Simulation of cardiac motion on 
190 
 
non-Newtonian, pulsating flow development in the  human left 
anterior descending coronary artery. 2008. 
88. Katritsis, D., et al., Vortex formation and recirculation zones in 
left anterior descending artery stenoses: computational fluid 
dynamics analysis. Physics in Medicine and Biology, 2010. 
55(5): p. 1395. 
89. Banerjee, R.K., et al., Physiological Flow Simulation in Residual 
Human Stenoses After Coronary Angioplasty. Journal of 
biomechanical engineering, 2000. 122(4): p. 310-320. 
90. Boutsianis, E., et al., Computational simulation of intracoronary 
flow based on real coronary geometry. European journal of 
Cardio-thoracic Surgery, 2004. 26(2): p. 248-256. 
91. Chen, M.C., et al., Computational hemodynamics of an implanted 
coronary stent based on three-dimensional cine angiography 
reconstruction. ASAIO journal, 2005. 51(4): p. 313-320. 
92. Frauenfelder, T., et al., In-vivo flow simulation in coronary 
arteries based on computed tomography datasets: feasibility and 
initial results. European radiology, 2007. 17(5): p. 1291-1300. 
93. Prosi, M., et al., Influence of curvature dynamics on pulsatile 
coronary artery flow in a realistic bifurcation model. Journal of 
Biomechanics, 2004. 37(11): p. 1767-1775. 
94. Arslan, N., et al. CFD modeling of blood flow inside human left 
coronary artery bifurcation with aneurysms. in IFMBE Proc. 
2005. 
95. Johnston, B.M.J.a.P.R., Simulations of pulsatile blood flow in 
tapered S-shaped in-plane and out-of-plane coronary arteries. 
18th World IMACS / MODSIM Congress, Cairns, Australia, 2009. 
96. Kim, H., et al., Patient-specific modeling of blood flow and 
pressure in human coronary arteries. Annals of Biomedical 
Engineering, 2010. 38(10): p. 3195-3209. 
97. Katritsis, D.G., et al., Flow Patterns at Stented Coronary 
Bifurcations: Computational Fluid Dynamics Analysis. 
Circulation: Cardiovascular Interventions, 2012. 5(4): p. 530-
539. 
98. Anand, M., K. Rajagopal, and K.R. Rajagopal, A Model 
191 
 
Incorporating some of the Mechanical and Biochemical Factors 
Underlying Clot Formation and Dissolution in Flowing Blood. 
Journal of Theoretical Medicine, 2003. 5(3-4): p. 183-218. 
99. Bodnár, T. and A. Sequeira, Numerical simulation of the 
coagulation dynamics of blood. Computational and 
Mathematical Methods in Medicine, 2008. 9(2): p. 83-104. 
100. Ku, D.N., BLOOD FLOW IN ARTERIES. Annual Review of Fluid 
Mechanics, 1997. 29(1): p. 399-434. 
101. Myers, J.G., et al., Factors Influencing Blood Flow Patterns in the 
Human Right Coronary Artery. Annals of Biomedical 
Engineering, 2001. 29(2): p. 109-120. 
102. LaDisa, J., Jr., et al., Three-Dimensional Computational Fluid 
Dynamics Modeling of Alterations in Coronary Wall Shear Stress 
Produced by Stent Implantation. Annals of Biomedical 
Engineering, 2003. 31(8): p. 972-980. 
103. Mittal, N., et al., Analysis of blood flow in the entire coronary 
arterial tree. American journal of physiology-Heart and 
circulatory physiology, 2005. 289(1): p. H439-H446. 
104. Blondel, C., et al., Reconstruction of coronary arteries from a 
single rotational X-ray projection sequence. Medical Imaging, 
IEEE Transactions on, 2006. 25(5): p. 653-663. 
105. Andriotis, A., et al., A New method of three dimensional coronary 
artery reconstruction from x-ray angiography: Validation 
against a virtual phandom and multislice computed tomography. 
Catheterization and Cardiovascular Interventions, 2008. 72: p. 
28-34. 
106. Perktold, K., et al., Validated computation of physiologic flow in a 
realistic coronary artery branch. Journal of Biomechanics, 1997. 
31(3): p. 217-228. 
107. Olufsen, M.S., Structured tree outflow condition for blood flow in 
larger systemic arteries. American journal of physiology-Heart 
and circulatory physiology, 1999. 276(1): p. H257-H268. 
108. Stergiopulos, N., J.-J. Meister, and N. Westerhof, Simple and 
accurate way for estimating total and segmental arterial 
compliance: the pulse pressure method. Annals of Biomedical 
192 
 
Engineering, 1994. 22(4): p. 392-397. 
109. Stergiopulos, N., P. Segers, and N. Westerhof, Use of pulse 
pressure method for estimating total arterial compliance in vivo. 
American journal of physiology-Heart and circulatory 
physiology, 1999. 276(2): p. H424-H428. 
110. Pullan, A., N. Smith, and P. Hunter, An anatomically based model 
of transient coronary blood flow in the heart. SIAM Journal on 
Applied Mathematics, 2002. 62(3): p. 990-1018. 
111. Vignon, I.E. and C.A. Taylor, Outflow boundary conditions for 
one-dimensional finite element modeling of blood flow and 
pressure waves in arteries. Wave Motion, 2004. 39(4): p. 361-
374. 
112. Vignon-Clementel, I.E., et al., Outflow boundary conditions for 
three-dimensional finite element modeling of blood flow and 
pressure in arteries. Computer Methods in Applied Mechanics 
and Engineering, 2006. 195(29): p. 3776-3796. 
113. Rauch, U., et al., Thrombus formation on atherosclerotic plaques: 
pathogenesis and clinical consequences. Annals of Internal 
Medicine, 2001. 134(3): p. 224-238. 
114. Lee, K.W. and G.Y. Lip, Acute coronary syndromes: Virchow's 
triad revisited. Blood coagulation & fibrinolysis, 2003. 14(7): p. 
605-625. 
115. Lowe, G.D.O., Virchow’s Triad Revisited: Abnormal Flow. 
Pathophysiology of Haemostasis and Thrombosis, 2003. 33(5-
6): p. 455-457. 
116. Blann, A.D., How a Damaged Blood Vessel Wall Contibutes to 
Thrombosis and Hypertenasion. Pathophysiology of 
Haemostasis and Thrombosis, 2003. 33(5-6): p. 445-448. 
117. Chung, I. and G.Y.H. Lip, Virchow’s Triad Revisited: Blood 
Constituents. Pathophysiology of Haemostasis and Thrombosis, 
2003. 33(5-6): p. 449-454. 
118. Watson, T., E. Shantsila, and G.Y.H. Lip, Mechanisms of 
thrombogenesis in atrial fibrillation: Virchow's triad revisited. 
The Lancet, 2009. 373(9658): p. 155-166. 
119. Furie, B. and B.C. Furie, Mechanisms of Thrombus Formation. 
193 
 
New England Journal of Medicine, 2008. 359(9): p. 938-949. 
120. Lawson, J.H., et al., A model for the tissue factor pathway to 
thrombin. I. An empirical study. Journal of Biological Chemistry, 
1994. 269(37): p. 23357-23366. 
121. Zarnitsina, V.I., A.V. Pokhilko, and F.I. Ataullakhanov, A 
Mathematical model for the spatio-temporal dynamics of 
intrinsic pathway of blood coagulation. I. The model description. 
Thrombosis Research, 1996. 84(4): p. 225-236. 
122. Riddel, J.P., et al., Theories of blood coagulation. Journal of 
Pediatric Oncology Nursing, 2007. 24(3): p. 123-131. 
123. Mackman, N., R.E. Tilley, and N.S. Key, Role of the Extrinsic 
Pathway of Blood Coagulation in Hemostasis and Thrombosis. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 2007. 
27(8): p. 1687-1693. 
124. Kleinschnitz, C., et al., Targeting coagulation factor XII provides 
protection from pathological thrombosis in cerebral ischemia 
without interfering with hemostasis. The Journal Of 
Experimental Medicine, 2006. 203(3): p. 513-518. 
125. Hoffman, M. and D.M. Monroe, A cell-based model of hemostasis. 
Thrombosis and Haemostasis, 2001. 85(6): p. 958-965. 
126. Smith, S.A., The cell-based model of coagulation. Journal of 
Veterinary Emergency and Critical Care, 2009. 19(1): p. 3-10. 
127. Mosesson, M.W., Fibrinogen and fibrin structure and functions. 
Journal of Thrombosis and Haemostasis, 2005. 3(8): p. 1894-
1904. 
128. Brass, L.F., Thrombin and Platelet Activation*. CHEST Journal, 
2003. 124(3_suppl): p. 18S-25S. 
129. Fernández-Ortiz, A., et al., Characterization of the relative 
thrombogenicity of atherosclerotic plaque components: 
Implications for consequences of plaque rupture. Journal of the 
American College of Cardiology, 1994. 23(7): p. 1562-1569. 
130. Reininger, A.J., et al., A 2-Step Mechanism of Arterial Thrombus 
Formation Induced by Human Atherosclerotic Plaques. Journal of 
the American College of Cardiology, 2010. 55(11): p. 1147-
1158. 
194 
 
131. Moroi, M., et al., Analysis of platelet adhesion to a collagen-
coated surface under flow conditions: the involvement of 
glycoprotein VI in the platelet adhesion. Blood, 1996. 88(6): p. 
2081-2092. 
132. Monroe, D.M., M. Hoffman, and H.R. Roberts, Platelets and 
Thrombin Generation. Arteriosclerosis, Thrombosis, and 
Vascular Biology, 2002. 22(9): p. 1381-1389. 
133. Rosing, J., et al., The role of activated human platelets in 
prothrombin and factor X activation. Blood, 1985. 65(2): p. 319-
332. 
134. Jesty, J., et al., Platelet activation in a circulating flow loop: 
combined effects of shear stress and exposure time. Platelets, 
2003. 14(3): p. 143-149. 
135. Rendu, F. and B. Brohard-Bohn, The platelet release reaction: 
granules' constituents, secretion and functions. Platelets, 2001. 
12(5): p. 261-273. 
136. Butenas, S., K.G. Mann, and Butenas, Blood Coagulation. 
Biochemistry (Moscow), 2002. 67(1): p. 3-12. 
137. Zwaal, R.F.A., P. Comfurius, and E.M. Bevers, Lipid–protein 
interactions in blood coagulation. Biochimica et Biophysica Acta 
(BBA) - Reviews on Biomembranes, 1998. 1376(3): p. 433-453. 
138. Esmon, C.T., Cell mediated events that control blood coagulation 
and vascular injury. Annual review of cell biology, 1993. 9(1): p. 
1-26. 
139. Dahlbäck, B., Blood coagulation. The Lancet, 2000. 355(9215): 
p. 1627-1632. 
140. Esmon, C.T., The roles of protein C and thrombomodulin in the 
regulation of blood coagulation. Journal of Biological Chemistry, 
1989. 264(9): p. 4743-6. 
141. Sadler, J.E., Biochemistry and genetics of von Willebrand factor. 
Annual Review of Biochemistry, 1998. 67: p. 395-424. 
142. Papadopoulos, K.P., M. Gavaises, and C. Atkin, A simplified 
mathematical model for thrombin generation. Medical 
Engineering & Physics, 2014. 36(2): p. 196-204. 
195 
 
143. Michaelis, L. and M.L. Menten, Kinetics of invertase action. 
Biochem. z, 1913. 49: p. 333-369. 
144. Hockin, M.F., et al., A Model for the Stoichiometric Regulation of 
Blood Coagulation. Journal of Biological Chemistry, 2002. 
277(21): p. 18322-18333. 
145. Zarnitsina, V.I., A.V. Pokhilko, and F.I. Ataullakhanov, A 
Mathematical model for the spatio-temporal dynamics of 
intrinsic pathway of blood coagulation. II. Results. Thrombosis 
Research, 1996. 84(5): p. 333-344. 
146. Xu, Z., et al., Computational Approaches to Studying Thrombus 
Development. Arteriosclerosis, Thrombosis, and Vascular 
Biology, 2011. 31(3): p. 500-505. 
147. Willems, G., et al., Simulation Model for Thrombin Generation in 
Plasma. Pathophysiology of Haemostasis and Thrombosis, 
1991. 21(4): p. 197-207. 
148. Jones, K.C. and K.G. Mann, A model for the tissue factor pathway 
to thrombin. II. A mathematical simulation. Journal of Biological 
Chemistry, 1994. 269(37): p. 23367-23373. 
149. Lo, K., W.S. Denney, and S.L. Diamond, Stochastic Modeling of 
Blood Coagulation Initiation. Pathophysiology of Haemostasis 
and Thrombosis, 2005. 34(2-3): p. 80-90. 
150. Bungay, S.D., P.A. Gentry, and R.D. Gentry, A mathematical 
model of lipid‐mediated thrombin generation. Mathematical 
Medicine and Biology, 2003. 20(1): p. 105-129. 
151. Beltrami, E. and J. Jesty, Mathematical analysis of activation 
thresholds in enzyme-catalyzed positive feedbacks: application to 
the feedbacks of blood coagulation. Proceedings of the National 
Academy of Sciences, 1995. 92(19): p. 8744-8748. 
152. Xu, C., et al., Simulation of a mathematical model of the role of 
the TFPI in the extrinsic pathway of coagulation. Computers in 
Biology and Medicine, 2005. 35(5): p. 435-445. 
153. Qiao, Y.H., et al., The kinetic model and simulation of blood 
coagulation--the kinetic influence of activated protein C. Medical 
Engineering & Physics, 2004. 26(4): p. 341-347. 
154. Wagenvoord, R., P.W. Hemker, and H.C. Hemker, The limits of 
196 
 
simulation of the clotting system. Journal of Thrombosis and 
Haemostasis, 2006. 4(6): p. 1331-1338. 
155. Huang, P.Y. and J.D. Hellums, Aggregation and disaggregation 
kinetics of human blood platelets: Part I. Development and 
validation of a population balance method. Biophysical Journal, 
1993. 65(1): p. 334-343. 
156. Huang, P.Y. and J.D. Hellums, Aggregation and disaggregation 
kinetics of human blood platelets: Part II. Shear-induced platelet 
aggregation. Biophysical Journal, 1993. 65(1): p. 344-353. 
157. Huang, P.Y. and J.D. Hellums, Aggregation and disaggregation 
kinetics of human blood platelets: Part III. The disaggregation 
under shear stress of platelet aggregates. Biophysical Journal, 
1993. 65(1): p. 354-361. 
158. Tandon, P. and S.L. Diamond, Hydrodynamic effects and receptor 
interactions of platelets and their aggregates in linear shear flow. 
Biophysical Journal, 1997. 73(5): p. 2819-2835. 
159. David, T., S. Thomas, and P.G. Walker, Platelet deposition in 
stagnation point flow: an analytical and computational 
simulation. Medical Engineering & Physics, 2001. 23(5): p. 299-
312. 
160. Wootton, D., et al., A Mechanistic Model of Acute Platelet 
Accumulation in Thrombogenic Stenoses. Annals of Biomedical 
Engineering, 2001. 29(4): p. 321-329. 
161. Brash, J.L., J.M. Brophy, and I.A. Feuerstein, Adhesion of platelets 
to artificial surfaces: Effect of red cells. Journal of Biomedical 
Materials Research, 1976. 10(3): p. 429-443. 
162. Mori, D., et al., Computational study on effect of red blood cells on 
primary thrombus formation. Thrombosis Research, 2008. 
123(1): p. 114-121. 
163. Sorensen, E.N., et al., Computational Simulation of Platelet 
Deposition and Activation: I. Model Development and Properties. 
Annals of Biomedical Engineering, 1999. 27(4): p. 436-448. 
164. Sorensen, E., et al., Computational Simulation of Platelet 
Deposition and Activation: II. Results for Poiseuille Flow over 
Collagen. Annals of Biomedical Engineering, 1999. 27(4): p. 
197 
 
449-458. 
165. David, T., P.G. de Groot, and P.G. Walker, Boundary-layer Type 
Solutions for Initial Platelet Activation and Deposition. Journal of 
Theoretical Medicine, 2002. 4(2): p. 95-108. 
166. Worth Longest, P. and C. Kleinstreuer, Comparison of blood 
particle deposition models for non-parallel flow domains. Journal 
of Biomechanics, 2003. 36(3): p. 421-430. 
167. Ruggeri, Z.M. and G.L. Mendolicchio, Adhesion Mechanisms in 
Platelet Function. Circulation Research, 2007. 100(12): p. 1673-
1685. 
168. Pivkin, I.V., P.D. Richardson, and G. Karniadakis, Blood flow 
velocity effects and role of activation delay time on growth and 
form of platelet thrombi. Proceedings of the National Academy 
of Sciences, 2006. 103(46): p. 17164-17169. 
169. Pivkin, I., P. Richardson, and G.E. Karniadakis, Effect of red blood 
cells on platelet aggregation. Engineering in Medicine and 
Biology Magazine, IEEE, 2009. 28(2): p. 32-37. 
170. Hubbell, J.A. and L.V. McIntire, Platelet active concentration 
profiles near growing thrombi. A mathematical consideration. 
Biophysical Journal, 1986. 50(5): p. 937-945. 
171. Folie, B.J. and L.V. McIntire, Mathematical analysis of mural 
thrombogenesis. Concentration profiles of platelet-activating 
agents and effects of viscous shear flow. Biophysical Journal, 
1989. 56(6): p. 1121-1141. 
172. Lobanov, A.I. and T.K. Starozhilova, The Effect of Convective 
Flows on Blood Coagulation Processes. Pathophysiology of 
Haemostasis and Thrombosis, 2005. 34(2-3): p. 121-134. 
173. Kuharsky, A.L. and A.L. Fogelson, Surface-Mediated Control of 
Blood Coagulation: The Role of Binding Site Densities and 
Platelet Deposition. Biophysical Journal, 2001. 80(3): p. 1050-
1074. 
174. Fogelson, A.L. and R.D. Guy, Platelet–wall interactions in 
continuum models of platelet thrombosis: formulation and 
numerical solution. Mathematical Medicine and Biology, 2004. 
21(4): p. 293-334. 
198 
 
175. Fogelson, A.L. and N. Tania, Coagulation under Flow: The 
Influence of Flow-Mediated Transport on the Initiation and 
Inhibition of Coagulation. Pathophysiology of Haemostasis and 
Thrombosis, 2005. 34(2-3): p. 91-108. 
176. Lai, M.-C. and C.S. Peskin, An Immersed Boundary Method with 
Formal Second-Order Accuracy and Reduced Numerical Viscosity. 
Journal of Computational Physics, 2000. 160(2): p. 705-719. 
177. Peskin, C.S., The immersed boundary method. Acta Numerica, 
2002. 11: p. 479-517. 
178. Fogelson, A.L. and R.D. Guy, Immersed-boundary-type models of 
intravascular platelet aggregation. Computer Methods in 
Applied Mechanics and Engineering, 2008. 197(25–28): p. 
2087-2104. 
179. Yang, X.S., R.W. Lewis, and H.Y. Zhang, Finite Element Analysis of 
Fogelson's Model for Platelet Aggregation. 2004. 
180. Leiderman, K. and A.L. Fogelson, Grow with the flow: a spatial–
temporal model of platelet deposition and blood coagulation 
under flow. Mathematical Medicine and Biology, 2011. 28(1): p. 
47-84. 
181. Xu, Z., et al., A multiscale model of thrombus development. 
Journal of The Royal Society Interface, 2008. 5(24): p. 705-722. 
182. Marée, A.M., V. Grieneisen, and P. Hogeweg, The Cellular Potts 
Model and Biophysical Properties of Cells, Tissues and 
Morphogenesis, in Single-Cell-Based Models in Biology and 
Medicine, A.A. Anderson, M.J. Chaplain, and K. Rejniak, Editors. 
2007, Birkhäuser Basel. p. 107-136. 
183. Xu, Z., et al., A Multiscale Model of Venous Thrombus Formation 
with Surface-Mediated Control of Blood Coagulation Cascade. 
Biophysical Journal, 2010. 98(9): p. 1723-1732. 
184. Xu, Z., et al., Study of blood flow impact on growth of thrombi 
using a multiscale model. Soft Matter, 2009. 5(4): p. 769-779. 
185. Anand, M., K. Rajagopal, and K.R. Rajagopal, A Model for the 
Formation and Lysis of Blood Clots. Pathophysiology of 
Haemostasis and Thrombosis, 2005. 34(2-3): p. 109-120. 
186. Oliver, J.A., et al., Thrombin Activates Factor XI on Activated 
199 
 
Platelets in the Absence of Factor XII. Arteriosclerosis, 
Thrombosis, and Vascular Biology, 1999. 19(1): p. 170-177. 
187. McCormick, S.M., et al., DNA microarray reveals changes in gene 
expression of shear stressed human umbilical vein endothelial 
cells. Proceedings of the National Academy of Sciences, 2001. 
98(16): p. 8955-8960. 
188. Sakariassen, K., et al., A perfusion chamber developed to 
investigate platelet interaction in flowing blood with human 
vessel wall cells, their extracellular matrix, and purified 
components. The Journal of laboratory and clinical medicine, 
1983. 102(4): p. 522. 
189. Van Veen, J.J., A. Gatt, and M. Makris, Thrombin generation 
testing in routine clinical practice: are we there yet? British 
Journal of Haematology, 2008. 142(6): p. 889-903. 
190. Baglin, T., The measurement and application of thrombin 
generation. British Journal of Haematology, 2005. 130(5): p. 
653-661. 
191. Gerotziafas, G.T., et al., Towards a standardization of thrombin 
generation assessment: The influence of tissue factor, platelets 
and phospholipids concentration on the normal values of 
Thrombogram-Trombinoscope assay. Thrombosis Journal, 2005. 
3(16). 
192. van't Veer, C. and K.G. Mann, Regulation of Tissue Factor 
Initiated Thrombin Generation by the Stoichiometric Inhibitors 
Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin 
Cofactor-II. Journal of Biological Chemistry, 1997. 272(7): p. 
4367-4377. 
193. Hemker, H.C. and S. Béguin, Thrombin generation in plasma: its 
assessment via the endogenous thrombin potential. Thrombosis 
and Haemostasis, 1995. 74(1): p. 134-138. 
194. Okorie, U.M., et al., Determination of surface tissue factor 
thresholds that trigger coagulation at venous and arterial shear 
rates: amplification of 100 fM circulating tissue factor requires 
flow. Blood, 2008. 111(7): p. 3507-3513. 
195. Liu, L., et al., Thrombin binding to platelets and their activation 
in plasma. British Journal of Haematology, 1994. 88(3): p. 592-
200 
 
600. 
196. Frojmovic, M.M., R.F. Mooney, and T. Wong, Dynamics of platelet 
glycoprotein IIb-IIIa receptor expression and fibrinogen binding. 
I. Quantal activation of platelet subpopulations varies with 
adenosine diphosphate concentration. Biophysical Journal, 1994. 
67(5): p. 2060-2068. 
197. Hemker, H.C., et al., Calibrated automated thrombin generation 
measurement in clotting plasma. Pathophysiology of 
Haemostasis and Thrombosis, 2003. 33(1): p. 4-15. 
198. Allen, G., et al., Impact of procoagulant concentration on rate, 
peak and total thrombin generation in a model system. Journal of 
Thrombosis and Haemostasis, 2004. 2(3): p. 402-413. 
199. Systems Biology Toolbox for MATLAB: A computational platform 
for research in Systems Biology Bioinformatics and Biology 
Insights, 2006. 22(4): p. 514-515. 
200. Ninivaggi, M., et al., Whole-Blood Thrombin Generation 
Monitored with a Calibrated Automated Thrombogram-Based 
Assay. Clinical Chemistry, 2012. 58(8): p. 1252-1259. 
201. Whelihan, M.F. and K.G. Mann, The role of the red cell membrane 
in thrombin generation. Thrombosis Research, 2013. 
202. van Dijk, K., et al., Factor VIII half-life and clinical phenotype of 
severe hemophilia A. Haematologica, 2005. 90(4): p. 494-498. 
203. Brummel-Ziedins, K., Models for thrombin generation and risk of 
disease. Journal of Thrombosis and Haemostasis, 2013. 11: p. 
212-223. 
204. Bonderman, D., et al., Coronary no-reflow is caused by shedding 
of active tissue factor from dissected atherosclerotic plaque. 
Blood, 2002. 99(8): p. 2794-2800. 
205. Arabinda Guha, R.B., William Konigsberg and Yale Nemerson, 
Affinity purification of human tissue factor: Interaction of factor 
VII and tissue factor in detergent micelles. Biochemistry, 1986. 
83: p. 299-302. 
206. Kulkarni, S., et al., A revised model of platelet aggregation. 
Journal of Clinical Investigation, 2000. 105(6): p. 783-791. 
201 
 
207. Ikeda, Y., et al., The role of von Willebrand factor and fibrinogen 
in platelet aggregation under varying shear stress. Journal of 
Clinical Investigation, 1991. 87(4): p. 1234. 
208. Louvard, Y., et al., Classification of coronary artery bifurcation 
lesions and treatments: time for a consensus! Catheter 
Cardiovasc Interv, 2008. 71(2): p. 175-83. 
209. Finet, G., et al., Fractal geometry of arterial coronary 
bifurcations: a quantitative coronary angiography and 
intravascular ultrasound analysis. EuroIntervention, 2008. 3(4): 
p. 490-8. 
210. A Mailhac, J.B., JT Fallon, A Fernandez-Ortiz, B Meyer, JH 
Chesebro, V Fuster and L Badimon, Effect of an eccentric severe 
stenosis on fibrin(ogen) deposition on severely damaged vessel 
wall in arterial thrombosis. Relative contribution of fibrin(ogen) 
and platelets. Circulation, 1994. 90(2): p. 988-996. 
211. MYUNGJIN KANG, H.S.J.a.K.C.K., In-vitro investigation of RBCs’ 
flow characteristics and hemodynamic feature through a 
microchannel with a micro-stenosis. INTERNATIONAL JOURNAL 
OF BIOLOGY AND BIOMEDICAL ENGINEERING, 2008. 2(1). 
212. Nurullah Arslan, V.T., Selman Nas, Ayse Durukan, CFD modeling 
of blood flow inside human left coronary artery bifurcation with 
aneurysms. 2005. 
213. Mounter C. Y. Chen, P.-C.L., James S. Y. Chen, Ned H.C. Hwang, 
Computational hemodynamics of an implanted coronary stent 
based on three dimensional cine angiography reconstruction. 
2005. 
214. Crampin, E.J., et al., Computational physiology and the physiome 
project. Experimental Physiology, 2004. 89(1): p. 1-26. 
215. D. Katritsis, A.T., A. Andriotis, I. Pantos, E. P. Efstathopoulos, G. 
Siontis, N. Karcanias, S. Redwood, M. Gavaises Vortex formation 
and recirculation zones in left anterior descending artery 
stenoses: Computational fluid dynamics analysis. 2010. 
216. Theodorakakos, A., et al., Simulation of cardiac motion on non-
Newtonian, pulsating flow development in the human left 
anterior descending coronary artery. Physics in Medicine and 
Biology, 2008. 53(18): p. 4875. 
202 
 
217. Kamiya, A. and T. Togawa, Adaptive regulation of wall shear 
stress to ﬂow change in the canine carotid artery. Am J Physiol, 
1980. 239(1): p. H14-21. 
218. Min, J.K., et al., DIagnostic accuracy of fractional flow reserve 
from anatomic ct angiography. JAMA, 2012. 308(12): p. 1237-
1245. 
219. BETA-CAE, S.S.A., META PostProcessor version 6.2.0. User’s 
Guide. 2008. 
220. Soulis, J.V., et al. Relative residence time and oscillatory shear 
index of non-Newtonian flow models in aorta. in Biomedical 
Engineering, 2011 10th International Workshop on. 2011. IEEE. 
221. Holme, P.A., et al., Shear-Induced Platelet Activation and Platelet 
Microparticle Formation at Blood Flow Conditions as in Arteries 
With a Severe Stenosis. Arteriosclerosis, Thrombosis, and 
Vascular Biology, 1997. 17(4): p. 646-653. 
222. Doriot, P.-A., et al., In-vivo measurements of wall shear stress in 
human coronary arteries. Coronary Artery Disease, 2000. 11(6): 
p. 495-502. 
223. Shaaban, A.M. and A.J. Duerinckx, Wall shear stress and early 
atherosclerosis: a review. American Journal of Roentgenology, 
2000. 174(6): p. 1657-1665. 
224. Li, Z.Y., et al., The mechanical triggers of plaque rupture: shear 
stress vs pressure gradient. Br J Radiol, 2009. 82 Spec No 1: p. 
S39-45. 
225. Katritsis, D.G., J. Pantos, and E. Efstathopoulos, Hemodynamic 
factors and atheromatic plaque rupture in the coronary arteries: 
from vulnerable plaque to vulnerable coronary segment. 
Coronary Artery Disease, 2007. 18(3): p. 229-37. 
226. Feldman, C.L., et al., Determination of in vivo velocity and 
endothelial shear stress patterns with phasic flow in human 
coronary arteries: a methodology to predict progression of 
coronary atherosclerosis. American Heart Journal, 2002. 143(6): 
p. 931-9. 
227. Wurzinger, L.J., P. Blasberg, and H. Schmid-Schonbein, Towards 
a concept of thrombosis in accelerated flow: rheology, fluid 
203 
 
dynamics, and biochemistry. Biorheology, 1985. 22(5): p. 437-
50. 
228. Bath, P. and R. Butterworth, Platelet size: measurement, 
physiology and vascular disease. Blood coagulation & 
fibrinolysis, 1996. 7(2): p. 157-161. 
229. Wolberg, A.S., Thrombin generation and fibrin clot structure. 
Blood Reviews, 2007. 21(3): p. 131-142. 
230. Hamdan, A., et al., A prospective study for comparison of MR and 
CT imaging for detection of coronary artery stenosis. JACC: 
Cardiovascular Imaging, 2011. 4(1): p. 50-61. 
231. Wellnhofer, E., et al., In-vivo coronary flow profiling based on 
biplane angiograms: influence of geometric simplifications on the 
three-dimensional reconstruction and wall shear stress 
calculation. Biomed Eng Online, 2006. 5(39): p. 39. 
232. Castoldi, E. and J. Rosing, Thrombin generation tests. 
Thrombosis Research, 2011. 127, Supplement 3(0): p. S21-
S25. 
 
 
